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SUMMARY 
 
Calcium and magnesium are of central importance for multiple 
essential physiological functions including muscle contraction and relaxation, 
neuronal excitability, bone formation, and enzymatic activity. Consequently, 
the body calcium and magnesium concentrations are tightly controlled by the 
intestine, kidney, and bone. It is well known that acid-base homeostasis 
affects the renal handling of the divalents calcium and magnesium, thus, 
chronic metabolic acidosis is associated with the development of 
hypercalciuria, hypermagnesuria, hypocalcemia, and hypomagnesemia. 
However, the molecular sensor triggering the renal wasting of calcium and 
magnesium during this disturbance of acid-base balance has remained 
unknown. 
The Ovarian cancer G-protein coupled Receptor 1 OGR1 (GPR68) is 
activated by extracellular protons and stimulates intracellular inositol-tris-
phosphate (IP3) production and intracellular Ca2+ rises. Interestingly, we 
detected OGR1 mRNA expression in the kidney in most nephron segments 
including the thick ascending limb and distal tubule, major sides of regulated 
calcium and magnesium reabsorption. The aim of the present project, 
therefore, was to investigate the physiological role of OGR1 which has 
remained elusive to date. Focusing mainly on the kidney we tested for a 
potential role of this proton sensor receptor in the renal calcium and 
magnesium handling, and evaluated its contribution to altered calcium and 
magnesium excretion during chronic metabolic acidosis. 
In the first part of my PhD project, we investigated the potential role of 
OGR1 in acid-base and electrolyte homeostasis during NH4Cl-induced 
metabolic acidosis using OGR1 deficient mice.  
Ogr1-/- mice demonstrated that OGR1 is dispensable for normal acid-
base status and adaptation to an acute (1 day NH4Cl) or chronic (7 days 
NH4Cl) acid-load. Interestingly, during acidosis, wild-type mice developed 
renal calcium and magnesium losses which were absent from Ogr1-/- mice. 
Bone morphology and in vitro reabsorptive activity of osteoclasts from Ogr1+/+ 
and Ogr1-/- mice were similar. We also found that OGR1 does not regulate 
expression levels of the major renal proteins involved in regulated renal 
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calcium and magnesium reabsorption, calbindin-D28K, TRPV5 and TRPM6. 
Ablation of OGR1, however, prevented the internalization of TRPV5 from the 
luminal membrane during acidosis. Our data suggest that stimulation of OGR1 
is responsible for the internalization of the TRPV5 calcium channel and urinary 
calcium wasting during metabolic acidosis. Therefore, OGR1 may represent a 
novel target for the treatment of renal osteodystrophy.  
Under normal conditions, analysis of different urinary electrolytes in the 
Ogr1-/- mice did not show any differences compared to the wild-type animals, 
however, urinary magnesium excretion was strongly reduced, and a tendency 
to a lower urinary calcium excretion was observed in the Ogr1-/- mice. 
Therefore we aimed in the second part of this project to further investigate the 
contribution of OGR1 to the regulation of renal calcium and magnesium 
handling using different calcium and magnesium diets.   
Ogr1-/- mice showed an altered renal excretion of magnesium after 2 
and 7 days high calcium diet, and 7 days low calcium diet. Similarly, ablation 
of OGR1 altered urinary magnesium excretion when animals were treated with 
high magnesium diet for 7 days.  Interestingly, we demonstrated that loss of 
OGR1 affected TRPM6 magnesium channel mRNA expression in the kidney 
in response to 2 and 7 days low and high calcium diets. However, normal 
intestinal TRPM6 mRNA expression was found in the Ogr1-/- mice during the 
same conditions. These preliminary results suggest that OGR1 may be 
involved in the renal regulation of the magnesium channel TRPM6 and 
therefore may have a role in the renal regulation of Mg2+ balance. Thus, 
whereas the presented data demonstrated that OGR1 affects active 
magnesium reabsorption, future experiments will have to investigate the exact 
mechanism by which OGR1 affects TRPM6 expression in the kidney. 
Finally, using different calcium and magnesium diets, preliminary results 
demonstrated that loss of OGR1 lead to significant changes in the urinary 
Ca2+ excretion, suggesting that OGR1 could also be also involved in renal 
calcium handling.  
In summary, using OGR1 deficient mice, we demonstrate in contrast to 
all expectations that there is no obvious role for OGR1 in osteoclast activation 
in vivo and no role in maintaining or controlling systemic acid-base status and 
renal acid excretion. However, we show that OGR1 is responsible for 
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increasing renal calcium and magnesium excretion during acidosis and that 
stimulation of OGR1 is responsible for the internalization of the TRPV5 
calcium channel and urinary calcium wasting during metabolic acidosis. And 
finely, we demonstrate that OGR1 may be involved in the control of the renal 
handling of magnesium and calcium. 
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DEUTSCHE ZUSAMMENFASSUNG DER DOKTORARBEIT 
 
Kalzium und Magensium sind von zentraler Bedeutung für eine Vielzahl 
von physiologischen Vorgängen, u.a. Muskelkontraktion und –relaxation, 
neuronale Erregbarkeit, Knochenbildung oder Enzymfunktion. Die 
Konzentration von Kalzium und Magnesium werden daher sehr genau 
kontrolliert und reguliert sowohl durch den Dünndarm, die Niere als auch 
Knochen. Die Tatsache, dass der Säure-Basenstatus die Ausscheidung von 
Kalzium und Magneisum beeinflusst, ist seit langem bekannt. Metabolische 
Azidose ist mit der Entwicklung von Hyperkalziurie, Hypermagnesurie, 
Hypokalzämie und Hypomagnesämie verbunden. Der genaue molekulare 
Mechanismus durch den ein gestörter Säure-Basenhaushalt die vermehrte 
Ausscheidung von Kalzium und Magnesium durch die Niere verursacht ist 
bislang allerdings unbekannt.  
Der OGR1 Rezeptor (GPR68, Ovarian cancer G protein coupled 
receptor 1) wird durch extrazelluläre Protonen aktiviert und stimuliert die 
intrazelluläre Produktion von Inositoltriphosphat (IP3) sowie einen Anstieg des 
intrazellulären Kalziums. Wir konnten OGR1 mRNA Expression in der Niere in 
den meisten Nephronabschnitten detektieren inklusive der dicken 
aufsteigenden Henle’schen Schleife und dem distalen Konvolut, wichtigen 
Nephronabschnitte der regulierten Reabsorption von Kalzium und 
Magnesium. Es war daher das Ziel der vorliegenden Arbeit die physiologische 
Rolle von OGR1, die bislang gänzlich unbekannt ist, zu untersuchen. Wir 
haben uns dabei vorallem auf die Niere konzentriert und eine mögliche Rolle 
von OGR1 in der Ausscheidung von Kalzium und Magnesium und deren 
Veränderungen während metabolischer Azidose untersucht.  
 
Im ersten Teil der Arbeit untersuchten wir die mögliche Rolle von 
OGR1 in der Säure-Basen- und Elektrolythomöostase unter basalen 
Bedingungen und während einer mit NH4Cl induzierten metabolischen 
Azidose in OGR1 defizienten Mäusen. Ogr1-/- Mäuse zeigten, dass OGR1 für 
einen normalen Säure-Basenstatus und für die Adaptation an eine akute (1 
Tag NH4Cl) oder chronische (7 Tage NH4Cl) Säurebeladung nicht benötigt 
wird. Allerdings entwickelten die Wildtypmäuse einen vermehrten renalen 
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Kalzium- und Magnesiumverlust, der in Ogr1-/- Mäusen nicht eintrat. 
Knochendichte und in vitro Reabsorptionskapazität von Osteoklasten war bei 
Ogr1+/+ und Ogr1-/- Mäusen ähnlich. Ausserdem konnten wir auch zeigen, 
dass OGR1 nicht die Expression der wichtigsten renalen Proteine (Calbindin-
D28K, TRPV5 und TRPM6), die an der Kalzium- und Magnesiumresorption 
beteiligt sind, verändert. Die genetische Ausschaltung von OGR1 verhinderte 
aber die Internalisierung des TRPV5 Kalziumkanals während metabolischer 
Azidose in den Knock-out Mäusen. Unsere Daten deuten daher darauf hin, 
dass die Stimulation von OGR1 (mit)verantwortlich ist für die Internalisierung 
von TRPV5 und damit für den renalen Kalziumverlust. OGR1 könnte daher ein 
neues Ziel für die Behandlung der renalen Osteodystrophie darstellen. 
 
Unter normalen Bedingungen zeigte die Urinanalyse in den Ogr1-/- 
Mäusen keine Veränderungen im Vergleich zu Wildtypmäusen ausser dass 
die renale Ausscheidung von Magnesium stark reduziert war und Kalzium 
eine Tendenz zu niedrigerer Ausscheidung zeigte. Wir versuchten daher im 
zweiten Teil der Arbeit den Beitrag von OGR1 zur Regulation der renalen 
Kalzium- und Magnesiumausscheidung mit Hilfe verschiedener Kalzium- und 
Magnesiumdiäten weiter zu untersuchen. Ogr1-/- Mäuse zeigten eine 
veränderte Magnesiumausscheidung nach 2 und 7 Tagen Hochkalziumdiät 
und 7 Tagen Niedrigkalziumdiät. Aehnlich verursachte die genetische 
Ausschaltung von OGR1 auch eine veränderte Magnesiumausscheidung bei 
einer Hochmagnesiumdiät für 7 Tage. Wir konnten zeigen, dass die 
Abwesenheit von OGR1 die Expression des Magnesiumkanals TRPM6 in der 
Niere verändert, interessanterweise auch nach 2 und 7 Tagen Kalziumdiäten. 
Im Darm blieb die Expression von TRPM6 normal. Diese vorläufigen 
Ergebnisse deuten an, dass OGR1 den TRPM6 Kanal reguliert und damit eine 
wichtige Rolle in der Kontrolle der renalen Magnesiumausscheidung haben 
könnte. Weitere Experimente sind notwendig um den genauen Mechanismus 
über den OGR1 TRPM6 reguliert aufzudecken. Darüberhinaus zeigten die 
verschiedenen Kalzium- und Magnesiumdiäten auch eine veränderte 
Kalziumausscheidung, ein möglicher Hinweis darauf, dass OGR1 eventuell 
auch die Ausscheidung von Kalzium beeinflusst. 
 
 6
Zusammenfassend lässt sich sagen, dass wir zeigen können, dass 
OGR1 im Gegensatz zu allen Erwartungen keine Rolle spielt in der 
Aktivierung von Osteoklasten in vivo und in vitro und auch keine wichtige 
Funktion hat in der Regulation der renalen Säure-Basenausscheidung und 
des systemischen Säure-Basenhaushaltes. Wir zeigen aber, dass OGR1 
verantwortlich ist für die vermehrte renale Kalzium- und 
Magnesiumausscheidung während Azidose und dass die Stimulation von 
OGR1 zur Internalisierung von TRPV5 führt. Ausserdem zeigen wir, dass 
OGR1 eventuell an der Kontrolle der renalen Kalzium- und 
Magnesiumausscheidung beteiligt ist.  
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1. INTRODUCTION 
 
Acid-base status affects the renal handling of calcium and magnesium 
(35; 50; 54; 55; 103). Clinical disorders such as distal renal tubular acidosis 
and renal failure result in chronic metabolic acidosis often associated with 
increased renal calcium and magnesium loss. In addition, hypercalciuria in 
these states may contribute to loss of calcium from bone resulting in the 
development of metabolic bone disease, such as osteopenia and 
osteoporosis, and often causes renal calcification and deterioration of kidney 
function (56). Nijenhuis et al. reported that chronic metabolic acidosis is 
associated with decreased renal expression of the epithelial calcium and 
magnesium channels TRPV5 and TRPM6 leading to the development of 
hypercalciuria and hypomagnesemia (54). However, the molecular pH sensor 
that triggers these renal calcium and magnesium loss has not been identified 
to date. 
Recently, OGR1 (ovarian cancer G-protein-coupled receptor 1, 
GPR68) has been described as a proton sensing receptor (5), OGR1 mRNA 
expression is wide-spread in most organs including major organs involved in 
maintaining calcium and magnesium homeostasis such as bone and kidney. 
Therefore, OGR1 represent an interesting candidate to be a part of the 
mechanism that translates the acid-base status to regulation of gene 
expression or transporter function in response to changes in systemic acid-
base balance. 
 
2. NOVEL G PROTEIN-COUPLED RECEPTORS  
 
G-protein-coupled receptors (GPCR) form the largest gene family in the 
human genome; these receptors have a common structural feature of a 
seven-helical transmembrane region. Actually, around 865 GPCR genes have 
been identified (1), about 367 of these genes have been described to be 
receptors for endogenous ligands (2), however, many GPCRs are still 
considered as orphan receptors.    
Recently, the proton sensing mechanism has been described as a new 
action mode of GPCRs activation, thus a new subfamily of GPCRs has been 
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identified to be activated by increasing extracellular H+-concentrations. OGR1 
(Ovarian Cancer G protein-coupled   receptor 1, GPR68), GPR4 and TDAG8 
(T cell death-associated gene 8) belong to this new subfamily (4; 5; 7; 8). 
OGR1 was initially cloned from an ovarian cancer cell line (8), but its 
expression is not restricted to cancer cells; OGR1 mRNA is expressed in 
several tissues, including the kidney, spleen, testis, intestine, brain, heart, and 
lung (Fig 6; 8). Moreover, immunohistochemistry revealed that the OGR1 
protein is expressed in active osteoblasts in rat bone sections (5).  
GPR4 receptor is widely expressed in many tissues including the kidney, 
spleen, testis, intestine, brain, heart, liver, lung, pancreas and fat tissue (Fig 8; 
9). Moreover, Northern blot analysis showed that the TDAG8 mRNA is mainly 
expressed in lymphoid tissues including, the spleen, thymus, lymph nodes and 
peripheral blood leukocytes (12; 13; 14). 
 
3. PROTON SENSING RECEPTORS AND LYSOLIPIDS 
 
OGR1, GPR4 and TDAG8 were initially described as receptors for 
sphingosylphosphorylcholine (SPC), lysophosphatidylcholine (LPC), and 
psychosine (18; 17; 9; 56). In 2000, Xu et al reported OGR1 to be a high 
affinity receptor for SPC, thus SPC was shown to elicit intracellular calcium 
transients and ERK activation in OGR1 transfected cells (18) this paper is 
today retracted. Similarly, GPR4 has been described as receptor for SPC and 
LPC (9), however, this publication is also today retracted. 
The original publications describing GPR4, OGR1, as receptors for LPC or 
SPC have now been mostly retracted, and the first studies exploring receptors 
of this family as pH sensors in physiology have appeared. Therefore to date 
these receptors are considered as proton-sensing receptors. 
 
4. GPCRS  AS PROTON-SENSING RECEPTORS  
 
Ludwig et al. (5) showed that at pH 7.8, OGR1 was inactive, but 
activated fully inositol-tris-phosphate (IP3) accumulation at pH 6.8. Moreover, 
site directed mutagenesis showed that histidine residues at the extracellular 
surface of OGR1 are involved in pH sensing (5).  
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Similarly, GPR4, and TDAG8 showed a number of highly conserved histidine 
residues that appear to be part of the ligand-binding pocket involved in pH 
sensing (5, 7). The proton sensibility of the three receptors OGR1, GPR4 and 
TDAG8 was also confirmed by Radu et al (15).  
Similarly, G2A a member of GPCRS mainly expressed in hematopoetic 
tissues and cells including the spleen, thymus, T-lymphocytes, B-lymphocytes, 
monocytes, and macrophages (10; 11) has been described by Murakami and 
co-workers (6) as another proton sensing receptor; they demonstrated that 
transient expression of this receptor caused inositol-tris-phosphate (IP3) 
formation at pH 7.6.  
However, the pH dependent stimulation of G2A could not be confirmed (15-
15-1); Radu and co-workers proposed that lack of many histidine residues at 
the extracellular surface, defined to be involved in the pH sensing mechanism 
of OGR1, could be the cause for insensitiveness of G2A to acidic pH.   
 
4.1 Proton sensing mechanism of OGR1 
 
Recently, Ludwig et al. (5) used an OGR1 3D model, based on the high 
similarity to rhodopsin. They predicted that extracellular histidine residue at 
position 17 (N-terminal), 20 (N-terminal), 84 (first outer loop), 169 (second 
outer loop) and 269 (helix VII proximity to the third outer loop) might be 
involved in the proton-sensing mechanism (Fig. 1). Thus, the substitution of 
histidines with phenylalanine in these positions of the OGR1 receptor resulted 
in the failure to stimulate inositol-tris-phosphate (IP3) response at pH 6.8; 
however, the activity was recovered at a more acidic pH (5). The mutation of 
several histidine residues shifted the concentration-response curve for 
extracellular protons to the right. Based on these studies, Ludwig et al. 
suggested that under alkaline conditions, the inactive state of the receptor is 
stabilized by the hydrogen bonding between the histidine residues. However, 
under acidic conditions, the hydrogen bonds are destabilized leading to the 
activation of the receptor (5). 
In OGR1 expressing cells, CuCl2 inhibited the proton induced response, 
probably by stabilizing the unprotonated state of histidine residues (5), In 
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addition, the mutation of the histidine at position 245 in OGR1 located in 
transmembrane helix VI facing the lipid environment, resulted in a marked 
reduction in the proton sensing response, suggesting that this position may be 
important for overall structural integrity (5). 
  
a                                                         b 
 
                            
 
Fig. 1 (a) Backbone of the OGR1 model with all histidine residues highlighted. (b) Close 
up view of the predicted interactions between H17 and H84, and between H20 and 
H269. Taken from: Ludwig et al. 2003 (5). 
 
 
 
 
 
 
 
 
 
 
 
 
 11
OGR1 SIGNALING PATHWAYS 
 
The activation of the proton sensor receptor OGR1 occurs in the 
physiological range of extracellular pH (5), and its EC50 is around pH 7.4. 
Experiments in OGR1 transfected cells showed that the proton stimulation of 
OGR1 results in the activation of phospholipase C via pertussis toxin sensitive 
G-proteins and increases in intracellular calcium concentrations (5). Moreover, 
Bektas et al (19) showed increased phosphorylation of ERK1/2 MAPK kinases 
in cells overexpressing OGR1. The proton-dependent increase in the inositol-
tris-phosphate response was also observed in human preosteoblasts and 
MG63 human osteosarcoma cells (5), in addition to the human 
medulloblastoma tissue and its corresponding neuronal cell line (23) where 
OGR1 was shown to be expressed. These results suggest that OGR1 is a 
sensor of extracellular pH and its stimulation leads to the activation of distinct 
intracellular signaling cascades. 
 
5. POTENTIAL PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL 
ROLES 
 
Acidification of the extracellular or interstitial space is described to 
occur under many physiological and pathophysiological states, including 
tumors, inflammation, ischemia, arthritis, and exercise. Although our 
knowledge of proton sensing GPCRs is preliminary, circumstantial evidences 
suggests different potential roles in multiple physiological and 
pathophysiological circumstances. 
 
6.1 OGR1 in tumors 
 
It is well known that tumors have a more acidic extracellular pH than 
the normal tissues. In some cases the pH has been described to drop to 5.8 
(20). This acidification is the result of the poorly organized vasculature of 
tumors which lead to a hypoxic environment. Although the extracelullar pH is 
low, the intracellular pH is normal because tumor cells stimulate proton efflux 
(21), thus preventing cellular acidosis and apoptosis. 
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Interestingly, high abundance of OGR1 mRNA has been found in different 
human tumors (22; 23; 24). Therefore, regulation of the intracellular pH by this 
proton sensing receptor could represent a mechanism of survival and 
invasiveness in tumors. 
 
6.2 OGR1 in bone 
 
Metabolic acidosis increases urinary calcium concentration without 
increasing intestinal calcium absorption, leading to bone calcium loss. 
However, it has been unclear how bone cells detect the increase in proton 
concentration.  
Recently, Ludwig et al. showed that OGR1 is expressed and functional 
in osteoblasts (5). On the other hand, Yang and coworkers demonstrated that 
OGR1 is expressed early during osteoclastogenesis and plays an important 
role in osteoclast differentiation (25).  Komarova et al reported that osteoclasts 
express OGR1 and that OGR1 would couple extracellular acidification to 
increases of intracellular calcium. They demonstrated that acidosis acts 
directly on osteoclasts to induce elevation of intracellular calcium leading to 
stimulation of bone resorption (26). Similarly, Frick et al (2009) showed that 
acid induced bone resorption in vitro may involve OGR1, and described OGR1 
as a prime candidate for an osteoblast proton sensor (27). 
In organ culture of bone, acidic conditions have been shown to induce 
cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) 
production, resulting in stimulation of bone calcium release (28). Interestingly, 
it has been shown that the OGR1 / Gq / phospholipase C / protein kinase C 
pathway regulates osteoblastic COX-2 expression and PGE2 formation in 
response to acidic pH (28). Taken together, these data suggest that OGR1 
may play an important role in pH sensing mechanisms in bone. 
 
6.3 OGR1 in vascular smooth muscle 
 
Systemic or local acidosis may cause vasodilation of systemic arterial 
beds, however, pulmonary arteries are resistant to the vasodilator effect of 
acidosis (29). Extracellular and intracellular pH have been shown to be 
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responsible for the vasoldilation of systemic arteries induced by acidosis (29; 
30) 
Recent studies demonstrated an important role of the ATP sensitive 
potassium channels in the acidosis induced vasodilation (30; 31; 32). 
Intracellular histidine residues have been shown to participate in the activation 
of the channel in response to intracellular acidosis (33). This potassium 
channel activation is one of the mechanisms of the intracellular pH effect on 
vasodilation. On the other hand, the mechanism by which extracellular pH 
induces relaxation of vascular smooth muscle cells remains unclear. 
Recently, OGR1 mRNA was found to be expressed in human aortic 
smooth muscle cells (34). Acidic extracellular pH has been shown to induce 
inositol-tris-phosphate production, a transient elevation in intracellular calcium 
concentration, and cAMP accumulation in these cells (34). In addition, Tumora 
et al demonstrated that siRNA against OGR1 abrogated acid induction PGI2 
formation. PGI2 is a vasodilating factor and may be involved in mediating the 
acidosis induced vasorelaxation (34). 
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6. PHYSIOLOGY OF CALCIUM AND MAGNESIUM HOMEOSTASIS  
 
Calcium and magnesium play an important role in different 
physiological functions of the body, including, neural excitability, bone 
formation, muscle contraction and relaxation, and enzymatic activity (35). 
Therefore, the body concentration of these divalent is tightly controlled.  
Calcium and magnesium are absorbed in the intestine, filtered and 
reabsorbed in the kidney, and stored in bone. Thus, their absorption and 
reabsorption by these organs is mediated by a passive paracelullar transport 
mechanism that connect the luminal compartment to the blood, and an active 
transcellular transport mechanism which involves the passage across the 
apical and the basolateral membranes of cells along the nephron or intestine 
(Fig. 2; 36) 
In the kidney, the epithelial calcium channel TRPV5 (Transient receptor 
potential cation channel, subfamily V, member 5) is responsible for the luminal 
calcium influx (Fig. 2A) and the connecting tubule (CNT) of the nephron. The 
Ca2+ is then transported from the apical to the basolateral membrane by the 
Ca2+ binding protein calbindin-D28K, and taken into the blood via the Na/Ca2+ 
exchanger (NCX1) and PMCA1b (36). However, in the intestine (duodenum), 
the apical Ca2+ influx is mediated by TRPV6 channels (transient receptor 
potential cation channel, subfamily V, member 6), then Ca2+ is transported 
from the apical to the basolateral membrane by the Ca2+ binding protein 
calbindin-D9K, and taken into the blood via the plasma membrane Ca2+ -
ATPase  PMCA1b (36).  
The epithelial Mg2+ transport in the renal distal convoluted tubules and 
the intestine is mediated by the epithelial magnesium channel TRPM6 
(transient receptor potential cation channel, subfamily M, member 6) (Fig. 2B). 
However, the molecular identity of different players that transport the Mg2+ 
from the apical to the basolateral membrane and then to the blood remains 
unknown. 
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Fig. 2 Transcellular Ca2+ and Mg2+ transport across renal and intestinal epithelia.  Taken 
from: Hoenderop JG et al. 2008 (36). Detailed description in the text. 
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7.1 Mechanisms of renal calcium reabsporption 
 
The kidney plays an important role in the regulation of body calcium 
balance. About 45% of the free ionized form of plasma Ca2+ is filtered in the 
kidney through the glomerulus, approximately 65% of the filtered Ca2+ is 
passively reabsorbed in the proximal tubule (96; 97), and 20% in the thick 
ascending loop of Henle (TAL) through tight junction proteins including 
claudin16 via a passive paracellular pathway (98; 71). It is important to note 
that the calcium reabsorption in proximal tubule and thick ascending loop of 
Henle (TAL) is not regulated and depends on the gradients created by NaCl 
and H2O reabsorption (37; 38). Finally, 15% of filtered Ca2+ is actively 
reabsorbed in the distal part of the nephron including, the late part of distal 
convoluted tubule (DCT2), and the connecting tubule (CNT) (Fig. 3; 99) where 
active calcium reabsorption is tightly regulated.   
The mechanism of active calcium reabsorption in DCT2 and CNT has 
been described to be divided into three steps (Fig. 3; 36): first, passive Ca2+ 
influx across the apical membrane via apically localized epithelial Ca2+ 
channel TRPV5, then cytosolic diffusion of Ca2+ to the basolateral membrane 
bound to vitamin D3-sensitive calcium-binding proteins (calbindin-D28K), and 
finally active transport of Ca2+ to the blood across the basolateral membrane 
by Na+/ Ca2+ exchanger (NCX1) and Ca2+-ATPase (PMCA1b) (39) (Fig. 3) 
Different factors have been shown to be involved in the regulation of 
active calcium reabsorption in the distal part of the nephron (DCT2 and CNT). 
Indeed, parathyroid hormone (PTH) plays an important role in the regulation of 
Ca2+ homeostasis. Changes in calcium plasma concentration are sensed in 
the parathyroid gland by the parathyroid Ca2+ sensing receptor and lead to the 
secretion of PTH (100). It is important to note that both DCT2 and CNT 
segments express the PTH receptors (101). PTH hormone has been shown to 
increase the expression of  TRPV5, calbindin-D28K, and NCX1 (102; 40, 41) in 
DCT2 and CNT, thus absence of PTH in parathyroidectomized rats resulted in 
decreased active Ca2+ reabsorption and development of hypocalcemia.  
Moreover, several studies showed that the active form of vitamin D 
(1,25-(OH)2 Vitamin D3) has a role in the Ca2+ homeostasis regulation (40; 42; 
43; 44; 49), and experiments on vitamin D knockout models showed a 
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significant downregulation of TRPV5, calbindin-D28K, and NCX1 mRNA in the 
kidney (49).  
Similarly, expression of TRPV5, NCX1, PMCA1b, and calbindin-D28K 
has also been shown to be increased by estrogen (46; 47), indeed, increased 
urinary calcium excretion and formation of renal stone are observed in women 
after menopause. This demonstrates the role of estrogens in the regulation of 
the active Ca2+ transport in the distal convoluted tubule. In addition, other 
studies reported that calcitonin also increases the active calcium transport in 
DCT and CNT (45). 
The dietary Ca2+ plays also an important role in the regulation of transport 
proteins participating in the renal active calcium reabsorption, indeed in the 
1α-OHase knockout mice (mice lacking the 25-hydroxyvitamin D3-1α-
hydroxylase enzyme which is responsible for the 1,25-(OH)2 vitamin D3 
synthesis in the kidney), high dietary Ca2+ intake resulted in the normalization 
of the decreased TRPV5, NCX1, and calbindin-D28K expression in the kidney 
(49), similarly, dietary calcium levels regulated TRPV5 expression in the 
vitamin D receptor knockout mice (107). These results demonstrate that 
dietary Ca2+ has a role in the regulation of calcium transport proteins 
expression in the kidney independently of the 1,25-(OH)2 vitamin D3. 
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Fig. 3 Transcellular Ca2+ and Mg2+ transport across renal epithelia. Taken from: 
Hoenderop JG et al 2005 (38). 
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7.2 Mechanisms of renal magnesium reabsorption 
 
Magnesium is an important divalent for different metabolic functions 
including neural excitability, muscular relaxation, and bone formation. The 
kidney plays a crucial role in controlling the magnesium homeostasis; however 
the exact mechanisms that regulate the renal magnesium handling are 
partially understood.  About 80% of the total plasma magnesium filters through 
the glomerulus (50), consequently, 10 to 20% of the filtered Mg2+ is 
reabsorbed in the proximal tubule (PT), and around 50 to 70% is reabsorbed 
through tight junction proteins including claudin-16 via a passive paracellular 
pathway in the thick ascending loop of Henle (TAL) (50; 76). Finally, 10% of 
the filtrated Mg2+ is actively reabsorbed in the distal part of the nephron 
specifically the superficial distal convoluted segment (DCT) where the final 
urinary magnesium excretion is determined (Fig. 3; 50; 51; 52). 
Little is known about the mechanism of active magnesium reabsorption 
in the distal convoluted tubule segment, the apically localized epithelial Mg2+ 
channel TRPM6 mediates passive entry of Mg2+ across the apical membrane 
in DCT (Fig. 3), however, transport proteins enabling the cytosolic diffusion of 
Mg2+ to the basolateral membrane (Mg2+ binding proteins) and its active 
transport across the basolateral membrane to the blood (putative Na+/ Mg2+ 
exchangers or ATP dependent Mg2+ pumps) remain unknown (Fig. 3).  
The epithelial magnesium channel TRPM6 has been described to be 
regulated by different factors. The epidermal growth factor EGF is expressed 
in the DCT along with the Mg2+ channel TRPM6 and has been shown to 
increase the activity of TRPM6 resulting in increased magnesium reabsorption 
in the DCT (104). Additionally, Groenestege et al (105) demonstrated that 
magnesium restriction as well as 17β-Estradiol increased expression of 
TRPM6 mRNA in the DCT which leads to increased Mg2+ reabsorption (105). 
However,  parathyroid hormone (PTH) and vitamin D3 have been shown to 
increase  Mg2+ transport only in a DCT cell culture model but  not in vivo (50; 
106).  
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7. ACID-BASE HOMEOSTASIS AND RENAL HANDLING OF CALCIUM 
AND MAGNESIUM  
Several studies demonstrated that acid–base balance affects renal 
handling of Ca2+ and Mg2+ (35; 50; 54; 55; 103). Renal Ca2+ and Mg2+ 
excretion is significantly increased during chronic metabolic acidosis (35; 50); 
however, chronic metabolic alkalosis results in decreased urine Ca2+ and Mg2+ 
excretion (35; 50). Recently, Bindels et al (54) proposed a molecular 
mechanism that may explain the renal calcium and magnesium excretion 
during disturbances of acid–base status. They showed that chronic metabolic 
acidosis decreased TRPV5 mRNA abundance and immunostaining intensity 
in the kidney, and enhanced calciuresis; however, chronic metabolic alkalosis 
increased the renal expression of TRPV5 mRNA and reduced urine Ca2+ 
excretion. Similarly, chronic metabolic acidosis decreased TRPM6 mRNA 
expression in the kidney, and increased urine excretion of Mg2+, whereas 
chronic metabolic alkalosis increased renal TRPM6 mRNA expression, and 
reduced urinary Mg2+ excretion.  
Other recent studies demonstrated that exposure of cells expressing 
the epithelial calcium channel TRPV5 to an acidic extracellular environment 
pH around 6.5, resulted in the internalization of TRPV5 from the plasma 
membrane leading to a decreased channel activity (83). However, exposure of 
the same cells to an alkaline extracellular milieu (pH 8) induced recruitment of 
TRPV5 to the plasma membrane and increased TRPV5 activity (83).  
In addition, Yeh et al (82) showed that acidification of the extracellular 
milieu reduced the channel conductance of TRPV5, and described the 
glutamate at position 522 in the pore helix of TRPV5 as an extracellular pH 
sensor of the channel. They proposed that the binding of protons to the sensor 
results in a conformational change of the pore helix of TRPV5 and reduces the 
channel activity at the apical membrane of the cell which is the cause of the 
calcium wasting observed during chronic metabolic acidosis (82) 
Taken together, these results suggest that regulation of Ca2+ and Mg2+ 
transport proteins may contribute to the effects of acid base status on divalent 
handling in the kidney. 
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8. MOUSE MODELS USED IN THIS PROJECT 
 
8.1. OGR1 deficient mice 
 
OGR1 deficient mice were purchased from Lexington (Ca, USA) by 
Novartis under the agreement that these mice could be used in collaborative 
projects and were provided to the Institute of Physiology under this 
agreement. OGR1 deficient mice (Ogr1-/-) were generated by replacing the 
first exon of OGR1 by a cassette expressing LacZ. All attempts to detect Beta-
galactosidase staining in OGR1 deficient mice, however, failed in our hands 
as well as in the hands of Novartis, possibly due to very low expression. 
 
9.2. NH4Cl-induced metabolic acidosis in Ogr1-/-  and wild-type mice 
 
Ammonium chloride (NH4Cl) is known to be an efficient chemical used 
to induce systemic metabolic acidosis in animals, different methods of NH4Cl 
administration have been described in several experimental studies (55; 54; 
58; 59; 60; 61; 62; 63; 64; 65; 66). The NH4Cl loading produces a metabolic 
acid load after metabolism in the liver. 
In the present project, we used two models of NH4Cl-induced metabolic 
acidosis animals, in the first; acute metabolic acidosis was induced using 
0.28M of NH4Cl in drinking water for 1 day with 1% sucrose added to control 
and NH4Cl-receiving groups. However, the second group of animals received 
2 g NH4Cl added to 100 g of food for 7 days in order to induce chronic 
metabolic acidosis. This amount of NH4Cl gives an equivalent NH4Cl load as 
compared to drinking water but prevents the induction of dehydration due to 
reduced water intake (Nowik, Wagner, unpublished results). 
 
9.3 Acetazolamide- induced metabolic acidosis in Ogr1-/- and wild-type 
mice 
 
In an alternative model of chronic metabolic acidosis, Ogr1-/- and wild 
type mice were treated for 7 days with the carbonic anhydrase inhibitor 
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acetazolamide that was added to mouse chow (20 mg/kg per d). 
Acetazolamide treatment causes metabolic acidosis by inducing urinary 
bicarbonate wasting due to inhibition of proximal tubular bicarbonate 
reabsorption (Fig. 4; 73; 74). This type of metabolic acidosis is characterized 
by high urinary pH and high net anion excretion and may give a hint as to 
distinguish between the effects of urinary and systemic pH. (75). 
 
 
 
 
 
 
 
Fig. 4 Bicarbonate absorption in the proximal tubule: Modified from: Wagner et al 2006 
(106). Bicarbonate absorption in the proximal tubule is mediated by the concerted action of 
the apical Na+/ H+ exchanger (NHE3), the vacuolar H+ ATPase and the extracellular and 
cytosolic carbonic anhydrase (CAII and CAIV), and is taken into the blood via the basolateral 
Na+/ HCO3- cotransporter (NBCe1). 
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10. AIM OF THE PROJECT 
 
It is well known that systemic acid-base homeostasis affects the renal 
handling of the divalents calcium and magnesium. Chronic metabolic acidosis 
has been associated with decreased renal expression of the epithelial calcium 
and magnesium channels TRPV5 and TRPM6 which may contribute to the 
development of hypercalciuria and –magnesuria and the subsequent 
hypocalcemia and -magnesemia. However, the molecular sensor(s) triggering 
the renal wasting of calcium and magnesium during this disturbance of acid-
base balance remain(s) unknown. 
Recently, Ludwig et al. (5) described the Ovarian cancer G-protein 
coupled Receptor OGR1 (GPR68) as a proton sensing receptor, they reported 
that its activation by protons lead to the inositol-tris-phosphate (IP3) formation, 
and elevation of intracellular calcium concentration. Interestingly, using 
quantitative real-time PCR, we detected OGR1 mRNA expression in the 
kidney and intestine, major sides of regulated calcium, magnesium, and acid-
base transport. Therefore, the primary goal of the present project was to 
investigate the physiological role of OGR1 focusing on kidney and intestine. 
For this purpose, we decided to: 
 
1. Explore the tissue distribution of OGR1 in different organs, and its 
cellular and sub-cellular localization especially in the kidney. 
2. Investigate for a potential role of OGR1 in the regulation of the local pH 
and acid-base transporters in the kidney, and explore the regulation of 
OGR1 expression in different levels. 
3. Investigate the potential contribution of OGR1 to the altered calcium 
and magnesium excretion observed during chronic metabolic acidosis. 
4.  Investigate the role of OGR1 in the renal calcium and magnesium 
handling under normal conditions. 
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11. MATERIALS AND METHODS 
  
11.1. Animals 
 
OGR1 deficient mice (Ogr1-/-) were generated by replacing the first 
exon of OGR1 by a cassette expressing LacZ and purchased from Lexington 
Inc (Ca, USA). Experiments were performed on Ogr1-/- and Ogr1+/+ male mice 
of 12-14 weeks of age, 25–30 g.  
All experiments were according to Swiss Animal Welfare laws and approved 
by the local veterinary authority (Veterinäramt Zürich). 
 
11.2. Genotyping of mice 
 
Ogr1+/- mice were bred with Ogr1+/- mice (C57BL/6J background). The 
resulting offspring was genotyped by PCR (5 min at 950C, 39 cycles of 30 sec 
at 940C, 30 sec at 650C, 45 sec at 720C) on genomic tail DNA using two sets 
of primers. One set of primers (5’-ACCACCAGTGATGCCTAGATCCTGA-3’, 
and 5’-AAGATGACCACGGTGCTGAGCACCA-3’) amplifies an 827 base pair 
segment. The other primer set (5’-AAGATGACCACGGTGCTGAGCACCA-3’ 
and 5’-CCATTCGACCACCAAGCGAAACATC-3’)  amplifies a segment of 1kb 
, thus identifying the wild-type allele by the presence of a 827 base pair PCR 
product, and the knockout allele by the presence of 1 kb PCR product (Fig. 5).    
 
 
Fig. 5 Mice genotyping: PCR analysis showing the identification of the Ogr1-/- knockout mice 
(PCR product of 1 kb), wild-type mice (PCR product of 827 base pair) and Ogr1+/- 
heterozygote mice (1 kb + 827 base pair). 
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11.3. Animal studies 
 
Mice were kept on a standard diet (Kliba, Kaiseraugst, Switzerland) if 
not stated otherwise. This diet contained 1.05 % calcium and 0.2 % 
magnesium. In order to induce acute metabolic acidosis in Ogr1-/- and wild-
type mice (8 animals per group), mice were given 0.28 M NH4Cl/ 2% sucrose 
in drinking water for 1 day as described previously (58). Another group of 
animals was given 2 g NH4Cl/100 g food for 7 days to induce chronic 
metabolic acidosis. Alternatively, addition of the carbonic anhydrase inhibitor 
acetazolamide (54) to mouse chow (20 mg/kg per d) during 7 days was 
applied in a third group of animals; the control group received standard diet for 
7 days.  
In order to investigate the contribution of OGR1 in the regulation of 
renal calcium and magnesium handling, mice were treated with different 
calcium and/or magnesium diets.  For the calcium treatment, a group of 
animals was given a low calcium diet containing 0.05% calcium, and 0.1% 
magnesium. Another group of mice was given a high calcium diet containing 
2% calcium and 0.1% magnesium (SAFE Scientific Animal Food & 
Engineering, France). Both groups were treated for 2 and 7 days. 
For the magnesium treatment, a group of animals was given a low 
magnesium diet containing 0.01% magnesium, and 0.76% calcium. Another 
group of mice was given a high magnesium diet containing 0.6% magnesium 
and 0.76% calcium (SAFE Scientific Animal Food & Engineering, France). 
Both groups were treated for 2 and 7 days. 
48 hours prior to sacrificing mice were housed in metabolic cages 
(Tecniplast, Buguggiate, Italy) and had free access to food and drinking water. 
Daily food and water intake, and body weights were measured, urine was 
collected under mineral oil and all stool samples were frozen at −20°C until 
analysis. At the end of experiment, mice were sacrificed and heparinised 
mixed arterial-venous blood was collected and analyzed immediately for pH, 
blood gases and electrolytes on a Radiometer ABL 505 (Radiometer, 
Copenhagen, Denmark) blood gas analyser. Serum was collected and frozen 
until further analysis. Both kidneys were harvested, rapidly frozen in liquid 
nitrogen, and stored at -80°C. 
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The 24 hours collected stool samples (around 900mg) were solubilized 
in 5ml of 1.2M nitric acid. After 12 hours incubation at 95°C, stool samples 
were centrifuged at 13’000 rpm for 10 min and the supernatants were saved 
and diluted with water to obtain a final volume of 10ml. The resulted samples 
were then frozen at −20°C until analysis. 
Urinary pH was measured using a pH microelectrode (691 pH-Meter, 
Metroholm). Urinary creatinine was measured by the Jaffe method (67). 
Ammonium in urine was measured by the method of Berthelot (68). Urinary 
and serum phosphate was measured using a commercial kit (Sigma 
Diagnostics, Munich, Germany). Urinary electrolytes (Ca2+, Mg2+,Na+, K+)  
were measured by ion chromatography (Metrohm ion chromatograph, 
Herisau, Switzerland). Serum and stool Ca2+ and Mg2+ were measured using a 
commercial kit (BioAssay Systems, Hayward, CA, USA). 
 
11.4. Real-time quantitative PCR 
 
11.4.1.  RNA extraction from total kidney 
 
 30 mg of frozen kidney tissue (8 kidneys for each condition) were 
homogenized in RLT-Buffer (Qiagen, Basel, Switzerland) supplemented with 
ß-mercaptoethanol to a final concentration of 1%. Total RNA was extracted 
using the RNeasy Mini Kit (Qiagen, Basel, Switzerland) according to the 
manufacturer’s instructions. RNA was bound on columns and treated with 
DNAse for 15 min at 25°C to reduce genomic DNA contamination. Purity of 
total eluted RNA was assessed by electrophoresis and the concentration was 
measured spectroscopically using the ND-1000 spectrophotometer NanoDrop 
Technologies, (Thermo SCIENTIFIC, Wilmington, USA). Total RNA samples 
were stored at –80°C. 
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11.4.2. Reverse transcription 
 
Each RNA sample was diluted to 100 ng/µl and 3 µl used as a template 
for reverse transcription using the TaqMan Reverse Transcription Kit (Applied 
Biosystems, Forster City, CA, USA). 300 ng RNA templates were diluted in a 
20 µl reaction mix that contained (final concentrations): RT buffer (1x), MgCl2 
(5.5 mM), random hexamers (2.5 µM), RNAse inhibitor (0.4 U/ µl), the 
multiscribe reverse transcriptase enzyme (1.25 U/ µl), deoxyNTP mix (500 µM 
each) and RNAse free water.  
 
11.4.3. Real-time PCR 
 
Quantitative real-time qRT-PCR was performed on the ABI PRISM 
7700 Sequence Detection System (Applied Biosystems, Forster City, CA, 
USA). Primers for all genes of interest were designed using Primer Express 
from Applied Biosystems (Table 1). Probes were labelled with the reporter dye 
FAM at the 5’ end and the quencher dye TAMRA at the 3’ end (Microsynth, 
Balgach, Switzerland). Primers were chosen to result in amplicons of 70–150 
bp spanning intron–exon boundaries to avoid the effect of potentially 
contaminating genomic DNA. The specificity of all primers was first tested in a 
standard PCR and resulted always in a single product of the expected size on 
1% agarose gels (data not shown). Real-Time PCR reactions were carried out 
as previously described (61). The expression of the genes of interest was 
calculated in relation to hypoxanthine guanine phosphoribosyl transferase 
(HPRT). Relative expression ratios were calculated as R=2(Ct(HPRT/β-actin)-Ct(test 
gene), where Ct represents the cycle number at the threshold 0.06. 
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Table 1. Sequences of primers and probes used for quantitative RT real-time PCR. 
 
Gene 
 
 
Acc. No. 
 
 
Primers 
 
 
Probe 
 
 
OGR1 
(Gpr68) 
 
NM_175493   
 
F: 5'-AGCCACGGCACACAGAAGA-3' 
 
R: 5'-ATGACCACGGTGCTGAGCA-3' 
 
 
5'-CGCAAGGACCAGATTCAGCGGCT-3' 
 
TRPM6 NM_153417 F: 5'- GAGAAGCTCAGGCGGAACC-3' 
 
R: 5'- TCCCATACCCAGAGGATGACA-3' 
 
5'- CAGAAGATACACACTTGCTCAAGACAAGGT-3' 
 
 
TRPM7 NM_021450 F: 5'-CAGCTTTGTTACCGGATTGGTT-3' 
 
R: 5'-CCACAGCTGAATAATAGTAATTTGTATCCA-3' 
 
5'-ACAGAGAAATGCCATCTGAAGGAGGAACAT-3' 
 
TRPV5 
 
NM_001007
572 
F: 5'- CGTTGGTTCTTACGGGTTGAAC-3' 
 
5'- GTTTGGAGAACCACAGAGCCTCTA-3 
 
5'TGTTTCTCAGATAGCTGCTCTTGTACTTCCTCT
TTGT-3' 
 
CaBP28K 
 
NM_009788 F: 5'- AACTGACAGAGATGGCCAGGTTA -3' 
 
5'-TGAACTCTTTCCCACACATTTTGAT -3'  
 
5'ACCAGTGCAGGAAAATTTCCTTCTTAAATTCCA-
3' 
 
HPRT 
 
NM_013556 
 
F: 5'-TTATCAGACTGAAGAGCTACTGTAAGATC-3' 
 
R: 5'-TTACCAGTGTCAATTATATCTTCAACAATC-3' 
 
5'-TGAGAGATCATCTCCACCAATAACTTTTATGT 
CCC-3' 
 
 
GPR4 NM_175668 F: 5'- CCTGGGCACTCATGTTGCT-3' 
 
R: 5'- GGTGGACACACTGCTCTGCA-3' 
 
5'-TGC TAC CGT GGC ATC CTG AGG GC-3' 
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11.5. Immunohistochemistry 
Wild-type and Ogr1-/- mice were anaesthetized and perfused through 
the left ventricle with PBS followed by paraformaldehyde–lysine–periodate 
(PLP) fixative (69). Kidneys were removed, flushed with fixative solution and 
postfixed overnight at 4°C by immersion in PLP. Organs were washed three 
times with PBS and 5 µm cryosections were cut after cryoprotection with 2.3 M 
sucrose in PBS for at least 12 hrs. Immunostaining was carried out as 
previously described (70). Briefly, sections were incubated with 1% SDS for 5 
min, washed 3 times with PBS and incubated with PBS containing 1% bovine 
serum albumin for 15 min prior to the primary antibody. The primary antibodies 
were diluted in PBS (rabbit anti-TRPV5 1:200, mouse anti Calbindin-D28k 
(1:20’000) and applied at room temperature for 75 min or overnight at 4°C. 
Sections were then washed twice for 5 min with PBS + 2.7% NaCl and once 
with PBS, and incubated with the secondary antibodies (Donkey anti-rabbit 
Alexa 594 and donkey-anti-mouse Alexa 488 (Jackson ImmunoResearch, 
West Grove, PA, USA) at dilutions of 1: 1000 and 1:400, respectively) for 1 h 
at room temperature. Sections were again washed twice with PBS + 2.7% 
NaCl and once with PBS before mounting with VectaMount (Vector 
Laboratories, Burlingame, CA, USA). Sections were viewed with a Nikon 
ECLIPSE TE 300/200 inverted microscope or a Leica SP1 UV CLSM confocal 
microscope. Pictures were processed and assembled using Adobe 
Photoshop.  
11.6. Western blot analysis 
 
Mice were anaesthetized with ketamine-xylazine intraperitonally, 
kidneys removed and rapidly frozen in liquid nitrogen. Kidneys were 
homogenized in an ice-cold K-HEPES buffer (200 mM mannitol, 80 mM K-
HEPES, 41 mM KOH, pH 7.5) with pepstatin, leupeptin, K-EDTA, and 
phenylmethylsulfonyl fluoride (PMSF) as protease inhibitors. Samples were 
centrifuged at 1’000 x g for 10 min at 4°C and the supernatant was saved. 
After measurement of the total protein concentration (Bio-Rad, Hercules, CA), 
50 µg of proteins were solubilized in Laemmli sample buffer, and SDS-PAGE 
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was performed on 10% polyacrylamide gels. For immunoblotting, the proteins 
were transferred electrophoretically to polyvinylidene fluoride membranes 
(Immobilon-P; Millipore, Bedford, MA). After blocking with 5% milk powder in 
Tris-buffered saline/0.1% Tween-20 for 60 min, the blots were incubated with 
the primary antibodies and mouse monoclonal anti-β-actin antibody (42 kDa; 
Sigma, St. Louis, MO) 1:5,000 either for 2 h at room temperature or overnight 
at 4°C. The primary antibodies were: rabbit anti TRPV5 (Alomone, Jerusalem, 
Israel) (1:1000), mouse monoclonal anti Calbindin-D28K (1:20000), guinea pig 
anti TRPM6 (1:1000) (AbCam, Cambridge, UK).  
The membranes were then washed three times, blocked for 1 h, and again 
incubated for 1 h at room temperature with the secondary goat anti-rabbit or 
goat anti-mouse or goat anti-guinea pig antibodies (1:5,000) linked to alkaline 
phosphatase (Promega). The protein signal was detected with the CDP Star 
chemiluminescence system (Roche Diagnostics, Basel, Switzerland) using the 
DIANA III-chemiluminescence detection system (Raytest, Straubenhardt, 
Germany). All images were analyzed using appropriate software (Advanced 
Image Data Analyser AIDA, Raytest) to calculate the protein of interest/actin 
ratio. 
 
11.7. Statistical analysis 
 
 Results are expressed as mean ± SEM. All data were tested for 
significance using ANOVA and unpaired student’s test where appropriate. 
Only values with p < 0.05 were considered as significant. Levels of 
significance are indicated in tables and figures. 
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12. RESULTS 
 
12.1. The H+-Activated Ovarian Cancer G Protein-Coupled Receptor 1   
(OGR1) is responsible for Renal Calcium and Magnesium Loss 
during Acidosis 
 
12.1.1. Tissue distribution of OGR1 and its expression in mouse kidney 
 
OGR1 mRNA is expressed in most mouse organs (Fig. 6A, B). High 
levels were found in spleen, lung and testis. Interestingly, OGR1 mRNA was 
also found with moderate levels in several epithelial structures including 
kidney and intestine (Fig. 6). Distribution of OGR1 mRNA was detected in 
various mouse nephron segments such as proximal tubule, thick ascending 
limb, distal convoluted tubule (major sites of regulated calcium and 
magnesium absorption), and along the collecting duct.  
Similarly, GPR4 mRNA expression was detected in most mouse organs 
(Fig. 8). High levels were found in spleen, lung, testis, pancreas, and fat 
tissues. Interestingly, GPR4 mRNA was also found with moderate levels in 
several epithelial structures including kidney and intestine. Finally, GPR4 
mRNA expression in the kidney did not show significant differences between 
wild-type and Ogr1-/- mice (Fig. 9). 
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Fig. 6 OGR1 expression in mouse organs. (A) Normal PCR and (B) real-time quantitative 
PCR analysis (n=4 animals) showing the tissue distribution of OGR1 in different mouse 
organs. (A) ß-actin served as control. (B) The expression of genes was calculated in relation 
to Glycerinaldehyd-3-phosphat-Dehydrogenase (GAPDH), and relative expression ratios were 
calculated as R=2(Ct (HPRT)-Ct (test gene)) Data are presented as means ± SEM.  
 
 
 
 
 
 
 
 
 
Fig. 7 OGR1 expression in mouse nephron segments. Real-time quantitative PCR (n=4 
animals) showing the distribution of OGR1 mRNA in different mouse nephron segments. The 
expression of genes was calculated in relation to Glycerinaldehyd-3-phosphat-
Dehydrogenase (GAPDH), and relative expression ratios were calculated as R=2(Ct (HPRT)-Ct (test 
gene)) . Data are presented as means ± SEM.  
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Fig. 8 GPR4 expression in mouse organs: Real-time quantitative PCR analysis (n=4 
animals) showing the tissue distribution of GPR4 mRNA in different mouse organs. The 
expression of genes was calculated in relation to Glycerinaldehyd-3-phosphat-
Dehydrogenase (GAPDH), and relative expression ratios were calculated as R=2 (Ct (HPRT)-Ct (test 
gene))  .Data are presented as means ± SEM.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Renal GPR4 mRNA expression in wild-type (Ogr1+/+) and OGR1 knockout mice 
(Ogr1–/–). Real-time quantitative PCR analysis (n=4 animals) showing GPR4 mRNA 
expression in wild-type (Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). The expression of genes 
was calculated in relation to Glycerinaldehyd-3-phosphat-Dehydrogenase (GAPDH), and 
relative expression ratios were calculated as R=2 (Ct (HPRT)-Ct (test gene)) . Data are presented as 
means ± SEM. * p < 0.05. 
(     Ogr1+/+ ,     Ogr1-/-).  
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12.1.2. OGR1 is dispensable for systemic acid-base homeostasis 
 
OGR1 is present in nephron segments that play a major role in renal 
acid excretion. Renal acid excretion is adapted to systemic acid-base status 
which may be mediated by intra- and extracellular acid sensors (72). Thus, we 
tested if OGR1 is required for normal acid-base status under basal conditions 
and during an acid-load. Mice were investigated on normal standard chow in 
metabolic cages and blood and urine were analyzed. No differences could be 
detected between Ogr1+/+ and Ogr1-/- mice with the exception of lower urinary 
magnesium excretion in Ogr1 deficient mice (Table 2).   
 To induce acute or chronic metabolic acidosis animals were given 
NH4Cl in the drinking water for 1 day or in food for 7 days, respectively (58). 
Despite similar intake of NH4Cl in wild-type and Ogr1-/- mice, OGR1 deficient 
mice were less acidotic at day 1 but were indistinguishable after 7 days. Urine 
analysis did not reveal any difference in acid excretion at day 1 or day 7 of 
NH4Cl-loading (Table 2). Thus, OGR1 is not required for normal acid-base 
homeostasis and appears not to be involved in the renal compensatory 
increase in acid excretion during a systemic acid load. 
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  Control   
 
 
1 day NH4Cl 
 
7 days NH4Cl 
 Ogr1+/+ Ogr1-/- Ogr1+/+ Ogr1-/- Ogr1+/+ Ogr1-/- 
 
Blood  
pH 7.29 ± 0.02 
 
7.28 ± 0.01 
 
7.12 ± 0.04 ### 
 
7.20 ± 0.03 # 
 
7.03 ± 0.05 ### 
 
7.08 ± 0.05 
pCO2  mmHg 45.6 ± 1.5 
 
48.4 ± 1.7 42.5 ± 2.5 49.2 ± 2.6 38.6 ± 3.1 40.2 ± 3.3 
[HCO3-] mM 21.2 ± 0.7  
  
22.4 ± 0.6 
  
13.7 ± 1.7 ### 
  
18.3 ± 0.7 ###* 
  
10.7 ± 1.4 ### 
  
11.7 ± 0.8 &&& 
 
[Na+] mM 144.5 ± 0.7 144.8 ± 1.0 
  
149.0 ± 0.8 ### 
  
149.5 ± 0.7 ## 151.2 ± 1.6 ### 
  
150.0 ± 1.2 ## 
  
[K+] mM 5.6 ± 0.5 
  
5.8 ± 0.4 
  
8.0 ± 0.3 ## 
  
7.5 ± 0.2 # 
  
6.8 ± 0.4 & 
 
6.7 ± 0.1 && 
 
[Cl-] mM 112.1 ± 0.5 
  
112.0 ± 0.9 
  
120.0 ± 1.0 ###  118.2 ± 1.2 ### 121.0 ± 1.5 ### 
 
120.8 ± 1.2 ### 
 
Ionized [Ca2+] mM  1.24 ± 0.04 
  
1.26 ± 0.04 
  
1.26 ± 0.02 
  
1.37 ± 0.03 #** 
 
1.35 ± 0.02 &&# 1.34 ± 0.03 
[Ca2+] mM in serum 2.10 ± 0.17 
 
2.33 ± 1.13 2.38 ± 0.09 2.51 ± 0.06 2.43 ± 0.05 2.26 ± 0.10 
[Mg2+] mM in serum 1.02 ± 0.04 1.06 ± 0.04 
 
1.20 ± 0.10 1.30 ± 0.03 ## 1.20 ± 0.03 ## 
 
1.15 ± 0.10 
 
Urine  
pH 6.28 ± 0.10 
  
6.65 ± 0.30 
 
5.72 ± 0.05 ### 
  
5.83 ± 0.09 # 5.54 ± 0.03 &### 
  
5.94 ± 0.08 #** 
 
Creatinine (mg/dl) 66.7 ± 6.4 62.0 ± 5.0 88.9 ± 10.7 
 
57.0 ± 3.7 44.2 ± 3.3 52.56 ± 14.3 
NH3/NH4+/ (mM)/crea (mg/dl) 0.75 ± 0.23 
  
1.4 ± 0.40 
  
2.91 ± 0.52 ## 
  
3.97 ± 0.54 ##  
  
8.82 ± 1.04 ###&&& 
  
7.98 ± 1.52 ###& 
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Na+(mM)/crea (mg/dl) 1.9 ± 0.1 
 
1.6 ± 0.1 
 
2.4 ± 0.1 ## 
 
2.9 ± 0.1 ###* 4.0 ± 0.6 ##& 3.9 ± 0.7 ## 
K+(mM)/crea (mg/dl) 6.0 ± 0.2 5.6 ± 0.2 6.2 ± 0.3 8.2 ± 0.4 **### 8.5 ± 0.8 && 6.0 ± 0.2 
Ca2+(mM)/crea (mg/dl) 0.04 ± 0.003 0.03 ± 0.004 0.03 ± 0.004 0.04 ± 0.003 0.12 ± 0.010###&&& 0.05 ± 0.010 ** 
 
Mg2+(mM)/crea (mg/dl) 0.56 ± 0.03 
 
0.37 ± 0.07 * 0.47 ± 0.03 
 
0.36 ± 0.07 0.86 ± 0.09 ##&& 
 
0.48 ± 0.10 ** 
 
Phosphate(mg/dl)/crea 
(mg/dl) 
0.3 ± 0.03 0.3 ± 0.02 0.4 ± 0.03 
 
0.3 ± 0.01 * 0.5 ± 0.08 # 0.3 ± 0.05 
Osmolality (mOsm/kg H2O) 2949 ± 315 2344 ± 182.2 3825 ± 471 
   
2687 ± 176 * 2602 ± 260 2837 ± 164 
Urine volume (ml)/ BW (g) 0.05 ± 0.005 0.05 ± 0.006 0.04 ± 0.004 
 
0.06 ± 0.003** 0.06 ± 0.008 & 
 
0.06 ± 0.006 
Weight change % 1.6 ± 0.5 1.7 ± 0.4 2.3 ± 0.3 2.6 ± 0.6 
 
2.6 ± 0.9 1.8 ± 0.6 
 
 
 
Table 2. Control and NH4Cl groups: Summary of blood and urine analysis for. (n=8 animals per group) Control group: animals that received standard 
diet; acidosis group: animals that received 0.28M NH4Cl in the drinking water for 1 day; or 2g NH4Cl/100g food for 7 days. 
Urinary excretion was normalized against creatinine (crea). BW: body weight. 
* Significantly different between Ogr1+/+ and Ogr1-/- for the same treatment, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
# Significantly different between control group and treated group for the same genotype, # p ≤ 0.05, ## p ≤ 0.01, ### p ≤ 0.001 
& significantly different between treated groups 1 day versus 7 days NH4Cl for the same genotype, & p ≤ 0.05, && p ≤ 0.01, &&& p ≤ 0.001 
 38
12.1.3. OGR1 is responsible for renal Ca2+ and Mg2+ loss during chronic 
metabolic acidosis 
 
NH4Cl-induced metabolic acidosis enhanced urine Ca2+ and Mg2+ 
excretion in wild-type mice, similar to what has been described previously (55; 
54). Surprisingly, urinary total Ca2+ and Mg2+ excretion as well as the corrected 
values for creatinine  did not increase in Ogr1-/-  mice (Fig. 10A,B), whereas all 
other urinary parameters were similar between wild-type and Ogr1-/- mice 
(Table 2) indicating a specific difference. Serum calcium and magnesium 
concentrations were not different between Ogr1+/+ and Ogr1-/- under all 
conditions (Fig. 11A, B). Also food intake and calculated intestinal Ca2+ and 
Mg2+ (the difference between the amount of Ca2+ and Mg2+ ingested over 24 
hrs and the amount of Ca2+ and Mg2+ detected in 24 hrs stool collections) 
were similar in both genotypes (Fig. 12) strongly suggesting an alteration on 
the level of the kidney. Hence, the proton-activated receptor OGR1 appears to 
be involved in the renal Ca2+ and Mg2+ loss during chronic metabolic acidosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 10. Urinary Ca2+ and Mg2+ excretion during metabolic acidosis in wild-type (Ogr1+/+) 
and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Acute and chronic metabolic 
acidosis were induced by NH4Cl-loading and resulted after 7 days in massive renal Ca2+ (A) 
and Mg2+  (B) excretion which was absent from Ogr1-/- mice. Control group: animals that 
received standard diet; acidosis group: animals that received 0.28M NH4Cl in the drinking 
water for 1 day; or 2g NH4Cl/100g food for 7 days. (     Ogr1+/ + ,     Ogr1-/-). 
Data are presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.  
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Fig 11. Serum Ca2+ and Mg2+ concentration during metabolic acidosis in wild-type 
(Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group). Serum total calcium 
(A) and magnesium (B) levels were not affected by NH4Cl-treatment and comparable in wild-
type and OGR1 deficient mice. Control group: animals that received standard diet; acidosis 
group: animals that received 0.28M NH4Cl in the drinking water for 1 day; or 2g NH4Cl/100g 
food for 7 days.  
(     Ogr1+/+  ,       Ogr1-/-). 
 
  
 
 
 
 
 
Fig 12. Intestinal absorption of Ca2+ and Mg2+ during metabolic acidosis in wild-type 
(Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). Intestinal calcium (A) and magnesium (B) 
absorption were not affected by NH4Cl-treatment and comparable in wild-type and OGR1 
deficient mice. Control group: animals that received standard diet; acidosis group: animals 
that received 0.28M NH4Cl in the drinking water for 1 day; or 2g NH4Cl/100g food for 7 days.  
(     Ogr1+/+ ,      Ogr1-/-). 
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12.1.4. OGR1 does not affect total bone development (data produced 
by Jürg Gasser at Novartis in Basel) 
 
NH4Cl-treatment did not affect the in vitro reabsorptive activity of 
osteoclasts from Ogr1+/+ and Ogr1-/- male and female mice (Fig. 12.1A; B). In 
addition, bone mineral density, cortical thickness and cancellous bone mineral 
density of wild-type (Ogr1+/+) and OGR1 knockout (Ogr1–/–) male and female 
mice were similar during metabolic acidosis (Fig. 12.2), suggesting that OGR1 
is not responsible for bone resorption during chronic metabolic acidosis. 
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Fig 12.1.  In vitro reabsorptive activity of osteoclasts from wild-type (Ogr1+/+) and OGR1 
knockout (Ogr1–/–) mice during acidosis. (A) Male mice, (B) female mice. The in vitro 
reabsorptive activity of osteoclasts was not affected by NH4Cl-treatment and comparable in 
wild-type and OGR1 deficient mice.  
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Fig 12.2. (A)Total bone mineral density, (B) cortical thickness and (C) cancellous bone mineral density of wild-type (Ogr1+/+) and OGR1 knockout 
(Ogr1–/–) male mice during metabolic acidosis.  Total bone development was not affected by NH4Cl-treatment and comparable in wild-type and OGR1 
deficient mice. Control group: animals that received standard diet; acidosis group: animals that received NH4Cl for 8 weeks. 
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Fig 12.2. (A)Total bone mineral density, (B) cortical thickness and (C) cancellous bone mineral density of wild-type (Ogr1+/+) and OGR1 knockout 
(Ogr1–/–) female mice during metabolic acidosis.  Total bone development was not affected by NH4Cl-treatment and comparable in wild-type and OGR1 
deficient mice. Control group: animals that received standard diet; acidosis group: animals that received NH4Cl for 8 weeks. 
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12.1.5. OGR1 induces TRPV5 internalization during metabolic acidosis 
 
Quantitative RT-PCR demonstrated that metabolic acidosis did not 
affect mRNA abundance of the TRPV5 Ca2+-channel. Calbindin D28k mRNA 
expression increased after 2 days NH4Cl-loading as demonstrated previously 
(55). Moreover, chronic metabolic acidosis was associated with elevated 
mRNA expression of the TRPM6 Mg2+ channel whereas TRPM7 mRNA 
remained unaffected. However, no differences were detected between Ogr1+/+ 
and Ogr1-/- (Fig. 13). Furthermore, immunoblotting for TRPV5, calbindin D28k, 
and TRPM6 under basal conditions or after 7 days of NH4Cl demonstrated 
comparable expression levels of these proteins in kidney (Fig. 14 and 15).  
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Fig 13. Effect of acute and chronic metabolic acidosis on renal mRNA expression of 
Ca2+ and Mg2+ transport proteins in (Ogr1+/+) and (Ogr1–/–) mice.  
Renal mRNA expression levels of the epithelial Mg2+ channels TRPM6 and TRPM7 (A and B, 
respectively) and the epithelial Ca2+ channel TRPV5 and the cytosolic Ca2+-binding protein 
calbindin-D28K (CaBP28K) (C and D, respectively)  were determined during acute and chronic 
metabolic acidosis by real-time quantitative PCR analysis (n=8 animals per group), The 
expression of genes was calculated in relation to hypoxanthine guanine phosphoribosyl 
transferase (HPRT), and relative expression ratios were calculated as R=2(Ct(HPRT)-Ct(test gene); 
Control group: animals that received standard diet; acidosis group: animals that received 
0.28M NH4Cl in the drinking water for 1 day; or 2g NH4Cl/100g food for 7 days. Data are 
presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.  
(     Ogr1+/+,        Ogr1–/–).   
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Fig 14. Effect of chronic metabolic acidosis on renal protein abundance of Ca2+ 
transport proteins in (Ogr1+/+) and (Ogr1–/–) mice.   
Renal protein expression levels of the epithelial Ca2+ channel TRPV5 and the cytosolic 
calbindin-D28K were determined during chronic metabolic acidosis by western blotting analysis 
(A). Bar graphs summarizing data from immunoblotting (B); (n=6 animals per group), All data 
were normalized against β-actin. Control group: animals that received standard diet; acidosis 
group: animals that received 2g NH4Cl/100g food for 7 days. Data are presented as means ± 
SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. 
(     Ogr1+/+,      Ogr1–/–).   
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Fig 15. Effect of chronic metabolic acidosis on renal protein abundance of the Mg2+ 
transporting channel TRPM6 in OGR1+/+ and OGR1–/– mice. Renal protein expression 
levels of the epithelial Mg2+ channel TRPM6 was determined during chronic metabolic 
acidosis by western blotting analysis (A). Bar graphs summarizing data from immunoblotting 
(B); (n=6 animals per group), All data were normalized against β-actin. Control group: animals 
that received standard diet; acidosis group: animals that received 2g NH4Cl/100g food for 7 
days.  
Data are presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. 
(     Ogr1+/+       Ogr1-/-). 
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TRPV5 channels can be internalized in a regulated manner (83; 85). 
We therefore tested if changes in subcellular distribution could contribute to 
the absence of hypercalciuria in Ogr1-/- mice. Kidneys from wild-type and Ogr1 
deficient mice under basal conditions and after 7 days of NH4Cl-induced 
metabolic acidosis were stained with antibodies against TRPV5 and calbindin 
D28k (Fig. 16A and B). TRPV5 and calbindin D28k related staining was 
detected only in the distal convoluted tubule and connecting segments as 
described previously (71). TRPV5 staining was predominantely located at the 
apical membrane in both wild-type and Ogr1-/- mouse kidneys under basal 
conditions consistent with similar urinary calcium excretion (Fig. 16A). 
However, in kidneys from wild-type mice with 7 days of NH4Cl treatment, 
TRPV5 staining was almost absent from the luminal membrane and detected 
mostly intracellularly (Fig 16B). In contrast, in Ogr1-/- kidneys, NH4Cl for 7 
days did not redistribute TRPV5 staining which remained mainly on the 
luminal membrane (Fig 16B). Thus, absence of OGR1 prevents internalization 
of TRPV5 during chronic metabolic acidosis. 
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Fig 16A. Effects of chronic metabolic acidosis on the cellular localization of the epithelial Ca2+ 
channel TRPV5 in Ogr1+/+ and Ogr1–/– mice. Immunohistochemical imaging of TRPV5 and calbindin-
D28K staining in kidney cortex of control group, (n=4 animals per group), (A1) Ogr1+/+, (A2) Ogr1–/–. 
TRPV5 (red), calbindin-D28K (green) Control group: animals that received standard diet.  
A1 
A2 
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Fig 16B. Effects of chronic metabolic acidosis on the renal localization of the epithelial Ca2+ channel TRPV5 
in Ogr1+/+ and Ogr1–/– mice. Immunohistochemical imaging of TRPV5 and calbindin-D28K staining in kidney cortex of 
7 days NH4Cl treated group; (n=4 animals per group) (B1) Ogr1+/+, (B2) Ogr1–/–, TRPV5 (red), calbindin-D28K (green) 
Control group: animals that received standard diet; acidosis group: animals that received 2g NH4Cl/100g food for 7 
days. 
B2 
B1 
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12.1.6. Acetazolamide-induced metabolic acidosis does not alter 
urinary Ca2+ and Mg2+ excretion in knockout mice (Ogr1–/–) 
 
In an alternative model of metabolic acidosis, acidosis was induced in 
mice treated with the carbonic anhydrase inhibitor acetazolamide. 
Acetazolamide causes metabolic acidosis by inducing urinary bicarbonate 
wasting due to inhibition of proximal tubular bicarbonate reabsorption (73; 74). 
This type of metabolic acidosis is thus associated with high urinary pH and 
high net anion excretion and may therefore allow distinguishing between the 
effects of urinary and systemic pH (75). 
Acetazolamide caused alkaline urinary pH, as expected (Table 3). In 
addition, urinary total and fractional Ca2+ and Mg2+ excretion were similar 
between wild-type and Ogr1-/- mice during acetazolamide treatment (Fig. 17A; 
B), also serum Ca2+ and Mg2+ concentrations (Fig. 18A; 18B), and all other 
urinary parameters (Table. 3) did not show significant differences between 
genotypes. Hence, inhibition of carbonic anhydrase does not alter urinary Ca2+ 
and Mg2+ excretion in knockout mice (Ogr1–/–), whereas NH4Cl-induced 
metabolic acidosis results in the exact opposite effects. Thus, luminal pH in the 
DCT/CNT seems to be important in the long-term hypercalciuric effect of 
chronic metabolic acidosis.  
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Fig. 17. Effect of acetazolamide-induced metabolic acidosis on urinary Ca2+ and Mg2+ 
excretion in wild-type (Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per 
group)  Mice were given the carbonic anhydrase inhibitor acetazolamide in food (20 mg/kg per 
d) for 7 days, which caused metabolic acidosis; Urinary Ca2+ (A) and Mg2+ (B) excretion were 
similar between wild-type and Ogr1-/- mice. Data are presented as means ± SEM, * p < 0.05.        
(     Ogr1+/+,       Ogr1–/–).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18. Effect of acetazolamide-induced metabolic acidosis on serum Ca2+ and Mg2+ 
levels in wild-type (Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) 
Mice were given the carbonic anhydrase inhibitor acetazolamide in food (20 mg/kg per d) for 7 
days, which caused metabolic acidosis; Serum Ca2+ (A) and Mg2+ (B) levels were similar 
between wild-type and Ogr1-/- mice. Data are presented as means ± SEM * p < 0.05.     
(     Ogr1+/+,       Ogr1–/–).   
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Table 3. Acetazolamide group: blood and urine analysis. (n=8 animals per group) Mice 
were given the carbonic anhydrase inhibitor acetazolamide in food (20 mg/kg per d) for 7 
days,  
Urinary excretion was normalized against creatinine (crea). BW: body weight. 
* Significantly different between Ogr1+/+ and Ogr1-/- , * p ≤ 0.05, ** p ≤ 0.01. 
 
 
 
 
 
 
 
 
 
 
 
  Acetazolamide group   
 
 Ogr1+/+ Ogr1-/- 
 
Blood 
[Ca2+] mM in serum 2.34 ± 0.06 
 
2.14 ± 0.04  
 
[Mg2+] mM in serum 0.95 ± 0.06 
 
0.91 ± 0.05 
 
 
Urine 
pH 8.00 ± 0.08 
 
7.83 ± 0.27 
 
Creatinine (mg/dl) 27.1 ± 1.1 
 
43.4 ± 5.4 * 
 
NH3/NH4+/ (mM)/crea (mg/dl) 2.0 ± 0.3 
 
0.9 ± 0.1 ** 
 
Na+(mM)/crea (mg/dl) 3.3 ± 0.3 
 
2.7 ± 0.4 
 
K+(mM)/crea (mg/dl) 7.6 ± 0.3 
 
6.9 ± 0.7 
 
Ca2+(mM)/crea (mg/dl) 0.031 ± 0.002 
 
0.039 ± 0.002 * 
 
Mg2+(mM)/crea (mg/dl) 0.024 ± 0.009 
 
0.042 ± 0.012 
 
Phosphate(mg/dl)/crea(mg/dl) 2.2 ± 0.2 
 
1.7 ± 0.3 
 
Urine volume (ml)/ BW (g) 0.08 ± 0.01 
 
0.05 ± 0.01 ** 
 
Weight change % 3.0 ± 0.9 
 
1.2 ± 0.5 
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12.1.7. Acetazolamide-induced metabolic acidosis does not alter renal 
mRNA and protein expression of Ca2+ and Mg2+ transport 
proteins in knockout mice (Ogr1–/–) 
 
During acetazolamide-induced metabolic acidosis, quantitative RT-PCR 
did not show differences between Ogr1+/+ and Ogr1-/- in renal mRNA 
expression levels of the epithelial Ca2+ channel TRPV5 and the cytosolic Ca2+-
binding protein calbindin-D28K (CaBP28K) and the epithelial Mg2+ channels 
TRPM6 and TRPM7 (Fig. 19). Furthermore, immunoblotting for TRPV5, 
calbindin D28k, and TRPM6 after 7 days of acetazolamide demonstrated 
comparable expression levels of these proteins in kidney (Fig. 20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 19. Effect of acetazolamide-induced metabolic acidosis on renal mRNA expression 
of Ca2+ and Mg2+ transport proteins in (Ogr1+/+) and (Ogr1–/–) mice.  (n=6 animals per 
group) Renal mRNA expression levels of the epithelial Ca2+ channel TRPV5 and the cytosolic 
Ca2+-binding protein calbindin-D28K (CaBP28K) (A and B, respectively)  and the epithelial Mg2+ 
channels TRPM6 and TRPM7 (C and D, respectively) were determined during chronic 
metabolic acidosis by real-time quantitative PCR analysis (n=8 animals per group), The 
expression of genes was calculated in relation to hypoxanthine guanine phosphoribosyl 
transferase (HPRT), and relative expression ratios were calculated as R=2(Ct(HPRT)-Ct(test gene). 
Mice were given the carbonic anhydrase inhibitor acetazolamide in food (20 mg/kg per d) for 7 
days, Data are presented as means ± SEM.  
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Fig 20. Effect of acetazolamide-induced metabolic acidosis on renal protein abundance 
of Ca2+ transport proteins in (Ogr1+/+) and (Ogr1–/–) mice.   
Renal protein expression levels of the epithelial Ca2+ channel TRPV5, the cytosolic calbindin-
D28K, and the epithelial Mg2+ channel TRPM6 were determined during chronic metabolic 
acidosis by western blotting analysis (A). Bar graphs summarizing data from immunoblotting 
(B); (n=6 animals per group), All data were normalized against β-actin. Mice were given the 
carbonic anhydrase inhibitor acetazolamide in food (20 mg/kg per d) for 7 days. Data are 
presented as means ± SEM. * p < 0.05. 
(     Ogr1+/+,       Ogr1–/–).   
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12.2. Role of the H+-Activated Ovarian Cancer G Protein-Coupled 
Receptor 1 (OGR1) in Renal Calcium and Magnesium handling 
 
 
The expression of the proton activated receptor OGR1 as described 
earlier in the text, was detected in the kidney in most nephron segments 
including the thick ascending limb and distal tubule, major sides of regulated 
calcium and magnesium reabsorption (37; 38; 50; 51; 52). Under normal 
conditions, analysis of different urinary electrolytes in the Ogr1-/- mice did not 
show any changes compared to the wild-type animals (table 4). However, 
urinary magnesium excretion was reduced, and a tendency to a lower urinary 
calcium excretion was observed (Fig. 21, Table 4). Thus we tested if OGR1 
contributes to the regulation of renal calcium and magnesium handling using 
different calcium and magnesium diets.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 21. Urinary Ca2+ and Mg2+ excretion in wild-type (Ogr1+/+) and OGR1 knockout mice 
(Ogr1–/–). (n=8 animals per group) Mice were investigated on normal standard chow in 
metabolic cages and urine analyzed. Ogr1 deficient mice showed lower urinary magnesium 
excretion (A), However; no significant differences could be detected for calcium excretion 
between Ogr1+/+ and Ogr1-/- mice (B).  
Data are presented as means ± SEM. * p < 0.05.  
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Table 4. Control group: Summary of blood and urine analysis. (n=8 animals per group) 
Mice were investigated in normal standard chow in metabolic cages and urine and blood 
analyzed. 
Urinary excretion was normalized against creatinine (crea). BW: body weight. 
* Significantly different between Ogr1+/+ and Ogr1-/- , * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
 
 
  Control group  
 
 Ogr1+/+ Ogr1-/- 
 
Serum 
[Ca2+] mM  2.10 ± 0.16 2.30 ± 0.12   
[Mg2+] mM  1.02 ± 0.04 1.06 ± 0.04 
 
Urine 
pH 6.28 ± 0.14 6.65 ± 0.26 
Creatinine (mg/dl) 55.8 ± 8.4 58.2 ± 8.3 
Na+(mM)/crea (mg/dl) 2.1 ± 0.5 2.5 ± 0.6 
K+(mM)/crea (mg/dl) 6.0 ± 1.1 6.7 ± 0.6 
Ca2+(mM)/crea (mg/dl) 0.042 ± 0.003 0.031 ± 0.004 
Mg2+(mM)/crea (mg/dl) 0.51 ± 0.14 0.34 ± 0.10 * 
Phosphate(mg/dl)/crea(mg/dl) 0.33 ± 0.03 0.29 ± 0.02 
Osmolality (mOsm/kg H2O) 2518 ± 525 3050 ± 509 
Urine volume (ml)/ BW (g) 0.04 ± 0.01 0.04 ± 0.06 
Weight change % 1.4 ± 1.3  0.3 ± 1.1 
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12.2.1. OGR1 and regulation of Ca2+ and Mg2+ handling by dietary 
intake of Ca2+  
 
 
12.2.1.1. OGR1 may be involved in the renal regulation of Mg2+ and 
Ca2+ handling by dietary intake of  Ca2+ 
 
Ogr1-/- mice showed an altered renal excretion of Mg2+ after 2 and 7 
days high Ca2+ diet (Fig. 22A; Table 5) and after 7 days low Ca2+ diet (Fig. 
22B; Table 6). Serum Mg2+ concentrations were not different between Ogr1+/+ 
and Ogr1-/- in all conditions (Fig. 24; Tables 5; 6) except after 7 days high Ca2+ 
treatment where the Mg2+ level in serum was higher in the Ogr1-/-  compared to 
the wild-type mice. These results suggest possible alterations of Mg2+ handling 
on the kidney level. 
In addition, Ogr1-/- mice showed an altered renal excretion of Ca2+ after 
2 and 7 days high Ca2+ diet (Fig. 23A; Table 5), However, urinary Ca2+ 
excretion levels were not different between Ogr1+/+ and Ogr1-/- when animals 
were treated with a low calcium diet (Fig. 23B) in all conditions, serum Ca2+ 
concentrations were not different between Ogr1+/+ and Ogr1-/- (Fig. 25; Table 
5; 6). These data suggest that OGR1 could be involved in the control of renal 
Ca2+ handling. 
It is important to note that after 2 days high Ca2+ diet changes in urinary 
Ca2+ and Mg2+ excretion were parallel, however, after 7 days high Ca2+ diet the 
differences between Ogr1+/+ and Ogr1-/- mice in the urinary Ca2+ and Mg2+ 
excretion were opposite (Fig 22A; 23A). In addition, after 7 days low Ca2+  diet, 
urinary Mg2+ level in Ogr1-/- was significantly higher compared to the Ogr1+/+ 
while no changes were detected in the urinary Ca2+ excretion (Fig. 22B; 23B).  
Taken together, these preliminary results suggest that the proton-
activated receptor OGR1 may be involved in the renal regulation of Mg2+ and 
Ca2+ handling by dietary intake of Ca2+. 
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Fig 22. Urinary Mg2+ excretion during high (2 %) or low (0.05 %) calcium diets in wild-
type (Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given 
either a high calcium diet (2% Ca2+) (A) or a low calcium diet (0.05% Ca2+) (B) for 2 or 7 days, 
respectively. Ogr1-/- mice showed altered Mg2+ excretion in these conditions. Control group: 
animals that received standard diet. Data are presented as means ± SEM. * p < 0.05, ** p < 
0.01, *** p < 0.001. 
(     Ogr1+/+,       Ogr1–/–).   
 
 
 
 
 
 
 
 
 
 
 
Fig 23. Urinary Ca2+ excretion during high and low calcium diets in wild-type (Ogr1+/+) 
and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given either a high 
calcium diet (2% Ca2+) (A) or a low calcium diet (0.05% Ca2+) (B) for 2 or 7 days, respectively. 
Control group: animals that received standard diet. 
Data are presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Fig 24. Serum Mg2+ concentration during high and/or low calcium diets in wild-type 
(Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given 
either a high calcium diet (2% Ca2+) (A) or a low calcium diet (0.05% Ca2+) (B) for 2 and 7 
days, respectively. Serum magnesium levels were not affected by low and high calcium diets 
and are comparable in wild-type and OGR1 deficient mice. Control group: animals that 
received standard diet. 
Data are presented as means ± SEM. * p < 0.05.  
(     Ogr1+/+,       Ogr1–/–).   
  
 
 
 
 
 
 
 
 
 
 
Fig 25. Serum total Ca2+ concentration during high and low calcium diets in wild-type 
(Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given 
either a high calcium diet (2% Ca2+) (A) or a low calcium diet (0.05% Ca2+) (B) for 2 and 7 
days, respectively. Serum total calcium levels were not affected by low and high calcium diets 
and are comparable in wild-type and OGR1 deficient mice. Control group: animals that 
received standard diet. Data are presented as means ± SEM. * p < 0.05. 
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Table 5. High calcium group: Summary of Blood and urine analysis. (n=8 animals per group) High calcium group: animals that received high calcium diet 
(2% Ca2+) for 2 and 7 days.  Urinary excretion was normalized against creatinine (crea). BW: body weight. 
* Significantly different between Ogr1+/+ and Ogr1-/- for the same treatment, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
# Significantly different between control group (Table 4) and treated group for the same genotype, # p ≤ 0.05, ## p ≤ 0.01, ### p ≤ 0.001 
    2 days 2%  Ca2+ 
 
7 days 2%  Ca2+ 
 Ogr1+/+ Ogr1-/- Ogr1+/+ Ogr1-/- 
 
Serum 
[Ca2+] mM  1.96 ± 0.10 2.30 ± 0.1 2.11 ± 0.04 2.34 ± 0.1  
[Mg2+] mM  0.98 ± 0.04 1.06 ± 0.03 0.82 ± 0.03 1.00 ± 0.07 * 
 
Urine 
pH 7.77 ± 0.41 ## 7.50 ± 0.25 # 7.53 ± 0.16 ### 7.53 ± 0.17 # 
Creatinine (mg/dl) 45.1 ± 2.8  57.6 ± 8.4  
 
35.5 ±9.3 32.6 ± 4.0 # 
Na+(mM)/crea (mg/dl) 9.4 ± 1.4 
###  9.8 ± 1.0 ### 15.3 ± 1.3 ### 11.4 ±2.0 ## 
K+(mM)/crea (mg/dl) 2.8 ± 0.4 
### 2.8 ± 0.4 5.4 ± 0.4 4.1 ± 0.8 #  
Ca2+(mM)/crea (mg/dl) 0.05 ± 0.01 
 0.04 ± 0.01 0.14 ± 0.02 0.05 ± 0.01 ** 
Mg2+(mM)/crea (mg/dl) 0.38 ± 0.05
 0.23 ± 0.06 0.18 ± 0.04 # 0.5 ± 0.1 * 
Phosphate(mg/dl)/crea(mg/dl) 0.20 ± 0.03 # 0.34 ± 0.08 0.65 ± 0.10 # 0.70 ± 0.20 # 
Osmolality (mOsm/kg H2O) 1028 ± 135 # 2006 ± 316 * 1953 ± 298 2062 ± 222 
Urine volume (ml)/ BW (g) 0.11 ± 0.02 0.02 ± 0.01 * 0.07 ± 0.01 0.07 ± 0.01 
Weight change % 2.0 ± 0.7  1.7 ± 0.4 0.8 ± 0.7  1.7 ± 1.0 
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Table 6. Low calcium group: Summary of Blood and urine analysis.  (n=8 animals per group) Low calcium group: animals that received low calcium diet 
(0.05% Ca2+) for 2 and 7 days.  Urinary excretion was normalized against creatinine (crea). BW,: body weight. 
* Significantly different between Ogr1+/+ and Ogr1-/- for the same treatment, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
# Significantly different between control group (Table 4) and treated group for the same genotype, # p ≤ 0.05, ## p ≤ 0.01, ### p ≤ 0.001 
  2 days 0.05% Ca2+ 
 
7 days 0.05% Ca2+ 
 Ogr1+/+ Ogr1-/- Ogr1+/+ Ogr1-/- 
 
Serum 
[Ca2+] mM 2.40 ± 0.07 2.08 ± 0.07 * 2.06 ± 0.03 2.00 ± 0.12 # 
[Mg2+] mM  1.12 ± 0.05 1.10 ± 0.08 1.00 ± 0.08 1.00 ± 0.10 
 
Urine 
pH 5.87 ± 0.17 5.82 ± 0.12 # 5.84 ± 0.04 # 5.86 ± 0.03 # 
Creatinine (mg/dl) 41.6 ± 6.0 37.6 ± 5.3 24.5 ± 5.3 ## 18.7 ± 1.3 ## 
Na+(mM)/crea (mg/dl) 16.0 ± 2.3 
### 9.4 ± 0.7 ###*  16.5 ± 1.9 ### 17.5 ± 0.6 ### 
K+(mM)/crea (mg/dl) 4.7 ± 0.2
 3.2 ± 0.3 
###** 
5.5 ± 0.7 6.5 ± 0.3 
Ca2+(mM)/crea (mg/dl) 0.06 ± 0.02 0.04 ± 0.01 0.07 ± 0.01 0.05 ± 0.01 
Mg2+(mM)/crea (mg/dl) 0.60 ± 0.005 0.41 ± 0.03 * 0.41 ± 0.10 0.72 ± 0.07 
#* 
Phosphate(mg/dl)/crea(mg/dl) 2.36 ± 0.44 
### 
1.88± 0.24 
### 
5.18 ± 0.6 ### 6.00 ± 0.41 ### 
Osmolality (mOsm/kg H2O) 3451 ± 345 1954 ± 241** 1731 ± 224 1852 ± 162 # 
Urine volume (ml)/ BW (g) 0.07 ± 0.01 # 0.1 ± 0.01 ### 0.06 ± 0.02 0.1 ± 0.01 ### 
Weight change % 0.94 ± 0.2 0.97 ± 0.6 1.3 ± 1.4 2.8 ± 0.5 
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12.2.1.2 OGR1 may be involved in the renal regulation of the 
epithelial Mg2+ channel TRPM6 by dietary intake of Ca2+ 
 
Quantitative RT-PCR demonstrated that loss of OGR1 affects TRPM6 
mRNA expression in the kidney in response to 2 and 7 days low and high Ca2+ 
diets    (Fig. 26). After 2 and 7 days high Ca2+ diet changes in TRPM6 mRNA 
expression were parallel to the urinary magnesium excretion in the kidney 
(Fig. 26; 22). However, after 2 days low Ca2+ diet, TRPM6 mRNA levels in 
Ogr1-/- were significantly higher compared to the Ogr1+/+ while no changes 
were detected in the urinary magnesium excretion (Fig. 26; 22).  
Importantly, TRPM7 and Paracellin (Claudin 16) mRNA levels 
remained unaffected after low and high Ca2+ dietary intake (Fig. 27 A and B) 
indicating a selective difference.  
In the intestine, no differences between Ogr1+/+ and Ogr1-/- mice were 
detected in TRPM6 and TRPM7 mRNA expression after 2 days high and low 
Ca2+ diet (Fig. 28). Thus, our preliminary data suggest that OGR1 may be 
involved in the renal regulation of the epithelial magnesium channel TRPM6 
expression by dietary Ca2+ intake.  
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Fig 26. Effect of high and low calcium diets on renal mRNA expression of the epithelial 
Mg2+ channels TRPM6 in (Ogr1+/+) and (Ogr1–/–) mice.  
Renal mRNA expression levels of the epithelial Mg2+ channels TRPM6 were determined in 
control, low calcium and high calcium groups by real-time quantitative PCR analysis (n=8 
animals per group), The expression of genes was calculated in relation to hypoxanthine 
guanine phosphoribosyl transferase (HPRT), and relative expression ratios were calculated as 
R=2(Ct(HPRT)-Ct(test gene); Control group: animals that received standard diet; Low calcium group: 
animals that received low calcium diet (0.05% Ca2+) for 2 and 7 days. High calcium group: 
animals that received high calcium diet (2% Ca2+) for 2 and 7 days.    Data are presented as 
means ± SEM. * p < 0.05 
(     Ogr1+/+,       Ogr1–/–).   
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Fig 27. Effect of high and low calcium diets on renal mRNA expression of Mg2+ 
transport proteins in (Ogr1+/+) and (Ogr1–/–) mice.  
Renal mRNA expression levels of the epithelial Mg2+ channel TRPM7 (A) and Paracellin 
(Claudin 16) (B) were determined in control, low calcium and high calcium groups by real-time 
quantitative PCR analysis (n=8 animals per group), The expression of genes was calculated 
in relation to hypoxanthine guanine phosphoribosyl transferase (HPRT), and relative 
expression ratios were calculated as R=2(Ct(HPRT)-Ct(test gene); Control group: animals that 
received standard diet; Low calcium group: animals that received low calcium diet (0.05% 
Ca2+) for 2 and 7 days. High calcium group: animals that received high calcium diet (2% Ca2+) 
for 2 and 7 days. Data are presented as means ± SEM. * p < 0.05. 
(     Ogr1+/+,       Ogr1–/–).   
A 
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Fig. 28 Effect of low and high calcium diets on intestinal mRNA expression of Mg2+ 
transport proteins in (Ogr1+/+) and (Ogr1–/–) mice.  
Renal mRNA expression levels of the epithelial Mg2+ channels TRPM6 and TRPM7 were 
determined in 2 days low and high calcium groups by real-time quantitative PCR analysis (n=8 
animals per group), The expression of genes was calculated in relation to hypoxanthine 
guanine phosphoribosyl transferase (HPRT), and relative expression ratios were calculated as 
R=2(Ct(HPRT)-Ct(test gene); Control group: animals that received standard diet; Low calcium group: 
animals that received low calcium diet (0.05% Ca2+) for 2 and 7 days. High calcium group: 
animals that received high calcium diet (2% Ca2+) for 2 and 7 days. Data are presented as 
means ± SEM. * p < 0.05. 
(     Ogr1+ +,       Ogr1–/–).   
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12.2.2.  OGR1 and regulation of Ca2+ and Mg2+ handling by dietary 
intake of Mg2+ 
 
 
12.2.2.1 OGR1 may be involved in the renal regulation of Ca2+ and 
Mg2+handling by dietary intake of Mg2+ 
 
Ogr1-/- mice showed an altered renal excretion of Mg2+ after 7 days high 
Mg2+ diet (Fig. 29A; Table 7) but not after low Mg2+ treatment (Fig. 24B; Table 
8).  Additionaly, urinary Ca2+ excretion levels were not different between 
Ogr1+/+ and Ogr1-/-  when animals were treated with both high and low Mg2+ 
diets (Fig. 30; tables 7 and 8). 
After 7 days high Mg2+ diet, serum Ca2+ and Mg2+ concentrations 
showed higher levels in the Ogr1-/- compared to the Ogr1+/+ (Fig. 31A; 32A), 
however no significant changes in the serum Ca2+ and Mg2+ concentrations 
were observed after 2 days high Mg2+ diet (Fig. 31A; 32A) or 2 and 7 days low 
Mg2+ diet (Fig. 31B; 32B).  
These preliminary data suggest that OGR1 could be involved in the 
control of renal Ca2+ and Mg2+ handling by dietary intake of Mg2+. 
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Fig 29. Urinary Mg2+ excretion during high and low magnesium diets in wild-type 
(Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given 
either a high magnesium diet (0.6% Mg2+) (A) or a low magnesium diet (0.01% Mg2+) (B) for 2 
and 7 days, respectively. Ogr1-/- mice showed altered Mg2+ excretion only after 7 days high 
magnesium diet. Control group: animals that received standard diet. 
Data are presented as means ± SEM. * p < 0.05.  
(     Ogr1+/+,       Ogr1–/–).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 30. Urinary Ca2+ excretion during high and low Magnesium diets in wild-type 
(Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given 
either a high magnesium diet (0.6% Mg2+) (A) or a low magnesium diet (0.01% Mg2+) (B) for 2 
and 7 days, respectively. Control group: animals that received standard diet.  
Data are presented as means ± SEM. * p < 0.05. 
(     Ogr1+ +,       Ogr1–/–).   
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Fig 31. Serum Mg2+ concentration during high and low magnesium diets in wild-type 
(Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given 
either a high magnesium diet (0.6% Mg2+) (A) or a low calcium diet (0.01% Mg2+) (B) for 2 and 
7 days, respectively. Control group: animals that received standard diet. 
Data are presented as means ± SEM. * p < 0.05. 
(     Ogr1+ +,       Ogr1–/–).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 32. Serum total Ca2+ concentration during high and low magnesium diets in wild-
type (Ogr1+/+) and OGR1 knockout mice (Ogr1–/–). (n=8 animals per group) Mice were given 
either a high magnesium diet (0.6% Mg2+) (A) or a low calcium diet (0.01% Mg2+) (B) for 2 and 
7 days, respectively. Control group: animals that received standard diet. 
Data are presented as means ± SEM. * p < 0.05. 
(     Ogr1+ +,       Ogr1–/–).   
0.0
0.5
1.0
1.5
Mg2+ in serum
Low Mg2+ diet
7 days
0.01% Mg2+
2 days 
0.01% Mg2+
Control 
M
g2
+  
(m
M
)
B A 
 Ca2+ in serum
low Mg2+ diet
0
1
2
3
C
a2
+  
(m
M
)
7 days
0.01% Mg2+
2 days 
0.01% Mg2+
Control 
Ca2+ in serum
high Mg2+ diet
0
1
2
3
**
7 days
0.6% Mg2+
2 days 
0.6% Mg2+
Control 
C
a2
+  
(m
M
)
B A 
 Mg2+ in serum
  High Mg2+ diet
0.0
0.5
1.0
1.5
7 days
0.6% Mg2+
2 days 
0.6% Mg2+
Control 
***
M
g2
+  
(m
m
ol
/l)
 70 
  2 days 0.6% Mg2+ 
 
7 days 0.6% Mg2+ 
 Ogr1+/+ Ogr1-/- Ogr1+/+ Ogr1-/- 
 
Serum 
[Ca2+] mM  2.31 ± 0.17 2.17 ± 0.05 1.83 ± 0.11 #  1.03 ± 0.20 ** 
[Mg2+] mM  1.10 ± 0.04 1.14 ± 0.03 1.02 ± 0.05 0.70 ± 0.03  ### 
***  
 
Urine 
pH 6.80 ± 0.23 7.40 ± 0.13 # 7.09 ± 0.14 ## 6.83 ± 0.12 
Creatinine (mg/dl) 127.2 ± 23.34 133.1± 21.38 # 16.17 ± 3.56 ### 33.55 ± 4.07 **# 
Na+(mM)/crea (mg/dl) 3.58 ± 0.56 4.13 ± 0.24 
# 25.37 ± 2.19 ### 12.69 ±1.03 ### 
*** 
K+(mM)/crea (mg/dl) 1.65 ±0.14 
### 1.74 ±0.13 ### 8.04 ± 0.86 4.63 ± 0.48 #** 
Ca2+(mM)/crea (mg/dl) 0.02 ±0.005 
## 0.01 ± 0.001 # 0.1 ± 0.012 0.054 ± 0.012 * 
Mg2+(mM)/crea (mg/dl) 0.18 ± 0.03 
##  0.16 ± 0.02 # 1.16 ± 0.12 ## 0.62 ± 0.1 ** 
Phosphate(mg/dl)/crea(mg/dl) 0.18 ± 0.01 ## 0.10±0.02 ###** 1.00 ± 0.08 ### 0.56 ± 0.14 * 
Urine volume (ml)/ BW (g) 0.043 ± 0.01 0.04 ± 0.01 0.06 ± 0.006 0.1 ± 0.01 ## 
Weight change % 3.64 ± 0.63 2.54 ± 0.59 2.83 ± 0.32 2.33 ± 0.60 
 
Table 7. High magnesium group: Summary of Blood and urine analysis.  (n=8 animals per group) High magnesium group: animals that received high 
magnesium diet (0.6% Mg2+) for 2 and 7 days.  Urinary excretion was normalized against creatinine (crea). BW: body weight. 
* Significantly different between Ogr1+/+ and Ogr1-/- for the same treatment, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
# Significantly different between control group (Table 4) and treated group for the same genotype, # p ≤ 0.05, ## p ≤ 0.01, ### p ≤ 0.001 
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Table 8. Low magnesium group: Summary of blood and urine analysis.  . (n=8 animals per group) Low magnesium group: animals that received low 
magnesium diet (0.01% Mg2+) for 2 and 7 days.  Urinary excretion was normalized against creatinine (crea). BW: body weight. 
* Significantly different between Ogr1+/+ and Ogr1-/- for the same treatment, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
# Significantly different between control group (Table 4) and treated group for the same genotype, # p ≤ 0.05, ## p ≤ 0.01, ### p ≤ 0.001 
  2 days 0.01% Mg2+ 
 
 
7 days 0.01% Mg2+ 
 Ogr1+/+ Ogr1-/- Ogr1+/+ Ogr1-/- 
 
Serum 
[Ca2+] mM  2.06 ± 0.09 2.01 ± 0.13 2.53 ± 0.18 & 2.16 ± 0.08 
[Mg2+] mM  0.65 ± 0.04 ### 0.60 ± 0.03 ### 0.73 ± 0.02 ### 0.73 ± 0.05 & ### 
 
Urine 
pH 6.55 ± 0.1 6.24 ± 0.05 6.07 ± 0.03 6.1 ± 0.02 
Creatinine (mg/dl) 40.72 ± 7.7 53.85 ± 12.9 33.06 ± 2.8 ## 17.4 ± 4.19 ### 
** 
Na+(mM)/crea (mg/dl) 12.75±1.24 
###  10.26 ±1.47 ## 12.26 ± 1.14 ###  24.78 ±2.99###**
K+(mM)/crea (mg/dl) 4.94 ± 0.4  3.34 ± 0.4 
### * 4.56 ± 0.43 8.96 ± 0.88 *** 
Ca2+(mM)/crea (mg/dl) 0.03 ± 0.01
# 0.03 ± 0.01 0.03 ± 0.01# 0.04 ± 0.01 
Mg2+(mM)/crea (mg/dl) 0.08 ± 0.01 
## 0.07 ± 0.01 ## 0.025 ± 0.01 ### 0.04 ±0.01 ## 
Phosphate(mg/dl)/crea(mg/dl) 1.37 ± 0.12 ### 1.02 ± 0.21 ##  1.52 ± 0.10 ## 3.28 ± 0.63### * 
Urine volume (ml)/ BW (g) 0.062 ± 0.01  0.03 ± 0.01  0.07 ± 0.01 # 0.1 ± 0.01 ## 
Weight change % 5.36 ± 0.7 # 4.45 ± 0.7 # 1.28 ± 0.2 1.0 ± 0.7 
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13. DISCUSSION  
 
13.1. Role of OGR1 in systemic and renal acid-base homeostasis 
 
Systemic acid-base homeostasis is mainly characterized by a constant 
pH of around 7.40 and a bicarbonate concentration of 25 mM in blood and 
most extracellular fluids. Both blood pH and bicarbonate concentration are 
regulated by different organs including kidney, lungs, intestine, skeletal 
muscle and bone, and may be altered by many factors such as physical 
activity, dietary intake, metabolism and diseases (106; 107). The kidney plays 
a major role in controlling systemic acid-base homeostasis and thus needs to 
respond to systemic and local changes in pH and bicarbonate levels. Several 
regulatory factors have been implicated into the control of renal acid-base 
handling such as the renin-angiotensin-aldosterone system or endothelin, in 
addition, local pH sensing mechanisms have been observed (107), however 
their molecular identity and regulation have remained elusive to date.  
Recently, Ludwig et al. reported that the novel G-protein coupled 
receptor OGR1 acts as a proton sensing receptor, and that its activation by 
extracellular protons leads to IP3 production and transient intracellular calcium 
release (5). In the present project, we demonstrated in agreement with 
previous studies (Xu Y 1996, Zhu K 2001), that OGR1 mRNA is expressed in 
various tissues including epithelial structures such as kidney and small and 
large intestine, where are expressed the major acid-base transporters. In the 
kidney we detected OGR1 expression in different nephron segments, 
importantly; the distal convoluted tubule and the collecting duct.  
Interestingly, using stably OGR1-transfected cells we demonstrated in 
a different project that did not contribute to this work (N Mohebbi, C 
Benabbas, CA Wagner unpublished results) that OGR1 affects in a pH-
dependent manner the activity of two important proton transporters in the 
kidney: NHE3, a major Na+/H+ exchanger in the proximal tubule (109), and 
vacuolar H+-ATPases which are expressed in the proximal tubule and the type 
A intercalated cells of the collecting duct (110). Therefore, we aimed in the 
present study to evaluate the potential role of OGR1 in the regulation of acid-
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base transport and homeostasis in vivo using the OGR1 deficient mouse 
model. 
Under control conditions, no differences in systemic acid-base 
parameters in blood or urine could be detected. Importantly, both wild-type 
and Ogr1–/– mice that received NH4Cl developed chronic metabolic acidosis 
characterized by a decrease in blood pH, a reduced serum HCO3– 
concentration, and a low urine pH with similar ammonium excretion, as was 
described in previous studies from our laboratory for other mouse models (75; 
61).  
However, in contrast to our expectations, during NH4Cl induced chronic 
metabolic acidosis, no impairment of acid-base handling was seen in the 
Ogr1–/– mice indicating that OGR1 is dispensable for normal acid-base status 
and adaptation to an acute or chronic acid-load.  
These results could be explained by the presence of other extracellular 
proton sensing receptors or pH-sensitive regulatory processes as well as by 
different mechanisms which may have a compensatory effect. Indeed, the 
presence of other regulatory factors in vivo (Ogr1–/– mouse model) could 
compensate for loss of OGR1 activity. The G-protein coupled receptor GPR4 
is expressed in various tissues including epithelial structures such as kidney 
and intestine, major sides of regulated acid-base transport. In the kidney, 
GPR4 mRNA expression was detected in different nephron segments 
importantly in the collecting duct along with OGR1 (A Velic, C Benabbas, CA 
Wagner unpublished results). However, we did not find changes in GPR4 
mRNA expression in OGR1 deficient mice. Moreover, mice deficient for OGR1 
and GPR4 do not show more exacerbated metabolic acidosis compared to 
their wild-type or single KO mice indicating that OGR1 and GPR4 do not 
compensate for each other (Velic, Wagner, unpublished results). 
Furthermore, the soluble adenylyl cyclase (sAC) has been described as 
an intracellular pH sensor that is expressed in different tissues including 
epididymis, testis and kidney (119; 120; 121; 122). In the kidney the sAC is 
mainly expressed in the thick ascending limb, the distal tubule and the 
collecting duct. The sAC is activated by a rise in intracellular calcium and 
bicarbonate ions, and its stimulation leads to intracellular elevation of cAMP 
concentrations (120; 123). Recently, Paunescu et al. (2008) showed that in 
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the kidney, the sAC is highly expressed in type A and B intercalated cells, and 
its localization partially overlaps with the V-ATPases (124). They therefore 
suggested that the sAC regulated cAMP signaling may constitute a general 
sensing mechanism for regulating V-ATPase mediated proton transport in the 
kidney (124). These findings are consistent with the hypothesis that the sAC 
could be a part of the pH sensing mechanism compensating the absence of 
OGR1.  
Furthermore, in a kidney proximal tubule epithelial cell line, Pyk2 
activation by intracellular acidification was shown to be required for acid 
activation of NHE3 and c-Src kinase (125). In addition, other studies 
suggested that intracellular acidosis in the proximal tubule cells is sensed by 
Pyk2 kinase which then activates c-Src. In a parallel pathway, acid activates 
ERK1/2 resulting in increased c-fos/c-jun abundance. Together with c-fos/c-
jun, Pyk2/c-Src increases transcription factors leading to the increased NHE3 
activity in the proximal tubule. We therefore speculate that Pyk2/c-Src 
pathway may be involved in the pH sensing mechanism compensating the 
absence of OGR1 activity (128). 
 Clearly, further work is needed to elucidate the role of OGR1 in the 
acid base regulation and to understand the exact mechanism of local pH 
sensing in the kidney. 
 
13.2. Role of OGR1 in renal calcium and magnesium excretion 
during metabolic acidosis 
 
It is well known that acid-base status affects renal handling of calcium 
and magnesium (35; 50; 54; 55). Different studies, including micropuncture 
experiments, demonstrated that disturbances in systemic acid-base balance 
specifically influenced Ca2+ and Mg2+ reabsorption in the DCT and CNT (103; 
111) major sides of OGR1 mRNA localization. In our study, we show that 
chronic metabolic acidosis that was induced by NH4Cl loading enhanced urine 
Ca2+ and Mg2+ excretion in wild-type mice. These results are in line with what 
has been described in previous studies (55; 54), however, the elevated urinary 
Ca2+ and Mg2+ excretion during acid load was not detected in Ogr1-/- mice, 
suggesting a participation of OGR1 in renal Ca2+ and Mg2+ handling. 
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Therefore, our study provided the first evidence for a pH-dependent role of 
OGR1 in the renal Ca2+ and Mg2+ loss during chronic metabolic acidosis. 
In addition, our findings clearly demonstrated that during chronic 
metabolic acidosis OGR1 is not involved in the regulation of transcriptional 
and translational levels of the epithelial Mg2+ channel TRPM6 that plays an 
important role in the active Mg2+ reabsorption (77; 78), the epithelial Ca2+ 
channel TRPV5 and the cytosolic calcium binding protein calbindin-D28K. Both 
proteins are involved in the active Ca2+ reabsorption in the DCT and CNT (35).  
Our study also demonstrated that in wild-type mice, chronic metabolic 
acidosis is responsible for the elevation of renal TRPM6 mRNA expression, 
but does not influence its protein level. However, the renal protein as well as 
mRNA levels of TRPV5 and calbindin-D28K were not influenced by these 
disturbances of acid-base balance. In contrast to our findings, Nijenhuis et al. 
reported that chronic metabolic acidosis is associated with decreased renal 
expression of TRPV5 calbindin-D28K and TRPM6 leading to the development 
of hypercalciuria and hypomagnesemia in mice (54). In this study, however, 
protein abundance was estimated from the intensity of immunohistochemical 
staining, a method that is rather error-prone and not very quantitative. 
Other observations clearly pointed out that extracellular acidification in 
vitro results in decreased TRPV5 channel activity at the apical cell membrane, 
as well as in a rapid retrieval of TRPV5 from the apical membrane, Lambers et 
al 2007 (83) demonstrated that the exposure of TRPV5-expressing cells to an 
alkaline extracellular environment (pH 8.0) caused rapid recruitment of 
TRPV5-containing vesicles to the cell surface and a consequent increase in 
TRPV5 activity (83). In the reciprocal experiment, acidic extracellular milieu 
(pH 6.5) induced the internalization of TRPV5-containing vesicles from the 
plasma membrane, resulting in a reduced channel activity (83). These data 
are compatible with our results which demonstrate for the first time in vivo that 
direct sensing of acid-base status at the membrane by OGR1 may participate 
in the regulation mechanism of the apically localized epithelial Ca2+ channel 
TRPV5 and lead to its internalization inducing hypercalciuria during chronic 
metabolic acidosis. 
Indeed, TRPV5 can be controlled by trafficking of the protein to and 
from the plasma membrane. S100A10 was recently identified as a binding 
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partner of TRPV5 (84). S100A10 is predominantly present as a 
heterotetrameric complex with annexin-2, which has been implicated in many 
cellular processes, including endocytosis and exocytosis (85). An important 
regulatory role has been proposed for the S100A10–annexin-2 heteromer in 
TRPV5 functioning (84). The binding of annexin-2 to TRPV5 through S100A10 
was shown to facilitate the translocation of TRPV5 toward the plasma 
membrane (85). S100A10 activity is regulated by intracellular calcium and 
stimulated by rises in intracellular calcium. The small GTPase Rab11a has 
also been identified as a novel TRPV5- associated protein (86). Rab11a is 
one of the key regulatory proteins that control the recycling of endosomes (87; 
89). 
On the other hand, experiments in transfected cell lines suggested that 
stimulation of OGR1 results in activation of phospholipase C via pertussis 
toxin sensitive G-proteins and a rise in intracellular Ca2+ concentrations (5). 
Also increased phosphorylation of ERK1/2 MAPK kinases upon 
overexpression of OGR1 was described (19). 
Therefore, our data suggest that the OGR1 signaling cascade may 
converge with the TRPV5 regulation pathway leading to the control of the 
protein trafficking to and from the plasma membrane, but future studies will 
have to elucidate the exact mechanism of this regulation.   
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Fig 33. Putative pathways of OGR1-TRPV5 regulation during chronic metabolic acidosis
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In our study, acetazolamide treated mice demonstrated that in mild 
systemic metabolic acidosis in the presence of an alkaline urine, no difference 
between wild-type and OGR1 deficient mice could be detected. Thus, these 
results may indicate that either OGR1 is localized to the luminal membrane 
and senses urinary pH or that another pH –sensitive mechanism is sensing 
luminal pH and overrides OGR1 dependent signals from the basolateral 
membrane. Unfortunately, OGR1 subcellular localization has not been 
determined to date due to the lack of specific antibodies (Mohebbi, Wagner, 
unpublished results). The localization of OGR1 on the luminal membrane 
would be difficult to reconcile with its pH-dependent activation which shows 
half-maximal activation around pH 7.3 and full activity at pH 6.8. Urinary pH in 
the DCT and CNT is physiologically in the range of pH 6.6- pH 7.0 and would 
lead to the tonic activation of OGR1. 
 
Regarding our results concerning the regulatory mechanism of the 
epithelial Ca2+ channel TRPV5, we can hypothesize that OGR1 may also 
participate in the regulation of the apically localized epithelial Mg2+ channel 
TRPM6 and leads to its internalization inducing hypomagnesemia during 
chronic metabolic acidosis. In line with our hypothesis, previous studies 
demonstrated that TRPM6 can be controlled by trafficking of the protein to and 
from the plasma membrane.  Very recently, Thébault et al. (118) showed that 
the epidermal growth factor EGF stimulates TRPM6 trafficking from the 
cytosol to the plasma membrane leading to its increased expression (118). 
Therefore, future studies will have to elucidate the exact mechanism by which 
OGR1 may regulate the renal TRPM6 expression during chronic metabolic 
acidosis. 
 
13.3. OGR1 and its role in bone 
 
It is well known that chronic metabolic acidosis increases urinary 
calcium excretion (35), hypercalciuria in these states may contribute to loss of 
calcium from bone resulting in the development of metabolic bone disease, 
such as osteopenia and osteoporosis (56). The proton sensing receptor OGR1 
was reported to be expressed and functional in both osteoblasts and 
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osteoclasts (5; 26). A recent study suggested that OGR1 is an osteoblast 
proton sensor and showed that this receptor is involved in acid induced bone 
resorption (27). Similarly, OGR1 was shown to be strongly up-regulated during 
osteoclastogenesis (25) and that in osteoclasts, its activation with extracellular 
protons results in intracellular calcium rise and bone resorption (26). 
Therefore, we aimed in a collaborative project with Novartis to evaluate 
the potential role of OGR1 in the proton sensing mechanism of bone cells 
using the OGR1 deficient mouse model. During NH4Cl induced chronic 
metabolic acidosis for 8 weeks bone morphology, total bone mineral density, 
in Ogr1+/+ and Ogr1-/- mice were similar. Moreover, the in vitro absorptive 
activity of osteoclasts insolated from wild-type and OGR1 deficient mice 
showed almost identical proliferation and reabsorptive capacities, in stark 
contrast to previous reports suggesting that OGR1 was criticial for osteoclast 
activation and activity (25; 26). Thus, our results strongly indicate that OGR1 
is not responsible for bone resorption during chronic metabolic acidosis. Bone 
resorption releases calcium and the hypercalcuria during chronic metabolic 
acidosis has been ascribed mainly to the release of calcium from bone (128). 
However, the fact that mice lacking the renal TRPV5 channel do not increase 
renal calcium excretion during metabolic acidosis may indicate that the major 
mechansim of hypercalcuria is actually the down-regulation of TRPV5 in the 
kidney (54).  
Thus our study suggests strongly that OGR1 is responsible for renal 
calcium loss due to the internalization of the renal epithelial Ca2+ channel 
TRPV5, and that its role in osteoclasts, that have been described in previously 
published data (25; 26; 27), is not sufficient to affect total bone development.  
Indeed, in line with our findings, Hui Li et al. (2009) recently reported 
OGR1 to be involved in osteoclastogenesis; however its role was not strong 
enough to affect overall bone development and density (126). 
 
13.4. OGR1 as a regulator of renal calcium and magnesium 
homeostasis and adaptation ? 
 
Previous studies in animal and cell models showed that Ca2+ and Mg2+ 
homeostasis is regulated by the dietary intake of Ca2+ and Mg2+. Indeed 
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TRPV5 channel, NCX1, and calbindin-D28K expression have been shown to be 
tightly regulated by the dietary intake of Ca2+ (49; 107). Similarly, the epithelial 
Mg2+ channel TRPM6 mRNA expression has been described to be regulated 
by dietary Mg2+ (105). Using different Ca2+ and Mg2+ diets, we demonstrated 
that OGR1 may participate in the renal regulation of Mg2+ and Ca2+ 
reabsorption by the dietary intake of Ca2+ and Mg2+. Our preliminary findings 
suggested that OGR1 may have a role in the regulation of the epithelial Mg2+ 
channel TRPM6 expression. Preliminary data also showed that OGR1 may be 
involved in the regulation of Ca2+ reabsorption by the dietary intake of Ca2+ 
and Mg2+. Collectively, our findings suggest that OGR1 may play a role in the 
regulation of renal Ca2+ and Mg2+ handling.  
 
Different mechanisms have been described to regulate total body Ca2+ 
and Mg2+ balance. Indeed, the Ca2+-sensing receptor (CaSR) plays crucial role 
in the molecular mechanism through which parathyroid cells are able to detect 
small changes in the blood Ca2+ and Mg2+ concentrations and control 
parathyroid hormone PTH secretion (100; 113). This hormone in turn is 
directly involved in the regulation of Ca2+ and Mg2+ homeostasis.  
In the kidney, the CaSR controls Ca2+ and Mg2+ reabsorption and 
regulates water and other electrolytes transepithelial movements (35). Indeed, 
increases in plasma Ca2+ and Mg2+ levels are sensed by the CaSR which 
permits the reabsorbed Ca2+ to decease Ca2+ and Mg2+ reabsorption by a 
negative feedback onto the cell preventing hypercalcemia (114). Recently van 
Abel et al. (115) demonstrated that the NPS R-467 (calcimimetic compound 
that activates CaSRs) reduced PTH and Ca2+ serum levels, and 
downregulates mRNA expression and protein levels of proteins involved in the 
active calcium reabsorption in the kidney (115). In addition experiments in 
DCT cells model showed that the vitamin D induced magnesium influx is 
blocked by high concentrations of extracellular calcium and this effect was 
inhibited by transfection with antisense CaSR oligodeoxynucleotides (116) 
suggesting a role of the CaSR in the regulation of Mg2+ transport in the DCT.  
Regarding our findings showing the calcium dependent role of OGR1 in 
the renal Ca2+ and Mg2+ handling regulation, we can hypothesize that the 
CaSR may be a part of this unknown mechanism. However our data are not 
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sufficient to define if OGR1 acts as agonist or antagonist to the CaSR. 
Experiments using specific blockers of the CaSR in Ogr1–/– mice are needed 
to elucidate the potential interaction between these two receptors and more 
studies are important to determine the exact intracellular pathway that may 
combine the effect of the CaSR and OGR1 on the renal calcium and 
magnesium handling.  
 
The PTH hormone plays also a crucial role in the regulation Ca2+ and 
Mg2+   balance, this hormone is secreted in the systemic circulation in 
response to low blood Ca2+ and Mg2+ concentrations, and acts directly on 
kidney and bone, where it activates the PTH hormone receptor. In the kidney 
PTH hormone receptor stimulates Ca2+ reabsorption in the DCT and CNT by 
increasing the renal expression of TRPV5, calbindin-D28K, and NCX1 (102; 40, 
41), and enhances Mg2+ transport in the DCT by an unknown mechanism 
(112; 50). The level of PTH is unknown in OGR1 deficient mice. However, the 
fact that phosphate homeostasis and urinary excretion is normal, suggests 
rather normal PTH and vitamin D3 levels. 
 
Vitamin D3 (1,25-(OH)2 Vitamin D3) is also involved in the Ca2+ and 
Mg2+  homeostasis regulation (40; 42; 43; 44; 49; 50). In the kidney, v1,25-
(OH)2 vitamin D3 increases active Mg2+ transport in the DCT (50; 112) and 
enhances active Ca2+ reabsorption by increasing TRPV5, calbindin-D28K, and 
NCX1 mRNA expressions (49). According to our results, we can speculate 
that the role of OGR1 in the regulation of renal Ca2+ and Mg2+ handling may 
converge with the mechanisms of PTH and vitamin D3 action in the kidney in 
response to changes in serum Ca2+ and Mg2+ concentrations. More studies 
are therefore essential to elucidate the role of PTH and vitamin D3 in the 
regulation mechanism of Ca2+ and Mg2+ homeostasis by OGR1. However, 
OGR1 itself is not sensitive to extracellular Ca2+ and Mg2+ concentrations, 
since variation of these divalent does not alter the pH-depdendent stimulation 
of IP3 formation in OGR1 transfected cell lines (Ludwig, Seuwen, Novartis 
Biomedical Reserach Institutes, unpublished results). 
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In summary, our findings demonstrate in contrast to our expectations 
that there is no obvious role for OGR1 in maintaining or controlling systemic 
acid-base status and renal acid excretion. We suggest that OGR1 may be a 
part of the mechanism involved in the renal regulation of Ca2+ and Mg2+ 
balance by acting on Ca2+ and Mg2+ transport proteins.  Therefore, we OGR1 
might be a novel target for the treatment of diseases related to Mg2+ and Ca2+ 
handling in the DCT such as isolated dominant hypomagnesemia IDH (93; 
94), Gitelman’s syndrome (91; 91) and renal osteodystrophy (127). 
Finally, the relation between OGR1 and the active Ca2+ and Mg2+ 
reabsorption in the DCT needs further investigation. Hypomagnesemia is 
frequently accompanied by inappropriate renal Ca2+ wasting (95), this is the 
case of patients with hypomagnesemia with secondary hypocalcemia HSH 
(95), the molecular explanation of this phenomenon however remains 
obscure. 
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ABSTRACT 
 
 
The ovarian cancer G protein coupled receptor 1 (OGR1) is activated by 
extracellular protons in the pH range between pH 7.8 and pH 6.8 leading to the 
formation of inositol-tris-phosphate and intracellular calcium transients (1).  The 
downstream targets and the physiological role in native tissues, however, have 
not been investigated to date. Here we show that OGR1 modulates 
sodium/proton exchanger (NHE) and H+-ATPase activity in the renal HEK293B 
cell line as well as in renal tubule cell fragments from mouse kidney. HEK293B 
cells were stably transfected with active OGR1 and a mutant lacking 5 histidine 
residues (H5Phe-OGR1) involved in the activation of the receptor. Switching 
extracellular pH from 8 to pH 7.1 stimulated NHE and H+-ATPase activity in 
OGR1 transfected cells but not in H5Phe-OGR1 transfected cells. Moreover, the 
stimulatory effect was reduced by ZnCl2 and CuCl2 that have been shown to 
inhibit OGR1 activation. The stimulatory effect of OGR1 on NHE activity was 
blocked by chelerythrine whereas the ERK1/2 inhibitor PD 098059 had only a 
partially inhibitory effect. OGR1 activation caused also transient increases in 
intracellular calcium in transfected HEK293B cells. Surprisingly, surface 
biotinylation revealed that activation of OGR1 caused a decrease in NHE3 
abundance. Furthermore, we isolated proximal tubules and outer medullary 
collecting ducts from kidneys of wildtype and OGR1 deificent mice and measured 
the effect of extracellular pH on NHE and H+-ATPase activity. In both nephron 
segments, the absence of OGR1 affected the pH-dependent activity of these 
proton extruding transport proteins. However, we did not detect OGR1 
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dependent increases in intracellular calcium in the proximal tubule, whereas the 
absence of OGR1 reduced intracellular calcium at pH 7.1 in the outer medullary 
collecting duct cells. 
In summary, this is the first evidence that OGR1 modulates the activity of two 
major plasma membrane proton transport systems, NHE and H+-ATPase, in a 
manner dependent on extracellular pH suggesting that OGR1 may be involved in 
the regulation of plasma membrane transport proteins and intra- and/or 
extracellular pH. These effects may help explaining the role of OGR1 in native 
tissues and its overexpression in cancer cell lines. 
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INTRODUCTION 
Protons in the extracellular compartments are produced by metabolism 
and excreted by cells using various pathways including transporters or vesicle-
mediated release (2-7). These protons challenge systemic acid-base balance 
and need to be buffered in order to avoid acidification of extracellular 
compartments. More recently, protons have attracted also attention as signalling 
molecules that may be involved in rapid transmission of signals. In the nematode 
C. elegans protons may act as neurotransmitters inducing contraction of certain 
muscles (8,9). Here, two genes encoding for cation channels, pbo-5 and pbo-6, 
are part of the proton-sensing and signal transducing complex (8). In mammals, 
a number of proton-activated channels or receptors have been identified, 
including the proton-activated ASIC-channels (10), proton-sensitive TRP-
channels (11), or the Calcium-sensing receptor modulated by extracellular pH 
(12-14). However, these receptors or channels are activated or modulated by 
proton concentrations that may occur in specialized compartments where pH 
may reach values in the range between pH 5 and pH 6.5.  
In contrast, a recently emerged small subfamily of G protein-coupled 
receptors is activated in the physiologic range prevailing in many extracellular 
compartments with half-maximal activation (EC50) around pH 7.2 – 7.4 (15). This 
subfamily is comprised of three members, OGR1 (ovarian cancer G protein-
coupled receptor 1; GPR68), GPR4 (G protein-coupled receptor 4),  and TDAG8 
(T cell death-associated gene 8; GPR65) (15,16). Ludwig et al. have shown in 
stably transfected cells and various cell lines that OGR1 acts as a proton-
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activated receptor stimulating inositol-trisphosphate (IP3) formation, release of 
intracellular calcium transients and activation of the mitogen-activated protein 
kinase/extracellular signal-regulated (ERK) kinase cascade. However, the 
downstream targets of OGR1 have remained elusive and very little is known 
about its physiological role (15,16). In fact, the recent generation of OGR1 
deficient mice has not shed new light on the physiological role of this receptor 
since no clear phenotype was reported (17).  
 
Systemic acid base homeostasis is tightly regulated by the lung and the 
kidneys mediating the daily renal acid excretion of approximately 70 mmoles of 
acid from a typical Western diet. Additionally, the kidneys compensate perfectly 
for variations of daily intake of acid equivalents or metabolic acid-base production 
by adapting acid-base excretion with great precision. Thus, an elaborate system 
of regulated acid-base transporters is inevitable to perform this task. Among 
these transporters, NHE3, the major Na+/H+ antiporter isoform in the renal 
proximal tubule and vacuolar-type H+-ATPases (H+-ATPases) on the plasma 
membrane of proximal tubules and the acid-secretory intercalated cells of the 
collecting duct provide for the majority of proton secretion by the kidney (18-22). 
Both transport proteins, NHE3 and H+-ATPases, are tightly regulated by a 
variety of hormones and conditions among them systemic acid-base and 
electrolyte status, and different hormones, most notably aldosterone and 
angiotensin II (20-27).  
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 NHE3 activity is not directly regulated by protons but by a signaling 
pathway including pH-sensing signaling molecules (28,29). Recently, 
Tsuganezawa et al. have shown that the acid-sensing pathway in the kidney 
involves activation of the proto-oncogene c-Src and ERK as well as c-fos, c-jun, 
junB, and egr-1 expression (29). Here, a member of the focal adhesion kinase 
(FAK) family, Pyk2 (proline-rich tyrosine kinase 2), plays a crucial role in acid 
activation of c-Src and NHE3 in cultured opossum kidney (OKP) proximal tubule 
cells (30). Pyk2 is activated by phosphorylation in response to various stimuli 
requiring intracellular calcium release (31,32). Pyk2 phosphorylation itself may be 
pH-sensitive and present the pH-sensor. Alternatively, a membrane-bound 
receptor sensing extracellular pH may affect Pyk2 activation thereby coupling 
extracellular pH and activity of renal acid-base transport.   
In this study, we demonstrate that OGR1 is involved in the acute 
regulation of proton extruding transporters, namely NHE3 and H+-ATPase, in 
response to changes of extracellular pH in cultured renal cells. This activation 
requires a cluster of histidine residues in the extracellular domains of the receptor 
and PKC activity. Additionally, using wild type and OGR1 deficient mice, we 
show that OGR1 modulates the pH-sensitive response of NHE3 and H+-ATPase 
activity in isolated proximal tubules and outer medullary collecting ducts 
(OMCDs).  
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MATERIALS AND METHODS 
Animal model 
Ogr1-/- mice were born at the expected mendelian ratio, showed no 
obvious gross anatomical abnormalities, postnatal survival, growth, body weight, 
and fertility was undistinguishable from wildtype and heterozygous litters. 
Histological analysis of various tissues including kidney did not show any 
abnormalities (data not shown). 
 
Isolation of proximal tubule and OMCD 
Proximal tubule and OMCD were isolated from wild type or Ogr1-/- mouse 
kidneys and transferred onto glass coverslips as described previously (23,33).  
 
Cell culture and cell preparations 
HEK293 cells and HEK293 cells stably transfected either with the human 
wildtype OGR1 construct or an OGR1 mutant lacking 5 histidine residues placed 
on top of helices I, IV and VII, and in extracellular loops 1 and 2 (H17, H20, H84, 
H169 and H269, substituted by phenylalanine: H5Phe) were described previously 
(15). All cells were maintained in Dulbecco’s modified Eagle’s medium/Ham’s F-
12 medium (1:1) supplemented with 10% fetal calf serum in a humidified 
atmosphere of 5% CO2, 95% air at 37 °C. Stable cell populations expressing the 
OGR1 receptor were isolated following selection with antibiotic G418 (400 μg/ml). 
For all pH and Ca2+ experiments, cells were passaged, disseminated onto 
coverslips and grown to subconfluency for 48 hours. The final medium exchange 
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was performed 24 hours before the experiments were started. Medium pH was 
maintained at pH 7.4.  
 
Intracellular pH and Ca2+ measurements 
For pHi measurements, either individual slides coated with cells or 
coverslips precoated with the cell adhesive Cell-Tak (BD Biosciences, Bedford, 
MA, USA) containing selected tubules were transferred to a perfusion chamber 
(≈ 3-5ml/min flow rate). The temperature of the chamber was maintained at 37°C 
by an electronic feedback circuit. The control bath solution was initially a HEPES-
buffered Ringer solution (125 mM NaCl/ 5 mM KCl/ 1 mM CaCl2/ 1.2 mM MgSO4/ 
2 mM NaH2PO4/ 32.2 mM HEPES/ 5 mM Glucose). Cell coated slides or single 
tubule fragments were loaded with the acetoxymethyl ester of the pH-sensitive 
dye BCECF (10 µM, Molecular Probes, Oregon, USA) for 10 min or the Ca2+-
sensitive dye FURA-2 (10 µg/ml, Molecular Probes, Oregon, USA) for 20 min and 
washed to remove all non-deesterified dye. Loading of cells and tubule fragments 
was performed in control solution at pH 8 to reduce OGR1 receptor activity. 
pHi was measured microfluorometrically by exciting the dye with a spot of light 
alternately at 490 and 440 nm while monitoring the emission at 532 nm with a 
video-imaging system (34,35). Intracellular acidification was induced using the 
NH4Cl (20 mM) prepulse technique for 5 min and then washed into a Na+-free 
solution (36). To measure H+-ATPase activity, bicarbonate-free solutions were 
used and Na+ was replaced by N-methyl-D-glucamine (NMDG). Sodium-proton-
exchanger (NHE) activity was calculated from the slope of the initial rapid 
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intracellular alkalinization after readdition of Na+. Each experiment was calibrated 
for pHi using the nigericin/high K+ method (37) and the obtained ratios were 
converted to pHi. Na+-independent pHi recovery rates in response to an acid load 
were calculated in nontransfected and stably transfected cells with OGR1 or the 
OGR1 mutant H5Phe as well as in proximal tubules and outer medullary 
collecting ducts (OMCDs) from wild type and Ogr1-/- mice. Na+-dependent pHi 
recovery was measured in proximal tubules and OMCDs in the pHi range of 
6.55–6.85. The pHi range chosen represented the average values found in the 
respective tubule segment. Data are shown as changes in pHi (∆pHi) per minute. 
Ca2+ measurements on mouse nephron segments were performed on hand 
dissected proximal tubules and outer medullary collecting ducts. In brief, mice 
were anesthetized with xylazine/ketamine i.p.. Both kidneys were cooled in situ 
with ice-cold control solution (130.7 mM NaCl, 5 mM KCl, 2 mM NaH2PO4, 1.2 
mM MgSO4, 10.5 Glucose, 2 mM Glutamine, 1 mM CaCl2, 32.5 mM HEPES, pH 
7.4) for one minute and then removed and cut into thin coronal slices for tubule 
dissection. Proximal straight tubules (S3 segments) and outer medullary 
collecting ducts (OMCD) were dissected, respectively, from the cortex medullary 
rays and the medulla at 4°C in control solution and the isolated nephron segment 
was transferred to the bath chamber. To measure intracellular calcium FURA-2 
was excited with light of 340/380 nm wavelengths. After loading with FURA-2 
nephron segments were first superfused with HEPES buffer at pH 8 and 
subsequently with HEPES buffer at pH 6.8. ATP at a concentration of 1 mM was 
used as control before starting the calibration using ionomycin at a final 
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concentration of 1 μM. [Ca2+]i was calculated from the ratio of fluorescence at 
excitations of 340/380 nm using the following equation as described previously: 
Cai2+ =  [(R - Rmin)/(Rmax - R)] x (Fmin/Fmax) x Kd, where R is the measured ratio of 
emitted light, Rmin, Rmax and Fmax are the fluorescence values at 380 nm with 1 
mM Ca2+ bath solution, Fmin is the fluorescence at 380 nm with 0 mM Ca2+ bath 
solution, and the dissociation constant (Kd) = 225 nM for fura-2-calcium binding 
(38). 
Chemicals were added to the perfusion solutions from stock solutions at 
the given concentrations for each experimental protocol. All chemicals were of 
highest purity and were purchased from Sigma if not annotated else wise. 
 
 
HEK cell lysate preparation (membrane fraction) and immunoblotting 
Cultures of HEK293 and OGR1-transfected cells were grown to 
confluency and washed 2x with PBS. Cells were lysed in a resuspension buffer 
(200 mM Mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5) and protease inhibitor 
mixture (1:1000, Roche Diagnostics, Indianapolis, IN, USA) by sonication, and 
centrifuged at 3000 rpm at 4°C for 10min. The supernatant was removed for a 
subsequent ultracentrifugation step at 41000 rpm at 4°C for 1 hour. The resulting 
pellets were resuspended in 200– 300 μl resuspension buffer and the protein 
concentrations were determined (BioRad Dc Protein Assay, Bio-Rad, Hercules, 
CA, USA). 75 µg of crude membrane protein was solubilized in Laemmli sample 
buffer, and SDS-PAGE was performed on 10% polyacrylamide gel. Proteins 
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were transferred electrophoretically from gel to a polyvinylidene difluoride 
membrane (Immobilon-P, Millipore, MA, USA). After blocking with 5% milk 
powder in Tris-buffered saline containing 0.1% Tween 20 for 60 min, the blots 
were incubated with the mouse monoclonal anti-c-myc primary antibody 
(Invitrogen, Oregon, USA) (1:5000) overnight at 4°C. After washing and 
subsequent blocking, blots were incubated with the secondary antibody (anti-
mouse Ig, horseradish peroxidase conjugated, GE Healthcare UK limited, United 
Kingdom) 1:10000 for 1 h at room temperature. Antibody binding was detected 
with the Immobilon Western Chemiluminescent horse radish peroxidase 
substrate (Millipore, Billerica, MA, USA), using the DIANA III-chemiluminescence 
detection system (Raytest, Straubenhardt, Germany). All images were analyzed 
using appropriate software (Advanced Image Data Analyzer, Raytest, Germany). 
 
Biotinylation of Cell-Surface Membrane Proteins  
The renal cell lines HEK293-OGR1 and HEK293-OGR1-H5Phe grown to 
confluency in 10-cm plates were incubated for 20 minutes prior to experiments in 
HEPES buffered, bicarbonate free solutions at pH 8 or pH 7.1 in order to 
inactivate or activate OGR1, respectively. After washing  with PBS, 0.1 CaCl2 
mM, 1 MgCl2 mM, cell surface-expressed proteins were biotinylated for 1 hr with 
2 mg/ml sulfo-LC-NHS-Biotin [sulfo-Succinimidyl-6-(biotinamido)hexanoate; 
Pierce, Rockford, IL, USA]  in buffer (150 mM NaCl ,10 mM triethanolamine , 2 
mM CaCl2 , pH 7.4, 4 C°). After incubation with 100 mM glycine, cells were lysed 
in RIPA buffer (150 mM NaCl/ 5 mM EDTA/ 50 mM Tris/ 1% Triton X-100/ 0.5% 
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Na-deoxycholate/0.1% SDS/5 µg/ml leupeptin/ 5 µg/ml pepstatin A). Lysates 
were centrifuged at 10,000 x g at 4°C for 1 hr, and the supernatants were 
incubated overnight with 100 µl of prewashed streptavidin beads (Pierce, 
Rockford, IL, USA). After centrifugation at 10,000 x g for 20 s, the pellets were 
washed sequentially with buffer A (50 mM Tris·HCl, pH 7.4/ 100 mM NaCl/ 5 mM 
EDTA), buffer B (50 mM Tris·HCl, pH 7.4/ 500 mM NaCl), and buffer C (50 mM 
Tris·HCl, pH 7.4). Proteins were eluted by addition of 20 µl of 2x loading buffer 
(containing 60 µg/µl DTT) and incubated at 95°C for 3 min. After centrifugation at 
3,000 x g for 10 min, supernatants were loaded on SDS/PAGE, and Western 
blotting was performed with rabbit anti-NHE3 antibody (1:5000).  
 
Immunohistochemistry 
In preparation for immunocytochemistry cells were passaged, 
disseminated onto coverslips, diluted with Dulbecco’s modified Eagle’s 
medium/Ham’s F-12 medium (1:1) 1:50 and grown for 48 hours. Slides were 
washed two times with phosphate buffered saline (PBS) solution to remove 
medium and fixed with PBS buffer containing 16% paraformaldehyde for 20 min. 
After washing again with PBS, slides were incubated with 1% SDS for 3 min, 
washed three times with PBS, and incubated with PBS containing 1% BSA and 
0.1% Triton X for 20 min before application of the primary antibodies. The 
primary antibodies (rabbit anti-OGR1 aff. purified 1:500, mouse monoclonal anti-
c-myc 1:500, Invitrogen, Oregon, USA) were diluted in PBS and applied either for 
75 min at room temperature or overnight at 4°C. Slides were washed twice for 5 
Mohebbi et al.,   OGR1 modulates proton extrusion 
 13
min with PBS + 2.7% NaCl and once with PBS. Hereafter, the respective 
secondary antibodies (donkey anti-mouse Alexa 488, donkey anti-rabbit Alexa 
594 diluted 1:1000, Invitrogen, Basel, Switzerland) and 4’,6-Diamidino-2-
phenylindole dihydrochloride (DAPI 1mg/ml, 1:500, Sigma) were applied for 1 h 
at room temperature. Slides were washed twice with PBS + 2.7% NaCl and once 
with PBS before mounting with VectaMount (Vector Laboratories, Burlingame, 
CA, USA). 
 
To perform immunohistochemistry on kidney slices, mice were perfused 
through the left ventricle with PBS followed by a paraformaldehyde-lysine-
periodate (PLP) fixative. Kidneys were removed and fixed overnight at 4°C by 
immersion in PLP. In the following, kidneys were washed three times with PBS, 
and after cryoprotection with PBS/30% sucrose solution, thin coronal slices were 
cut, and frozen in liquid propane cooled with liquid nitrogen. The procedure of the 
immunostaining was carried out as described previously (39-42). In brief, 
sections were incubated with 1% SDS + 0.1 % Triton-X for 5 min, washed three 
times with PBS, and incubated with PBS containing 1% BSA and 0.1 % Triton-X 
for 15 min before application of the primary antibodies. The primary antibodies 
(rabbit anti-OGR1 aff. purified 1:500, polyclonal anti-human AQP-2 1:400, Santa 
Cruz Biotechnology, CA, USA) were diluted in PBS + 0.1 % Triton-X and applied 
either for 75 min at room temperature or overnight at 4°C. Sections were washed 
twice for 5 min with PBS + 2.7% NaCl, once with PBS, and incubated for 1 h at 
room temperature with the respective secondary antibodies (donkey anti-rabbit 
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Alexa 594 and donkey anti-goat Alexa 488 diluted 1:1000, Invitrogen, Basel, 
Switzerland). Sections were again washed twice with PBS + 2.7% NaCl and once 
with PBS before mounting with VectaMount (Vector Laboratories, Burlingame, 
CA, USA).  
All sections were viewed using a confocal microscope (Leica CLSM). 
Pictures were processed (overlaid) using Adobe Photoshop software. 
 
Statistical analysis 
All data are presented as means ± SEM. All data were tested for 
significance using the unpaired t Test or one way ANOVA test, and only results 
with p <0.05 were considered statistically significant. 
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RESULTS  
 
Activation of OGR1 stimulates NHE and H+-ATPase activity  
OGR1 upregulates NHE activity in cells.  
OGR1 was stably expressed in the human renal cell line HEK293 which is 
known to express various transport proteins involved in renal acid secretion such 
as the sodium/proton exchanger NHE3 or V-type H+-ATPases (43). Successful 
expression of OGR1 was tested by western blotting (Fig. 1A) demonstrating the 
presence of OGR1 in transfected cells. Two major bands were observed at 
approx. 70 kDa and 90 kDa. 
To examine the effect of OGR1 activation on sodium/proton exchange 
(NHE) activity, we performed intracellular pH measurement with the pHi-sensitive 
dye BCECF in the human renal cell line HEK293 at two different extracellular pH 
values. Cells were preincubated for 20 min in HEPES buffer at pH 8 to reduce 
basal OGR1 activity. The Na+-dependent recovery rate indicating NHE activity 
was significantly increased in OGR1-transfected cells compared to 
nontransfected HEK293 cells at baseline pH 8 (0.11 ± 0.007 vs. 0.05 ± 0.002 
units pH/ min)(Fig. 1 B). Preincubation of cells for 20 min at pH 7.1 to stimulate 
OGR1 activity caused an even more pronounced stimulatory effect on NHE 
activity  (0.20 ± 0.010 vs. 0.09 ± 0.003 units pH/ min) (Fig. 1 B, C, table 1). 
In contrast, cells expressing the OGR1 mutant (5 extracellular histidines 
residues mutated to phenylalanine: OGR1-H5Phe) showed the same activity as 
nontransfected HEK293 cells at pH 8 (0.06 ± 0.006 vs. 0.05 ± 0.002 units pH/ 
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min) that could not be stimulated by changing the pH to 7.1 (0.03 ± 0.001 units 
pH/ min) (Fig. 1C). Mutation of the 5 histidines residues reduced and left shifted 
the OGR1 dependent increase in intracellular IP3 formation (Fig. 1D) as 
described previously (15).  
To determine the affected NHE isoform we used S3226 as a specific 
inhibitor of the NHE subtype 3 (NHE3) (44). Addition of 100 nM S3226 resulted in 
a significant decrease of the NHE activity at pH 7.1 in OGR1 transfected cells 
suggesting NHE3 as the main type of NHE involved (0.20 ± 0.010 units pH/ min 
in the absence of S3226 vs. 0.05 ± 0.004 units pH/ min in the presence of 
S3226)).  
 
pH-dependent changes of the H+-ATPase activity in cells.  
In contrast to the NHE activity the Na+-independent pHi recovery of OGR1 
transfected cells was downregulated at pH 8 compared to HEK control cells (-
0.007 ± 0.0009 vs. 0.004 ± 0.0007 units pH/ min, respectively). We have 
previously shown that this Na+-independent pHi-recovery rate is sensitive to the 
H+-ATPase inhibitor bafilomycin and is thus due to the activity of V-type H+-
ATPases (35). However, at pH 7.1 H+-ATPase activity was significantly 
stimulated versus control (0.013 ± 0.0007 vs. 0.008 ± 0.0009 units pH/ min, 
respectively). In contrast to the OGR1 transfected clone, OGR1 mutant cells 
showed a higher H+-ATPase activity at pH 8 and a downregulation at pH 7.1 
(0.009 ± 0.0010 vs. 0.006 ± 0.0009 units pH/ min, respectively) (Fig. 2, table 1). 
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Inhibitory effect of ZnCl2, CuCl2 but not psychosine on OGR1 dependent 
stimulation of NHE activity.  
Previous data have shown that micromolar concentrations of Zn2+ and 
Cu2+ ions inhibited OGR1-dependent IP3 formation stimulated by lowering 
extracellular pH (15). Moreover, psychosine has been implicated as an inhibitor 
of proton-dependent stimulation of OGR1(45) even though the role of lipids in 
OGR1 stimulation or inhibition is very controversial (16). Thus, we tested whether 
ZnCl2, CuCl2, and psychosine have an effect on the OGR1 dependent stimulation 
of NHE and H+-ATPase activity. ZnCl2 and CuCl2 reduced at 10 μM significantly 
the OGR1 dependent stimulation of the NHE activity (0.20 ± 0.010 vs. 0.14 ± 
0.014 and 0.12 ± 0.008 units pH/ min) (Fig. 3A). Psychosine (10 µM) had no 
significant effect on NHE stimulation. Higher concentrations of psychosine (100 
μM) led frequently to loss of BCECF from cells and detachment of cells 
suggesting cytotoxicity. In contrast, H+-ATPase activity was significantly reduced 
by psychosine but not by ZnCl2 and CuCl2 (Fig. 3B). Higher concentrations of 
these inhibitors were also tested but resulted in unspecific effects (data not 
shown).  
 
Intracellular signaling mediating OGR1 dependent pH effects on NHE activity. 
 OGR1 has been shown to couple to Gq proteins, phospholipase C, and to 
induce intracellular Ca2+ transients in transfected cells (15). Similarly, NHE3 
activity can be stimulated by signaling cascades activated by intracellular Ca2+ 
transients involving down-stream signals such as protein kinase C and MAP-
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kinases ERK1/2 (30,46-49). As expected, there was a significant increase of 
intracellular calcium concentration in OGR1 transfected cells compared to HEK 
control cells when extracellular pH was rapidly switched from pH 8 to pH 7.1  (-
1.8 ± 0.75 vs 117.3 ± 17.16 nM Ca2+). ATP (1 mM) was subsequently applied to 
all cells to confirm viability (Fig. 4B). Chelerythrine (1 µM), an inhibitor of protein 
kinase C (PKC) completely prevented the OGR1 dependent stimulation of NHE 
activity. In contrast, inhibition of ERK1/2 activation with PD098059 (20 µM) 
decreased basal NHE activity but did not prevent the OGR1 dependent 
stimulation of NHE activity (Fig. 5). Thus, OGR1 activation causes a transient 
increase of intracellular Ca2+ and stimulates NHE activity requiring intact PKC.  
 
OGR1 stimulation reduces NHE3 surface expression 
Cells stably transfected with OGR1 or the OGR1-H5Phe mutant were 
incubated for 1 h at pH 8 and then either left at pH8 or incubated at pH 7.1 for 20 
min. Surface expression of the major active NHE isoform in HEK293 cells, NHE3, 
was assessed by surface biotinylation. Surprisingly, expression of OGR1 
reduced NHE3 surface expression at pH 8 as compared to cells expressing 
inactive receptor. Moreover, activation of the OGR1 receptor at pH 7.1 
decreased NHE3 surface erxpression whereas in cells expressing the inactive 
H5Phe mutant NHE3 surface expression was increased (Fig. 6). Thus, activation 
of the OGR1 receptor in HEK293 cells reduces NHE3 surface abundance. 
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Modulation of Na+/H+ exchanger and H+-ATPase activity in proximal tubules. 
OGR1 mRNA has been detected in most segments of the mouse nephron by 
real-time PCR, including the proximal tubule and all subsegments of the 
collecting duct with highest abundance in the outer medullary collecting duct.  In 
order to assess the impact of OGR1 dependent effects of extracellular pH on 
NHE and H+-ATPase activity in native tissue, we isolated late proximal tubules 
from wildtype and Ogr1-/- mouse kidneys and measured NHE and H+-ATPase 
activity at two different pHo, pH 8 and pH 7.1. NHE activity in late proximal 
tubules from wild type mice did not show any significant alteration when changing 
the extracellular pH from pH 8 to 7.1 (Fig. 7A). In contrast, in late proximal 
tubules of Ogr1-/- mice NHE activity was significantly upregulated at pH 7.1 
compared to pH 8 (0.36 ± 0.02 vs. 0.22 ± 0.02 units pH/ min, respectively). H+-
ATPase activity was lower at pH 7.1 in proximal tubules from both wild type and 
OGR1 deficient mice. However, in Ogr1-/- mice H+-ATPase activity at pH 8 was 
lower and higher at pH 7.1 when compared to wild type animals (Fig. 7B). Thus, 
absence of OGR1 in the proximal tubule affects the response of NHE and H+-
ATPase activity to changes in extracellular pH.  
 
H+-ATPase activity is regulated by OGR1. In the outer medullary collecting duct 
(OMCD) intercalated cells, H+-ATPases represent the major acid-extruding 
pathway (22). Therefore we also tested for the pH and OGR1-dependent 
regulation of H+-ATPase activity in intercalated cells in the OMCD.  H+-ATPase 
activity in OMCD intercalated cells from wild type mice was markedly reduced 
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when extracellular pH was changed from pH 8 to pH 7.1 (Fig. 8, table 1). 
Interestingly, H+-ATPase activity in OMCD intercalated cells from OGR1 deficient 
mice was much lower at pH 8  and significantly increased at pH 7.1 (Fig. 8).   
 
Intracellular calcium transients in proximal tubule and OMCD of wildtype and 
OGR1 deficient mice.  
In a last series of experiments we tested if OGR1 mediates detectable 
changes in intracellular Ca2+ upon extracellular acidification. Freshly dissected 
proximal tubule and OMCDs from wildtype and Ogr1-/- mice were prepared and 
intracellular calcium transients measured using FURA-2. In proximal tubule cells 
changing extracellular pH from 8 to 6.8 did not result in a rise of intracellular Ca2+ 
as observed in OGR1 transfected HEK293 cells. However, in proximal tubule 
cells from Ogr1-/- mice, extracellular acidification significantly decreased 
intracellular Ca2+ which was not observed in wild type proximal tubules (WT 5.9 ± 
7.9 vs. Ogr1-/- -23.4 ± 8.3 nmol/l) (Fig. 9). Application of ATP (1 mM) elicited 
intracellular Ca2+ transients of similar magnitude in both wild type and OGR1 
deficient proximal tubules. In OMCD intercalated cells, no appreciable changes in 
intracellular calcium concentration could be detected upon switching extracellular 
pH from 8 to 6.8 in tubules from Ogr1+/+ and Ogr1-/- mice, whereas ATP readily 
increased intracellular Ca2+ (Fig. 9).  
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DISCUSSION 
All (eukaryotic) cells need to regulate intracellular pH and thus  be able to 
sense pH and consecutively activate signaling pathways responsible for the 
adaptive response such as proton or bicarbonate secretion (22). The role of 
protons as signaling molecules has been previously discussed in various 
contexts and a number of proton-activated channels or receptors have been 
identified (8-14). Recently, Ludwig et al. have demonstrated that the Ovarian 
Cancer G protein-coupled receptor 1 (OGR1) acts as a proton-activated receptor 
via IP3 formation and release of intracellular calcium transients (15).  
OGR1 has been initially identified as being differentially expressed in ovarian 
cancer cells (50) and was later reported to be activated by the lipid messengers 
sphingosylphosphorylcholine (SPC) and lysophosphatidylcholine (LPC) (51). 
Similarly, the closely related GPR4 receptor was reported to by activated by SPC 
and LPC (52). However, these reports could not be substantiated and confirmed 
by others (16) and the original publications have been retracted in the meantime 
(51,53). OGR1 deficient mice have recently been described (17) but no specific 
phenotype could be found. The number of osteoclasts may be slightly reduced, 
less peritoneal macrophages were observed and LPS-induced ERK 
phosphorylation in macrophages appeared to be reduced (17). Most importantly, 
no difference in sphingosylphosphorylcholine and lysophosphatidylcholine 
induced effects could be observed (17) in line with the notion that OGR1 is not a 
lipid receptor but may act as a receptor for protons in vivo. 
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Here we used two different approaches to examine the role of OGR1 in the 
context of acute regulation of acid-base transport proteins. Renal epithelial cells 
(HEK293B) cells were stably transfected with active OGR1 and its less active 
mutant OGR-H5Phe. Secondly, we used native tissues from OGR1 deficient 
mice.  
 
In the renal epithelial HEK293B cell line, OGR1 acted as a sensor of 
extracellular pH and stimulated sodium/proton exchange and H+-ATPase activity. 
Incubation of cells at pH 7.1 which leads to more than half-maximal activation of 
the receptor (54) caused a strong stimulation of NHE activity in OGR1 expressing 
cells but not in cells lacking OGR1 or expressing the H5Phe mutant. This mutant 
displays activation and IP3 formation only at much more acidic extracellular pH 
than the wildtype receptor and demonstrates that not the presence of OGR1 but 
its activity mediate the effect of extracellular pH on NHE activity. 
 
OGR1 has been shown to couple to Gq proteins, phospholipase C, and to induce 
intracellular Ca2+ transients in transfected cells (15). Of interest, some recent 
studies have investigated the signaling pathway of acid stimulation of NHE3 and 
it has been demonstrated that the signaling cascades stimulating NHE3 activity 
involve/include intracellular Ca2+ transients, protein kinase C (PKC) and MAP 
kinases ERK1/2 (27,29,47,55). In agreement with these data, we found 
intracellular Ca2+ transients in OGR1 transfected cells at pH 7.1, where OGR1 is 
fully active. Moreover, addition of chelerythrine, an inhibitor of PKC, completely 
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prevented the OGR1 dependent stimulation of NHE activity. Interestingly, 
inhibition of the MEK/ERK kinases with PD98059 resulted only in a partial 
decrease of NHE activity. Regulated trafficking of NHE3 contributes importantly 
to NHE3 activity regulation. In the renal OKP cell line chronic media acidification 
results enhanced NHE3 activity, increased apical membrane NHE3 protein 
abundance, and more NHE3 mRNA and protein abundance (56). Fan et al. 
studied the role of parathyroid hormone (PTH) on NHE3 activity and protein 
abundance in parathyroidectomized rats and described that PTH decreases 
NHE3 activity via a phosphorylation-dependent mechanism followed by a 
decrease in apical membrane NHE3 protein via changes in protein trafficking 
(57). In order to test, if the effect of OGR1 on NHE3 is secondary to increased 
surface protein abundance, were assessed surface expression of NHE3. 
Surprisingly, activation of OGR1 by acidic pH caused a reduction of NHE3 
surface protein expression within 20 mins while NHE3 activity is increased. Thus 
our data suggest a dual effect of OGR1 on NHE3 membrane abundance and 
activity. 
OGR1 activation stimulates IP3 formation which is inhibited by micromolar 
concentrations of ZnCl2 and CuCl2, (54) whereas the role of the lipid messenger 
psychosine is rather controversial (52) since the data on psychosine have been 
partly retracted (58). In our study, ZnCl2 and CuCl2 reduced significantly the 
OGR1 dependent stimulation of NHE activity while psychosine had no effect. In 
contrast, H+-ATPase activity was not affected by ZnCl2 and CuCl2 while 
application of psychosine resulted in lower basal H+-ATPase activity. Thus, 
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psychosine does not act as inhibitor of OGR1-mediated stimulation of NHE and 
H+-ATPase activity. 
 
To confirm our cell experiment data, we tested the pH dependent effect of 
OGR1 on NHE and H+-ATPase activity in isolated proximal tubules and outer 
medullary collecting ducts of wild type and OGR1 deficient mice. We and others 
have previously shown that NHE activity in mouse proximal tubule is mainly due 
to NHE3 activity (59) Acute changes in the extracellular pH of proximal tubules 
did not affect NHE activity in wild type mice while OGR1 deficient mice 
demonstrated a significant increase in NHE activity. In contrast, in proximal 
tubules from OGR1 deficient mice, H+-ATPase activity was lower at alkaline pH 
and higher at acidic pH than in the respective wildtype control tubules. These 
observations indicate that OGR1 is not the only pH-sensing mechanism in mouse 
proximal tubules and that the effects of OGR1 on NHE and H+-ATPase activity  
are distinct. In the case of NHE activity, OGR1 appears to exert an inhibitory 
effect which is in contrast to our observations in the HEK293B cell model. This 
may indicate that the effects of OGR1 on transporters may be depending on the 
cellular context. Clearly, further studies are required to address these questions 
in more detail. 
 
The intercalated cells of the collecting ducts are the major site of final 
tuning of urinary acidification (1). . . In parallel to the proximal tubule data, we 
found that H+-ATPase activity of wild type mice was higher at pH 8 compared to 
Mohebbi et al.,   OGR1 modulates proton extrusion 
 25
OGR1 deficient mice. In contrast, more acidic pH resulted in a decreased H+-
ATPase activity in wild type mice while OGR1 deficient mice showed a 
stimulation of H+-ATPase activity. Thus, taken together, our experiments with 
native OGR1 KO mouse tissue suggest that the presence or absence, 
respectively, of the OGR1 receptor modulatesthe pH-dependent regulation of 
both major renal acid-base transport proteins, namely NHE and H+-ATPase.  
 
 
Acute stimulation of NHE3 activity by acid has been demonstrated in the renal 
opossum kidney OKP cell line and a signaling pathway implicated includingc-Src, 
ERK, and increases in c-fos, c-jun, junB, and egr-1 expression (29,60). Li et al. 
showed that Pyk2 (prolin-rich kinase 2) is possibly upstream of this pathway and 
that activation requires calcium (30). The role of this pathway in the regulation of 
H+-ATPase activity has not been reported to date.  Whether OGR1 plays a role 
in the activation or modulation of the pyk2 dependent pathway remains to be 
investigated. However, we tested if OGR1 dependent intracellular calcium 
transients could be detected in isolated proximal tubules and outer medullary 
collecting ducts. In the proximal tubule, no pH dependent changes in [Ca2+]i could 
be observed. Similarly, in the outer medullary collecting duct, no effect of pH was 
seen in wildtype cells but in cells from OGR1 deficient mice, a significant 
decrease was observed indicating that OGR1 may be involved in regulating 
intracellular calcium concentrations. 
 
Mohebbi et al.,   OGR1 modulates proton extrusion 
 26
In summary, OGR1 has an impact on acid regulation of two major proton 
extruding transporters, NHE3 and H+-ATPase, in cultured renal cells. The acid-
activated signaling pathway of OGR1 involves PKC activity in cells, and a cluster 
of histidine residues are integral to OGR1 activation. In addition, OGR1 alters the 
pH-sensitive response of NHE and H+-ATPase activity in proximal tubules and 
OMCDs of mice. To our knowledge, this is the first study describing the impact of 
OGR1 on major renal acid-base transport proteins..  
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FIGURE LEGENDS 
 
Table 1. Summary of intracellular pH (pHi) measurements in cells (HEK293, 
HEK-OGR1 transfected and the HEK-OGR1-H5PHe mutant) and in proximal 
tubule and OMCD fragments from wildtype and OGR1 deficient mice. Data 
are presented as statistical mean ± SEM. If not stated otherwise substances 
were used at the following concentrations: ZnCl2 10 µM, CuCl210 µM; psychosine 
10 µM; Chelerythrine 1 µM; PD098059 20 µM. n.d., not determined. † 
significantly different between HEK and HEK-OGR1 or Ogr1+/+ and Ogr1-/- mouse 
samples for the same treatment., ‡ significantly different between HEK-OGR1 
and HEK-OGR1-H5Phe for the same treatment, # significantly different between 
HEK and HEK-OGR1-H5Phe for the same treatment, § significantly different 
between OGR1 pH 7.1 and OGR1 pH 7.1 plus different treatments, & 
significantly different between Ogr1+/+ or Ogr1-/- pH 8 and Ogr1+/+ or Ogr1-/- pH 
7.1, ¶ significantly different between Ogr1+/+ and Ogr1-/- at pH 8 or pH 7.1.  * p 
<0.05, ** p <0.01, *** p <0.0001.  
 
Figure 1. pH-dependent stimulation of the Na+/H+ exchanger activity in 
OGR1 expressing cells.  
(A) Expression of myc-tagged human OGR1 was detected and confirmed in 
transfected cells but not in untransfected cells as two major bands around 65 and 
85 kDa, respectively. (B) Original pHi tracing of single representative HEK293 
and HEK-OGR1 expressing cells. Removal of NH4Cl from the bath causes a 
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rapid intracellular acidification, addition of sodium to the bath realkalinizes cells 
due to sodium/proton exchanger activity as described previously (61). The initial 
rate of alkalinization was faster in HEK293B cells expressing OGR1. (C) 
Summary of NHE activities at pH 8 and pH 7.1 in HEK293, HEK293 cells 
transfected with OGR1 or the H5PHE OGR1 mutant. HEK293 cells untransfected 
(HEK), HEK293 cells stably transfected with human OGR1 (OGR1) or the OGR1 
mutant where 5 histidine residues were mutated to phenylalanine (OGR1-H5Phe) 
were preincubated for 10 min in HEPES buffer at pH 8 or 7.1 before starting pHi 
measurements. Each bar represents measurements from at least 3 different 
batches of cells, *** p <0.0001. (D) IP3 formation was measured in stably 
transfected HEK293 cells expressing the OGR1 mutant H5Phe in the absence 
(0) or presence of lithium (Li). OGR1-H5Phe expressing cells have a markedly 
reduced IP3 formation at pH 6.8 where the wild type receptor is fully active (15).  
 
Figure 2. OGR1 stimulates H+-ATPase activity. (A) Original pHi tracing of 
representative HEK293 and OGR1 expressing cells after addition of Na+ free 
HEPES buffer. The slow intracellular alkalinization in the absence of sodium is 
due to H+-ATPase activity. (B) The rate of Na+-independent pHi recovery was 
reduced at pH 8 and increased at pH 7.1 in OGR1 transfected cells. In contrast, 
OGR1-H5Phe cells demonstrated an increase at pH 8 and decreased activity at 
pH 7.1. Each bar summarizes data from at least 3 different batches of cells. * p 
<0.05, ** p <0.01, *** p <0.0001. 
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Figure 3. ZnCl2 and CuCl2 reduce the OGR1 dependent stimulation of NHE 
and H+-ATPase activity. ZnCl2 (100 μM), CuCl2 (10 μM), and psychosine (10 
μM) were applied to all solutions. (A) ZnCl2 and CuCl2 reduced significantly the 
OGR1 dependent stimulation of NHE activity whereas psychosine had without 
effect. (B) H+-ATPase activity was significantly reduced by psychosine only but 
not by ZnCl2 and CuCl2. However, psychosine and CuCl2 affected also basal H+-
ATPase activity. Each bar summarizes data from at least 3 different batches of 
cells. * p <0.05, ** p <0.01, *** p <0.0001. 
 
Figure 4. pH-dependent stimulation of intracellular calcium transients in 
HEK293 and OGR1 expressing cells. (A) HEK293 or OGR1 transfected cells 
were preincubated 10 min in HEPES buffer at pH 8 before starting calcium 
measurements. Changing pH to 7.1 induced a significant increase in the 
intracellular calcium concentration in OGR1 transfected cells compared to HEK 
cells (shown as FURA-2 340/380 nm fluorescence ratio from a single OGR1 
transfected cell compared to a HEK cell). ATP (1 mM) was used as a positive 
control. (B) Summary of data from all experiments. Each bar summarizes data 
from at least 3 different independent experimentesfrom at least 3 different 
batches of cells. ** p <0.001, *** p <0.0001 
 
Figure 5. OGR1-dependent stimulation of Na+/H+ exchanger activity 
requires PKC but not ERK1/2. The PKC inhibitor chelerythrine (1 μM) and the 
ERK1/2 inhibitor PD098059 (20 μM) were added to all solutions. Addition of 
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chelerythrine resulted in a significant decrease of the Na+-dependent pHi 
recovery in OGR1 transfected cells but not in untransfected HEK293 cells at pH 
7.1. Inhibition of the ERK1/2 pathway markedly reduced NHE activity in OGR1 
transfected cells. However, the baseline NHE activity was also reduced by 
PD098059 and could be partly stimulated by OGR1. Each bar represents data 
from at least 3 different batches of cells. *** p <0.0001.  
 
Figure 6. OGR1 alters NHE3 surface expression. Cells stably transfected with 
OGR1 or the inactive H5Phe OGR1 mutant were incubated for 20 min in HEPES 
buffer at pH 8 or pH 7.1. Upon biotinylation and streptavidine precipitation, 
samples were subjected to SDS PAGE and incubated with an anti-NHE3 
antibody. (A) The presence of OGR1 increased NHE3 surface expression at pH8 
and activation of OGR1 at pH 7.1 reduced NHE3 surface expression. 
Representative blot from four qualitatively identical experiments. β-actin was 
probed to exclude biotinylation of cytosolic proteins. (B) Summary of four 
independent experiments based on densitometry of membranes and 
normalization of bands to OGR1 expressing cells at pH 8. (C) Ratio between 
NHE3 abundance in total lysates and NHE3 abundance in biotinylated proteins. * 
p < 0.05, **p < 0.01. 
 
 
Figure 7. pH dependent changes of NHE and H+-ATPase activity in proximal 
tubules of OGR1 deficient mice. (A) In freshly isolated mouse proximal tubules 
Mohebbi et al.,   OGR1 modulates proton extrusion 
 31
Na+/H+ exchanger activity was measured as the rate of Na+-dependent pHi-
recovery (in the nominal absence of bicarbonate) after preincubation of tubules at 
pH 8 or 7.1 for 10 min. NHE activity was stimulated in proximal tubules from 
Ogr1-/- but not from wild type mice. (B) pH-dependent downregulation of H+-
ATPase activity (Na+-independent pHi-recovery rate) in proximal tubules from 
wild type and OGR1 deficient mice. In parallel to NHE activity, H+-ATPase activity 
was lower in Ogr1-/- mice at pH 8 compared to control and increased at pH 7.1. 
Wild type mice showed a significant decrease of the Na+-independent pHi 
recovery at pH 7.1 compared to pH 8. Each bar contains measurements from at 
least 3 different tubules from 3 different mice. ** p <0.001, *** p <0.0001  
 
Figure 8. H+-ATPase activity is stimulated in intercalated cells from the 
outer medullary collecting duct of OGR1 deficient mice at pH 7.1. Freshly 
isolated outer medullary collecting ducts (OMCD) of wild type and Ogr1-/- mice 
were preincubated for 10 min in HEPES buffer at pH 8 or pH 7.1 before the 
experiment. At pH 8 the Na+-independent pHi recovery was decreased in Ogr1-/- 
mice compared to wild type animals. In contrast, at pH 7.1 H+-ATPase activity is 
significantly increased in Ogr1-/- mice compared to wild type mice. Each bar 
contains measurements from at least 3 different tubules from 3 different mice. *** 
p <0.0001    
 
Figure 9. Intracellular calcium measurements in proximal tubules and 
medullary collecting ducts of wild type and OGR1 deficient mice. Freshly 
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hand-dissected proximal tubules or outer medullary collecting ducts (OMCDs) 
from wild type and Ogr1-/-  mice were preincubated for 20 min in HEPES buffer at 
pH 8. (A) Original Ca2+ tracing of a single proximal tubule cell from a wild type 
mouse. Changing extracellular pH from 8 to 6.8 did not affect intracellular 
calcium concentration. Addition of ATP (1 mM) resulted in an increase in the 
intracellular calcium signal. (B) Original fluorescence tracing from a single 
proximal tubule from an Ogr1-/- mice. Switching extracellular pH from 8 to 6.8 
resulted in a slight decrease of the intracellular calcium signal. ATP used as 
control resulted in a distinct  rise of the intracellular signal. (C) Summary of Ca2+ 
measurements in proximal tubule cells from wild type and Ogr1-/- mice. Activation 
of OGR1 by changing the extracellular pH to 6.8 resulted in a slight (significant or 
not ?) increase of intracellular calcium in proximal tubules of wild type mice 
compared to Ogr1-/- mice. (D) Summary of Ca2+ measurement in OMCDs from 
wild type and Ogr1-/- mice. Intracellular calcium signals after changing 
extracellular pH to 6.8 was decreased in OMCDs from wild type mice compared 
to OGR1 deficient mice. Each bar represents measurements from at least XX 
tubules from 3 different mice per group.  * p <0.05, ** p <0.01 
 
 
 
 
Table 1.  
 
 
 Na+ independent  
pHi recovery 
No. of cells (tubule 
fragments) 
Na+ dependent pHi 
recovery 
No. of cells (tubule 
fragments) 
Cell experiments 
HEK, pH 8 0.004 ± 0.001 100 (6) 0.05 ± 0.002 47 (3) 
HEK-OGR1, pH 8 -0.007 ± 0.001***† 119 (8) 0.11 ± 0.007***† 115 (6) 
HEK-OGR H5Phe, pH 8 0.009 ± 0.001***‡***# 74 (4) 0.06 ± 0.006***‡ 74 (4) 
HEK, pH 7.1 0.008 ± 0.001 165 (10) 0.09 ± 0.003 165 (10) 
HEK-OGR1, pH 7.1 0.013 ± 0.001***† 270 (16) 0.20 ± 0.010***† 262 (16) 
HEK-OGR1 H5Phe, pH 7.1 0.006 ± 0.001***‡ 90 (5) 0.03 ± 0.001***‡# 90 (5) 
HEK, pH 7.1 + ZnCl2 0.008 ± 0.001 78 (4) 0.07 ± 0.002 78 (4) 
HEK-OGR1, pH 7.1 + ZnCl2 0.017 ± 0.006 106 (7) 0.14 ± 0.014**§ 80 (7) 
HEK, pH 7.1 + CuCl2 0.013 ± 0.002 75 (4) 0.06 ± 0.003 75 (4) 
HEK-OGR1, pH 7.1 + CuCl2 0.014 ± 0.001 70 (4) 0.12 ± 0.008***§ 74 (4) 
HEK, pH 7.1 + psychosine 0.005 ± 0.001 95 (5) 0.08 ± 0.002 95 (5) 
HEK-OGR1, pH 7.1 + psychosine 0.005 ± 0.001***§ 59 (3) 0.17 ± 0.009 59 (3) 
HEK, pH 7.1 + chelerythrine -0.007 ± 0.001 75 (4) 0.08 ± 0.005 75 (4) 
HEK-OGR1, pH 7.1 + chelerythrine -0.001 ± 0.0003 103 (6) 0.04 ± 0.002***†***§ 102 (6) 
HEK, pH 7.1 + PD098059 0.003 ± 0.001 76 (5) 0.03 ± 0.006 79 (5) 
HEK-OGR1, pH 7.1 + PD098059 0.002 ± 0.0004 49 (3) 0.11 ± 0.007***‡***§ 49 (3) 
Mouse experiments 
Ogr1+/+ proximal tubule, pH 8 0.09 ± 0.002 101 (7) 0.26 ± 0.02 101 (7) 
Ogr1-/- proximal tubule, pH 8 0.07 ± 0.003***¶ 80 (6) 0.22 ± 0.02 81 (6) 
Ogr1+/+ proximal tubule, pH 7.1 0.04 ± 0.0002***& 73 (6) 0.31 ± 0.02  73 (6) 
Ogr1-/- proximal tubule, pH 7.1 0.05 ± 0.003***&**¶ 90 (8) 0.36 ± 0.02***& 90 (8) 
Ogr1+/+ OMCD, pH 8 0.12 ± 020 34 (6) n.d. n.d. 
Ogr1-/- OMCD, pH 8 0.05 ± 0.003***¶ 73 (11) n.d. n.d. 
Ogr1+/+ OMCD, pH 7.1 0.06 ± 0.008**& 47 (10) n.d. n.d. 
Ogr1-/- OMCD, pH 7.1 0.10 ± 0.006**¶***& 30 (9) n.d. n.d. 
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 Renal Acid-Base Transport:
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Their functional importance has been demonstrated by 
the identiﬁ cation of mutations in some of these proteins 
in patients with different forms of renal tubular acidosis 
(see below) and in mouse models deﬁ cient for the respec-
tive genes. The kidney employs three major processes in 
the maintenance of acid-base homeostasis: (i) the reab-
sorption of ﬁ ltered bicarbonate mainly in the proximal 
tubule and to a lesser extent in the thick ascending limb; 
(ii) the excretion of acid/protons in the collecting duct, 
and (iii) the synthesis of ammonia and the use of ammo-
nia, phosphate and citrate as so-called titratable acids to 
bind protons and thereby maximizing the kidneys ability 
to excrete protons. 
 Bicarbonate Reabsorption and Handling of 
Titratable Acids in the Proximal Tubule 
 The proximal tubule reabsorbs the bulk of ﬁ ltered bi-
carbonate, approximately 70–80% of the ﬁ ltered load. 
This process requires a luminal carbonic anhydrase (CA 
type IV) facilitating the formation of CO 2  and H 2 O from 
ﬁ ltered HCO 3 
–  and excreted H + . CO 2  diffuses into the cell 
and is rapidly rehydrated and HCO 3 
–  and H +  formed cat-
alyzed by a cytosolic CA (type II). HCO 3 
–  is extruded into 
blood via the basolateral electrogenic Na + /HCO 3 
–  cotrans-
porter NBCe1, whereas protons are secreted into urine 
via apical Na + /H +  exchangers (isoforms NHE3 and pos-
sibly NHE8) and vacuolar type H + -ATPase  [1] . Similar 
processes underlie reabsorption of bicarbonate in the 
 Key Words 
 Acid-base transport, renal   Homeostasis   Renal 
tubular acidosis
 Abstract 
 Systemic acid-base homeostasis is the product of com-
plex interactions between metabolism, regulated exhala-
tion of CO 2  by the lungs and acid or base excretion by the 
kidneys. The importance of renal acid-base transport has 
been highlighted by mutations identifi ed in several pro-
teins involved in this task in patients with inborn forms of 
renal tubular acidosis. The underlying mechanisms of 
disease have been further studied in genetically altered 
mouse models and cell culture. An interesting fi eld of re-
search has focused on the question how changes in me-
tabolism or acid-base homeostasis are sensed and result 
in altered excretion of acid or bases by the kidney. Sev-
eral hormonal pathways including aldosterone and endo-
thelin were implicated, a novel subfamily of proton-sens-
ing receptors has been identifi ed, and signaling molecules 
described that are activated by changes in pH. 
 Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 The ability of the kidney to excrete acids or bases de-
pends critically on the expression of various specialized 
and spatially arranged transport proteins and enzymes. 
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thick ascending limb accounting for about 20% of the ﬁ l-
tered bicarbonate  [2] . 
 The proximal tubule also plays an important role in 
the synthesis of the major titratable acid, NH 3 /NH 4 
+ , syn-
thesized from glutamine yielding two HCO 3 
–  and NH 3  
molecules as well as glucose. The synthesis of NH 3 /H 4 
+  is 
highly regulated and stimulated during metabolic acido-
sis and requires the extraction of glutamine from blood 
across the basolateral membrane  [3] . The amino acid 
transporter responsible for glutamine uptake into proxi-
mal tubular cells has been identiﬁ ed as SNAT3 (SLC38A3) 
and is upregulated both on mRNA and protein levels dur-
ing metabolic acidosis  [4, 5 ; Moret, Dave, Schulz, Verrey, 
Wagner, own unpublished observations]. Interestingly, 
SNAT3 is localized only in the late proximal tubule under 
normal conditions but its expression spreads to earlier 
proximal segments during acidosis. The second impor-
tant titratable acid, phosphate, is also regulated by the 
proximal tubule as most phosphate is reabsorbed at this 
site via the apical Na + /phosphate cotransporter NaPi-IIa. 
During acidosis renal phosphate excretion is increased. 
In rats, but not in mice, acidosis downregulates NaPi-IIa 
activity and expression in the kidney  [6, 7] . Interestingly, 
phosphate uptake from diet and expression of the intes-
tinal NaPi-IIb phosphate transporter are stimulated dur-
ing acidosis in mice  [7] . This could provide phosphate for 
renal excretion and help to protect bone from massive 
phosphate loss during acidosis. 
 Secretion of Protons or Bicarbonate from 
Intercalated Cells 
 The ﬁ nal tuning of urinary acidiﬁ cation occurs in the 
late distal tubule, the connecting segment, the cortical and 
medullary collecting duct mainly through the action of 
intercalated cells  [8] . At least two types of intercalated 
cells have been described based on morphological and 
functional criteria: acid-secretory type-A intercalated 
cells (A-IC) and bicarbonate-excreting type-B intercalat-
ed cells (B-IC). A-IC express vacuolar H + -ATPases on the 
luminal membrane excreting protons into urine which 
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 Fig. 1. Transport mechanisms involved in 
acid-base transport and ammoniagenesis in 
the proximal tubule. For clarity processes 
are depicted in two different cells but occur 
in all cells of the proximal tubule. Bicarbon-
ate absorption is mediated by apical Na + /
H +  exchangers (NHE) and vacuolar H + -
ATPases in concert with extracellular and 
cytosolic carbonic anhydrases (CAII and 
CAIV). Bicarbonate is released into blood 
via the basolateral electrogenic Na + /HCO 3 
–  
cotransporter (NBCe1). Ammoniagenesis 
takes place in the proximal tubule during 
normal conditions mainly in the S3 seg-
ment. It involves uptake of glutamine (Gln) 
from urine and blood via several apical and 
basolateral Na + -dependent amino acid 
transporters. Gln is converted to glutamate 
(Glu) by the action of the mitochondrial 
phosphate-dependent glutaminase (PDG) 
and further metabolized to   -ketoglutarate 
(  -KG) via the glutamine dehydrogenase 
(GDH). Eventually, glucose and CO 2  are 
produced by the cytosolic phosphoenolpyr-
uvate carboxykinase (PEPCK). During this 
process HCO 3 
–  and NH 3 /NH 4 
+  are formed. 
NH 3  diffuses into the lumen whereas NH 4 
+  
is transported via NHE into urine. During 
acidosis ammoniagenesis is increased and 
the expression of the basolateral glutamine 
transporter SNAT3 stimulated. 
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stem from the hydration of CO 2  and subsequent forma-
tion of protons and bicarbonate by the cytosolic CAII 
isoform. The bicarbonate is released into blood via the 
basolaterally expressed chloride-bicarbonate exchanger 
AE1 (band 3). In contrast, B-IC express an apical chlo-
ride-bicarbonate exchanger excreting bicarbonate into 
urine. Protons are secreted into blood by basolateral H + -
ATPases. The apical Cl – /HCO 3 
–  exchanger is most likely 
represented by pendrin. The function and regulation of 
pendrin has recently gained much attention because of its 
regulated expression in response to dietary chloride in-
take and the fact that pendrin-deﬁ cient mice are more 
sensitive to dietary salt restriction and do not increase 
blood pressure in response to aldosterone analogues  [9–
11] . These ﬁ ndings suggest a role of pendrin in chloride 
conservation by the kidneys and blood pressure regula-
tion. Pendrin may also be important for protecting the 
body from the development of metabolic alkalosis as ev-
ident from pendrin-deﬁ cient mice and a mouse model 
lacking the B1 subunit of the basolateral proton pump of 
B-IC and reduced pendrin abundance. Both mouse mod-
els are more prone to the development of metabolic alka-
losis  [10, 12] . An additional Cl – /HCO 3 
–  exchanger, AE4, 
has been identiﬁ ed in non-type A-IC. The subcellular lo-
calization of AE4 appears to be species speciﬁ c. In the 
rabbit AE4 is localized in the apical membrane whereas 
in the rat and mouse AE4 is found on the basolateral side 
 [13, 14] . 
 Regulation of Renal Acid-Base Transport 
 The renal excretion of acid and base equivalents by the 
kidney is inﬂ uenced by many factors such as diet, elec-
trolyte status, physical activity, and drugs. Several hor-
mones have been identiﬁ ed that could link metabolism 
and renal acid-base transport such as aldosterone, angio-
tensin II, endothelin, insulin-like growth factor 1, anti-
diuretic hormone, and thyroid hormones. 
 The vasoconstrictor endothelin has appeared over the 
last years as an important factor regulating renal acid
secretion. Endothelin production in arteries and proxi-
mal tubules is increased during metabolic acidosis  [15, 
16] . The stimulatory effect of endothelin on Na + /H +  
exchanger(s) and vacuolar H + -ATPases in the proximal 
and distal tubules is mostly mediated by ET-B receptors 
 [17, 18] . Furthermore, the increased urinary acid excre-
tion in animals on a diet rich in protein depends on en-
dothelin. 
 The importance of aldosterone for ﬁ nal urinary acidi-
ﬁ cation has been known for decades and insufﬁ ciency of 
aldosterone synthesis, excretion or signaling underlies the 
hyperkalemic type of distal renal tubular acidosis (dRTA) 
 [19] . Two ﬁ ndings have shed new light on aldosterone. 
First, a high-protein diet providing a dietary acid load 
stimulates renal acid excretion via endothelin, increasing 
aldosterone secretion  [20] . Blocking either the endothelin 
or aldosterone pathway results in an inappropriate uri-
nary acidiﬁ cation. Second, aldosterone stimulates vacu-
olar H + -ATPase activity also in a way distinct from the 
classic route (i.e. via the mineralocorticoid receptor and 
subsequent regulation of transcription). In freshly isolat-
ed mouse and human outer medullary collecting ducts, 
aldosterone directly stimulates insertion of proton pumps 
into the membrane in a rapid non-genomic manner. This 
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 Fig. 2. Transport schemes for type A and non-type A intercalated 
cells. Type A intercalated express an apical H + -ATPase secreting 
protons into urine and a basolateral Cl – /HCO 3 
–  exchanger, AE1, 
releasing bicarbonate into blood. Protons and bicarbonate are pro-
vided by a cytosolic carbonic anhydrase (CAII). Basolateral Cl –  
channels and a K + /Cl –  symporter (KCC4) may be involved in re-
cycling chloride ions for AE1 activity. Non-type A intercalated cells 
express a vacuolar H + -ATPase on the basolateral side (type B IC) 
or on both sides (non-A/non-B IC). Both subtypes, however, express 
the Cl – /HCO 3 
–  exchanger pendrin on their luminal side. 
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effect is mediated by a complex signaling cascade via 
small G proteins, phospholipase C, protein kinase C, 
ERK1/2 kinases as well as elements of the protein kinase 
A-dependent pathway  [21] . 
 Besides these hormonal pathways, a novel concept of 
local pH sensing and regulation of acid-base transporters 
has emerged. Incubation of the renal OK cell line with an 
acid medium increases Na + /H + -exchange activity via a 
src-like tyrosine kinase and pyk2  [22, 23] . Pyk2 is acti-
vated in vitro in a slightly acidic buffer and phosphory-
lates and activates src  [22] . However, it is unclear if pyk2 
is the pH sensor itself. A novel subfamily of G protein-
coupled receptors may contain such pH sensors. Three 
members of this subfamily, OGR1, GPR4 and TDAG8, 
are activated by extracellular protons with half-maximal 
activation occurring in the pH range of 7.4–7.0. Activa-
tion of OGR1 increases intracellular calcium and IP 3  lev-
els, known stimuli for Na + /H + -exchange activity  [24] . 
GPR4 and TDAG8 couple to cAMP- and PKA-depen-
dent pathways. Both OGR1 and GPR4 are expressed in 
the kidney and at least in the case of OGR1 its localiza-
tion in the basolateral membrane of almost all nephron 
segments appears ideally suited for an extracellular pH 
sensor [Mohebbi, Benabbas and Wagner, unpublished 
observations]. In addition to direct proton sensing, also 
sensors for CO 2  and HCO 3 
–  may exist. The recently dis-
covered soluble adenylate cyclase is expressed in several 
HCO 3 
– -transporting epithelia including the kidney and is 
activated in the physiological HCO 3 
–  concentration range 
 [25] . In addition, evidence from isolated perfused proxi-
mal tubules suggest that basolateral HCO 3 
–  or CO 2  sensors 
exist and regulate ﬂ uid and bicarbonate ﬂ uxes  [26] . 
 Inherited Disorders of Renal Acid-Base 
Transport 
 Genes responsible for several rare inherited disorders 
of renal acid-base transport have been identiﬁ ed  [27] . 
Mutations in two genes, the Na + /HCO 3 
– -cotransporter 
NBCe1 (SLC4A4) and CAII, cause defective bicarbonate 
absorption in the proximal tubule. The gene encoding the 
electrogenic Na + /HCO 3 
–  cotransporter (SLC4A4) under-
lies proximal renal tubular acidosis associated with blind-
ness. Patients suffer from excessive urinary bicarbonate 
wasting and severe metabolic acidosis. The transporter is 
not only expressed on the basolateral side of the proximal 
tubule but also in the eye. Functional analysis of a num-
ber of mutants revealed that some mutants are retained 
in the endoplasmic reticulum, others are inserted into the 
membrane but show reduced function, and at least in the 
case of one mutant aberrant trafﬁ cking to the apical mem-
brane in polarized cells was found  [28, 29] . Mutations in 
the CAII gene cause a mixed type of proximal and dRTA 
due to its expression in both segments. Patients also suf-
fer from cerebral calciﬁ cation and osteopetrosis  [30] . 
 Inherited forms of dRTA can be caused by mutations 
either in two different subunits of the vacuolar H + -ATPase 
(ATP6V1B1 (B1 subunit), ATP6V0A4 (a4 subunit)) or 
the Cl – /HCO 3 
– -exchanger AE1 (Band 3, SLC4A1)  [1, 27] . 
All forms are clinically characterized by hyperchloremic 
metabolic acidosis and hypokalemia and are often associ-
ated with retarded growth in infants with rickets. In 
adults, osteomalacia develops with high urinary calcium 
and nephrocalcinosis and nephrolithiasis. dRTA due to 
mutations in proton pump subunits is transmitted in an 
autosomal recessive way, whereas dRTA caused by AE1 
mutations mostly follows an autosomal dominant inher-
itance. In rare cases, AE1 mutations can also cause auto-
somal recessive dRTA which has been detected in sev-
eral patients in Southeast Asia  [27] . 
 Patients with mutations in the B1 proton pump sub-
unit often also suffer from sensorineural deafness due to 
its expression in the inner ear. A mouse model deﬁ cient 
for the  Atp6v1b1 gene has been generated and shown to 
develop an incomplete dRTA  [31] . Due to the expression 
of the B1 subunit also in bicarbonate-secretory type B 
intercalated cells, mice lacking the B1 subunit are suscep-
tible to more severe metabolic alkalosis  [12] . Thus proton 
pumps containing the B1 subunit are involved in both 
acid secretion as well as in bicarbonate secretion during 
metabolic acidosis or alkalosis, respectively. 
 The AE1 chloride-bicarbonate exchanger is expressed 
both in red blood cells (RBC) and in acid-secretory type 
A-IC. Due to this expression pattern, mutations in the 
AE1 gene cause spherocytosis, Southeast Asian ovalocy-
tosis and dRTA. However, with rare exceptions, only ei-
ther RBC or the kidney are affected. This may be par-
tially explained by two different observations. AE1 inter-
acts in RBC with glycophorinA and this interaction 
functionally rescues many mutations observed in dRTA 
 [32] . However, glycophorin A is not present in interca-
lated cells  [32] and its absence may thus cause a renal 
defect, whereas the mutations have less functional conse-
quences in RBC. Second, wild-type AE1 has to be sorted 
to the basolateral side of type-A intercalated cells in order 
to mediate the vectorial transport of bicarbonate into 
blood. Some dRTA mutations when expressed in polar-
ized cell lines appear at the apical membrane or are re-
tained intracellularly  [33, 34] . Missorting would obvious-
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ly not affect AE1 function in non-polarized RBC but re-
verse the physiological direction of transport in kidney. 
However, it remains to be clariﬁ ed if the mistargeting of 
mutant AE1 also occurs in vivo. dRTA caused by muta-
tions in AE1 is mostly inherited in an autosomal domi-
nant way in contrast to other genetic forms of dRTA. It 
has been suggested that the formation of functional het-
erodimers of normal and mutant AE1 may explain this 
pattern of inheritance. This interpretation is partly sup-
ported by two observations. A common mutant found in 
Southeast Asian ovalocytosis is functionally inactive and 
decreases transport activity in RBC without giving rise to 
dRTA  [35] . Secondly, a mouse model lacking AE1 both 
in RBC and the kidney. Mice lacking one allele (hetero-
zygotes) show no sign of metabolic acidosis whereas ho-
mozygotes completely lacking AE1 show a severe pheno-
type with high postnatal lethality, very low hematocrit 
and hemoglobin levels. Surviving mice suffer from dRTA, 
severe hyperchloremic metabolic acidosis, growth retar-
dation, nephrocalcinosis with high urinary calcium and 
phosphate levels and low urinary citrate. In addition, 
mice are unable to concentrate urine and are dehydrated. 
However, the vasopressin-regulated AQP2 water channel 
is found predominantly in intracellular vesicles in the in-
ner medulla pointing to a deranged regulation and pos-
sibly explaining the concentrating defect also seen in 
dRTA patients  [36] . The defective AQP2 regulation may 
at least in part be explained by the concomitant hypercal-
ciuria that may activate calcium-sensing receptors inhib-
iting AQP2 trafﬁ cking  [37] . 
 Conclusion and Outlook 
 Work over the last few years has identiﬁ ed a number 
of novel transport proteins that contribute directly or in-
directly to the kidney’s ability to excrete acid or bicarbon-
ate, respectively. Rare mutations found in patients with 
several forms of renal tubular acidosis in some of these 
transport proteins have made it possible to gain deeper 
insight into mechanisms of renal acid-base transport. 
Newly developed genetic animal models facilitate the ex-
amination of transport processes and their regulation, 
and identify compensatory mechanisms activated by loss 
of function. However, little is known at present about the 
signals by which kidney cells sense systemic or local 
changes in acid-base balance. Hormones such as endothe-
lin and the angiotensin-aldosterone system contribute to 
regulation. Novel putative proton-sensing receptors may 
also be involved in this task, however, their physiological 
role remains to be proven. The cellular events triggered 
by changes in acid-base homeostasis have only begun to 
be unraveled. Their elucidation will deepen our under-
standing of how cells in general and kidney cells in par-
ticular regulate intra- and extracellular pH homeostasis. 
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Essential role for collectrin in renal amino acid
transport
UrsulaDanilczyk1, Renu Sarao1, Christine Remy2, Chahira Benabbas2, Gerti Stange2, Andreas Richter3, SudhaArya4,
J. Andrew Pospisilik1, Dustin Singer2, Simone M. R. Camargo2, Victoria Makrides2, Tamara Ramadan2,
Francois Verrey2, Carsten A. Wagner2 & Josef M. Penninger1
Angiotensin -converting enzyme 2 (ACE2) is a regulator of the renin
angiotensin system involved in acute lung failure, cardiovascular
functions and severe acute respiratory syndrome (SARS) infections
in mammals1–3. A gene encoding a homologue to ACE2, termed
collectrin (Tmem27), has been identified in immediate proximity
to the ace2 locus4. The in vivo function of collectrin was unclear.
Here we report that targeted disruption of collectrin in mice results
in a severe defect in renal amino acid uptake owing to downregula-
tion of apical amino acid transporters in the kidney. Collectrin
associates with multiple apical transporters and defines a novel
group of renal amino acid transporters. Expression of collectrin in
Xenopus oocytes and Madin–Darby canine kidney (MDCK) cells
enhances amino acid transport by the transporter B0AT1. These
data identify collectrin as a key regulator of renal amino aciduptake.
ACE2 is a chimaeric protein that has emerged from the duplication
of two genes: homology with ACE at the catalytic domain and homo-
logy with collectrin in the membrane proximal domain (Fig. 1a). In
the mouse, collectrin is expressed in the kidneys4 and pancreas5,6 and
to a lesser extent in the intestine (duodenum, jejunum and ileum),
liver, heart and stomach (Supplementary Fig. 1). To assess the in vivo
function of collectrin, we generated collectrin knockout mice
(Fig. 1b). Mice were crossed with the transgenic Cre deleter strain
to ubiquitously delete collectrin7 (Supplementary Fig. 2a). The null
mutation of collectrin was verified by the absence of collectrin mes-
senger RNA transcripts and protein (Supplementary Fig. 2b, c).
ACE2 expression in the kidneys was not altered in collectrin mutant
mice (Supplementary Fig. 2c). Collectrin null mice were born at the
expected mendelian frequency, indistinguishable from their hetero-
zygous and wild-type littermates. Collectrin mutant males (collec-
trin2/y) and females (collectrin2/2) were fertile and we failed to
observe any overt morphological alterations in all organs analysed,
including kidney, for up to six months of age (Fig. 1c).
Collectrin was originally reported to be expressed in collecting
ducts4 and b-islet cells of the pancreas5,6. We therefore assessed
whether collectrin is involved in renal salt and/or glucose balance.
Na1 excretion in urine was comparable in collectrin1/y and collec-
trin2/ymice. Loss of collectrin also did not affect the levels of calcium,
potassium, phosphate, chloride, urea, uric acid or creatinine in urine
and blood (Supplementary Table 1). collectrin mutant mice had the
same glucose concentration as their wild-type littermates in serum
and urine. Surprisingly, storage of the urine samples collected from
mutant mice at 4 uC resulted in the formation of large white preci-
pitates (Fig. 1d). Morphological analysis revealed large needle-like
crystals in the urine of the collectrin null mice whereas such crystals
were never observed in wild-type mice (Fig. 1e). Biochemically, these
crystals were not composed of common urinary crystal components
such as ammonium urate, sodium urate, calcium oxalate dihydrate
or calcium phosphate. High performance liquid chromatography
(HPLC) analyses showed that these crystals contained,10%phenyl-
alanine (Phe) and 90% tyrosine (Tyr) (see Fig. 1f). When animals
were fed a tyrosine-free and phenylalanine-free diet or when the
animals were fasting, no crystals were formed in the urine of collectrin
null mice (Fig. 1d), indicating that the observed changes are not
caused by tyrosinaemia8,9. Thus, loss of collectrin expression results
in the formation of tyrosine/phenylalanine crystals in the urine.
To determine whether collectrin deficiency caused a more general
defect in amino acid handling in the kidneys, we assessed urinary
amino acid contents. Whereas in wild-type mice almost all amino
acids are reabsorbed from the urine, deletion of collectrin resulted in
severe leakage of all amino acids (Fig. 1g). Concentrations of the
amino acids were also lower in the serum of mutant mice, although
amino acids were still present (Supplementary Fig. 3). Urinary out-
put was higher in collectrin2/ymice (3.316 0.25ml urine per 24 h) as
compared to collectrin1/y littermates (1.656 0.28ml urine per 24 h)
whichmay be owing to the higher concentration of osmotically active
solutes in urine from collectrin-deficient mice. Water restriction for
24 h demonstrated that collectrin-deficient mice were not able to
concentrate urine to the same degree, confirming that the higher
urinary output is due to a primarily renal defect (Supplementary
Fig. 4). Thus, collectrin is critical for normal amino acid reabsorption
in the kidney.
Amino acid reabsorption occurs in the proximal tubules of the
kidney10. Immunohistochemical staining showed that collectrin is
indeed expressed at the luminal side of brush border membranes in
proximal tubules (Fig. 2a), which is a specialized microenvironment
involved in amino acid reabsorption11. Biochemically, we confirmed
specific expression of collectrin in brush border membrane vesicles
(BBMV) isolated from the kidney of collectrin1/y, but not collectrin2/y
mice (Fig. 2b). BBMV isolates were free from contamination
(assessed by the absence of the collecting duct marker aquaporin 2;
Fig. 2b). In addition, collectrin mRNA was found to be highly
expressed in proximal tubules (Fig. 2c). Thus, collectrin is localized
in brush border membranes of proximal tubules.
Because collectrin is predicted to be a type I transmembrane pro-
tein having only one transmembrane helix4, it was unlikely that col-
lectrin itself forms an amino acid transport pore. Because collectrin
expression parallels that of the B0 cluster of the solute carrier SLC6
proteins B0AT1, XT3s1/SIT1, XT2 and XT3, a recently identified
subfamily of Na1-dependent transporters of neutral amino
acids12–17, we assessed whether loss of collectrin may affect these
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amino acid transporters. Immunoblots of BBMVs revealed that the
neutral amino acid transporter B0AT1 was markedly downregulated
in collectrin2/y mice (Fig. 2d and Supplementary Fig. 5a, b). Protein
expression of the three other members of the SLC6 family XT3s1/
SIT1, XT2 and XT3, and expression of EAAC1, the apical transporter
responsible for glutamate/aspartate reabsorption18, was also mark-
edly downregulated (Fig. 2e). By contrast, expression of b0,1AT (also
known as slc7a9) (Fig. 2e), the exchanger mediating apical uptake of
cystine, arginine, lysine and ornithine19, and expression of the baso-
lateral amino acid transporter subunits 4F2hc and LAT2 (ref. 10)
remained unchanged (Supplementary Fig. 5b). Expression of the
sodium/phosphate co-transporter Na1/Pi IIa was also not affected
in collectrin null mice (Fig. 2d). mRNA expression of all these
transporters was comparable in collectrin1/y and collectrin2/y mice
(Supplementary Fig. 6). Immunoblotting of total kidney membranes
demonstrated that the abundance of these amino acid transporters
was also decreased to a similar extent as observed in BBMVs
(Supplementary Fig. 5b).
To test whether reduced expression resulted in decreased amino
acid transport activity, we isolated BBMVs and measured Na1-
dependent amino acid uptake rates. As expected from the urinary
loss of B0AT1 substrates, the uptake rate of glutamine and phenyl-
alanine in BBMV from kidneys of collectrin null mice was decreased
compared to control littermates, whereas uptake of phosphate was
not affected (Fig. 2f). These data show that loss of collectrin is asso-
ciated with reduced expression and impaired activity of apical, Na1-
dependent amino acid transporters in the kidney.
To identify the molecular pathway by which collectrin regulates
amino acid transporters, we first examined whether collectrin can
associate with B0AT1 and/or other transporters. Immunopre-
cipitations from BBMV lysates showed direct binding between collec-
trin andB0AT1,XT2 andXT3 in collectrin1/y, but not collectrin2/ymice
(Fig. 3a). Moreover, collectrin co-localized with B0AT1 in the early
proximal S1 tubule (Fig. 3b). As a control, collectrin did not associate
with b0,1AT (Fig. 3a). The specificity of the collectrin band was con-
firmed by pre-incubation with the antigenic peptide (Supplementary
Fig. 7a, b). Renal amino acid transporters such as LAT2 or y1LAT1
form functional heterodimers with a second subunit, 4F2hc (ref. 10).
In all known instances, this heterodimerization is stabilizedbydisulph-
ide bonds20. Under reducing conditions (1DTT), collectrin appears as
a single band with gel mobility of ,44 kDa, whereas B0AT1 can be
detected as a single band that corresponds to a monomeric form of
Figure 1 | Tyrosine crystals and renal amino acid loss in collectrin2/ymice.
a, Schematic outline of homologous regions between collectrin and ACE2.
Collectrin lacks the HEMGH carboxypeptidase domain. The black boxes
indicate the transmembrane domains. Leader peptides are shown in light
blue. b, Gene targeting (flox-and-delete) strategy for the generation of
collectrinmutant alleles. Upon breeding with Cre deletermice, animals with
excision of exon 2 were selected. c, H&E-stained sections of kidney isolated
from six-month-old collectrin1/y and collectrin2/y mice. Top panels,
overview over cortex; bottom panels, normal medullary structures. d, At
4 uC, largewhite precipitates form in the urine of collectrinnull (2/y) but not
control wild-type (1/y) mice. These precipitates disappear upon fasting for
24 h. e, Formation of needle-like crystals in the urine of collectrin null mice.
f, HPLC analysis of crystals isolated from the urine of collectrin2/ymice. The
crystals co-elute with tyrosine and phenylalanine. mAU, milli-absorbance
units. g, Excretion of all amino acids tested in collectrin2/y mice. Urine was
collected from four-month-old collectrin1/y and collectrin2/y littermates and
analysed byHPLC. Values aremean6 s.e.m. of tenmice per group. P, 0.05
(Student’s t-test and analysis of variance, ANOVA).
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B0AT1 (Fig. 3c). Unlike 4F2hc and its catalytic subunits, B0AT1 and
collectrin migrate under non-reducing (no dithiothreitol, 2DTT)
conditions with the same mobility as under reducing conditions
(Fig. 3c), indicating that the association between collectrin and
B0AT1 aswell as other transporters occurs throughnon-covalent inter-
actions. Thus, collectrin co-localizes and specifically associates with a
subgroup of renal amino acid transporters.
To define the molecular mechanism of collectrin-regulated amino
acid transport, we examined the effect of collectrin on B0AT1 func-
tion using Xenopus laevis oocytes and polarized MDCK cells. Two
days of expression of B0AT1 alone in Xenopus oocytes conferred only
a low transport activity for the B0AT1 substrate L-isoleucine16
(Fig. 4a). Collectrin alone did not exhibit any transport activity.
However, co-expression of B0AT1 with collectrin resulted in a strik-
ing increase in L-isoleucine uptake (Fig. 4a). As a control, co-express-
ion of collectrin with the Na1/phosphate IIa co-transporter in
oocytes did not affect the rates and kinetics of phosphate uptake
(Fig. 4b). To assess whether collectrin changes binding of
L-isoleucine to its transporter B0AT1, we measured the apparent
affinity (Km) for L-isoleucine uptake (Fig. 4c). Co-transport of
L-isoleucine with Na1 generated a saturable, reversible inward cur-
rent with an apparent Km for L-isoleucine of 0.996 0.17mM when
B0AT1 was expressed alone, and of 0.786 0.10mMwhen B0AT1 was
co-expressed with collectrin. Thus, the collectrin-induced increase in
L-isoleucine transport is not due to a change in apparent affinity, but
due to an increase in the maximal transport rate of B0AT1, probably
as a result of increased surface expression. Indeed, expression of
collectrin allowed functional surface expression of B0AT1 and apical
uptake of L-isoleucine in polarized kidney MDCK cells (Fig. 4d).
Thus, collectrin enhances functional surface expression of the SLC6
family transporter B0AT1.
We conclude that genetic inactivation of collectrin in mice results
in a major defect in renal amino acid reabsorption. Collectrin con-
trols protein expression and function of apical amino acid trans-
porters in the brush border membranes of proximal tubules.
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Figure 2 | Defective expression of amino acid transporters in collectrin
mutant mice. a, Immunodetection of collectrin (green) in kidneys of
collectrin1/y and collectrin2/ymice. Note that collectrin localizes to proximal
tubules. b, Western blot analysis of brush border membranes from
collectrin1/y and collectrin2/ymice. Protein extracts from total lysates (50 mg
per lane) and renal brush border membranes (10 mg per lane) were analysed
using antibodies to collectrin, aquaporin (AQP2), and b-actin. c, Collectrin
mRNA expression in proximal tubules (PT) and total kidneys (T). RNA was
isolated from wild-type mice and reverse transcribed (1RT). Equal loading
was confirmed byGapdh. d, e,Western blot analysis of proteins (50mg) from
brush border membranes isolated from collectrin1/y and collectrin2/y mice.
In d and e, data from three different mice are shown for each genotype.
Molecular sizes are indicated in kDa. f, Na1-dependent uptake of the amino
acids phenylalanine (Phe) and glutamine (Gln) and uptake of phosphate
into BBMVs from collectrin1/y and collectrin2/y mice. All experiments were
done in triplicates from each kidney. Values are mean6 s.e.m. of four mice
per group. *P, 0.001 (Student’s t-test).
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Figure 3 | Collectrin associates with apical amino acid transporters
through non-covalent interactions. a, Renal brush border membrane
proteins (100mg) from collectrin1/y and collectrin2/y mice were incubated
overnight with anti-B0AT1, anti-XT2, and anti-XT3 and anti-b0,1AT
antibodies. Immunoprecipitated (IP) complexes were analysed by western
blot using an anti-collectrin antibody (arrow). b, Collectrin co-localizes with
B0AT1 in kidney proximal tubules. Kidney sections fromwild-typemice were
stained with antibodies to collectrin (green) and B0AT1 (red). Yellow
indicates co-localization. S1, initial part of the proximal tubule. G,
glomerulus. Magnifications, 3400. c, Western blot analysis of isolated renal
brush border membranes under reducing (1DTT; 100mM) and non-
reducing (2DTT) conditions from collectrin1/y and collectrin2/y mice using
antibodies directed against collectrin and B0AT1. Under reducing as well as
under non-reducing conditions collectrin and B0AT1 appear as bands of,44
and,60 kDa, respectively (arrows). Molecular sizes are indicated in kDa.
LETTERS NATURE |Vol 444 |21/28 December 2006
1090
Nature Publishing Group ©2006
Mechanistically, collectrin associates with several amino acid trans-
porters, enhances their surface expression, and thereby increases
amino acid transport function. These data identify the ACE2 homo-
logue collectrin as a regulator of renal amino acid uptake and may
provide a molecular explanation for aminoaciduria in Hartnup dis-
ease, Fanconi syndrome, or diabetes.
METHODS
collectrin knockout mice. A gene-targeting vector containing three loxP sites
flanking exon 2 and aNeo selection cassette was constructed. Chimaeric progeny
were crossed to the C57BL/6J Cre deleter line7 to generate complete null animals.
mRNA and protein analyses. Real-time polymerase chain reaction (PCR) was
performed as described12. For protein analyses, total cell lysates and BBMVs of
adult mouse kidney were prepared21 and probed with antibodies to mouse
b0,1AT, NaPi IIa, aquaporin 2, collectrin, XT2, XT3, SIT1, B0AT1, ACE2,
LAT2 and 4F2. For immunoprecipitations, brush border membrane proteins
were probed with antibodies to B0AT1, XT2, XT3 and b0,1AT.
Urine and plasma analyses. Urine was collected over 24 h in a metabolic cage.
Urinary crystals were observed under a magnification of 31,000. For HPLC
analysis19, crystals were dissolved in 0.1M HCl. Na1, K1 and Cl2 were assayed
by indirect potentiometry. Phosphate was determined using the phosphomoly-
bdate method. Calcium levels were obtained by cresolphthalein. Glucose, urea
and uric acid were measured using Reflovet (Roche).
Histology and immunohistochemistry. Paraffin sections were stained with
haematoxylin and eosin (H&E). Immunohistochemistry was performed with
an affinity purified anti-collectrin antibody. B0AT1 was detected using a rabbit
anti-mouse B0AT1 antibody.
Amino acid transporter activities. Uptake of 3H-Phe, 14C-Gln and 32PO4 was
determined in BBMVs at 60 s. The final amino acid concentration was 1mM.
Measurements were done in parallel in the presence of either Na1 or K1.
Expression studies and uptake measurements in Xenopus laevis oocytes and
kidney MDCK cells were performed as described22,23.
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Figure 4 | Collectrin enhances B0AT1 transport activity. a, Xenopus laevis
oocytes were injected with murine B0AT1, collectrin, or B0AT1 plus
collectrin RNA. L-isoleucine transport was determined two days after
injection. Each bar representsmean transport activity6 s.d. (n5 15 oocytes
analysed). b, Xenopus laevis oocytes were injected with murine Na1/Pi IIa
alone or Na1/Pi IIa plus collectrin; phosphate transport (mean6 s.d.) was
then determined at the indicated time points. n5 7 oocytes per sample.
c, The half-maximal uptake rate Km of L-isoleucine by B
0AT1 at six days of
expression in the absence or presence of collectrin.Kmwas determined using
two electrode voltage clamps at 250mV using 0–10mM of L-isoleucine in
the presence of 100mM Na1. Data was normalized to 10mM L-isoleucine
for n5 11 oocytes per group. d, MDCK cells were transduced with murine
B0AT1, collectrin, B0AT1 plus collectrin, or empty vector (pLHCX). Bars
represent themean uptake of 300mML-isoleucine in 3min6 s.d. *P, 0.001
(Student’s t-test).
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